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Torque teno virus (TTV) is a single stranded circular DNA virus and, despite its widespread 
nature in the human population, its pathogenesis is still unknown. Factors complicating TTV 
research include its huge genetic diversity, difficulties identifying an uninfected control 
population, the lack of a small animal model and lack of a good cell culture system for viral 
propagation. Recently we have identified a TTV homologue (RoTTV) in wild rodents. 
RoTTV was frequently observed in wood mice and field voles. RoTTV infections were also 
found in bank voles but not in Mus musculus populations. Analysis of complete genome 
sequencing shows that several genetic variants are found in wild rodent population with two 
distinct species containing several diverse genotypes. Furthermore, multiple variants were 
present in single individuals, consistent with infection patterns seen in humans.  
 
RoTTV transcripts in infected wild wood mice have also been detected and fully sequenced. 
Predicted protein coding regions from these transcripts have been expressed in cell culture 
and show the different expression patterns. Using cloned genomic DNA it has also been 
possible to observe the transcription from the virus in vitro and it was shown Ro TTV viral 
titer in the supernatant of culture fluid increased. In addition, Ro TTV propagation was 
observed by using the supernatant of culture fluid. Using cloned genomic DNA and the 
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CHAPTER I. INTRODUCTION 
 
In 1997, Torque teno virus (TTV) was discovered from the serum of a patient with acute 
post-transfusion hepatitis of non A-G etiology and classified as genus Anellovirus. 
Anelloviruses are widely distributed in human and animal population and has extensive 
genetic diversity. Many aspects of TTV infection are still unknown, especially pathogenesis. 
No study has found TTVs related disease and TTV is an orphan virus.  
 
 
1.1. Torque teno virus (TTV) and related Anelloviruses                                                                                          
1.2. Genetic diversity  
1.3. Epidemiology/Prevalence    
1.4. TTV structure and cording  
1.5. Replication and Pathogenesis  
1.6. Immunology of TTV infection 
1.7. Model of TTV infection 
1.8. Aims of project 
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1.1. Torque teno virus (TTV) and related Anelloviruses 
Torque teno virus (TTV) has been classified into a new viral family, Anelloviridae, and it was 
found in a non-A , B, C, D, or E post-transfusion hepatitis patient (Nishizawa et al., 1997). The 
TTV genome is encased in a capsid and consists of a single-stranded circular DNA (ssDNA) 
ranging in size from 3.5 to 3.9 kb while the virion has been estimated to be 30-32nm by electron 
microscopy (Mushahwar et al., 1999; Itoh et al., 2000). TTV is non-envelop virus (Mushahwar et 
al., 1999; Okamoto et al., 1998). PCR analysis of human serum or plasma showed that TTV is 
ubiquitous, with a ~90% DNA prevalence among healthy adults (Kakkola et al. 2002; reviewed 
in Hino and Miyata, 2007). Some time after discovery of TTV, related viruses which have similar 
genomes were discovered and named Torque teno midi virus (TTMDV, 3.2kb) and Torque teno 
mini virus (TTMV, 2.8-2.9kb). Currently, TTV infection has not been linked to specific disease 
(reviewed in Hino and Hironori, 2007). However, we cannot exclude the possibility that TTV 
may damage the host, because there are reports which reveal the positive correlation between 
active TTV replication and severity of certain diseases including AIDS (Shibayama et al. 2001,) 
pulmonary disease (Maggi et al. 2003,) haematologic disorders (Miyamoto et al. 2000,) cancer 










Chapter I                                                                                                      Introduction 
3 
 
1.1.1. TTV discovery 
Hepatitis, inflammation of the liver, affects millions of people. Most cases are caused by hepatitis 
virus infection such as hepatitis A, B, C, D, and E, and donated blood is screened for Hepatitis B 
Virus and Hepatitis C Virus. However, there are still many hepatitis cases which cannot be 
ascribed to these viruses, and many researchers have tried to find the unidentified hepatitis 
viruses. In 1997, Nishizawa et al. applied Representational Difference Analysis (RDA) method 
which subtracted the host genome using virus negative sample, and amplified a new virus 
genome from a hepatitis patient (initials T.T.) who exhibited elevation of alanine 
aminotransferase (ALT) level after transfusion (Nishizawa et al. 1997). Later, this virus was 
named Torque teno virus (latin ―torques‖, necklace; ―tenuis‖, thin) (Biagini et al. 2004.) Further 
studies showed TTV from serum is sensitive to DNase I and Mung Bean Nuclease, but TTV is 
resistant to RNaseA and restriction enzyme. Furthermore, TTV had a density of 1.26 g/cm(3) in 
sucrose, and it did not change after tween 80 treatment which would destroy the envelop. 
Moreover, when the virus genome sequence was further extended, the two extremities were 
connected in GC-rich stretch of about 100 nucleotides (nt) and it showed the genome was a 
closed circular genome. According to these studies, TTV was concluded to be a non-enveloped 
single stranded negative sense circular DNA virus (ss DNA) (Mushahwar et al., 1999; Okamoto 
et al., 1998). TA278, the prototype TTV isolate of the entire genome length was finally 
determined to be 3,853 nt with four predicted ORFs, and the unique stem loop structure in GC-
rich region and rep-motif in ORF1 which would play the important role of virus replication were 
observed (Okamoto et al.,1999b; Okamoto et al.,1999c). After the discovery, it is found that TTV 
has high genetic variability, and more than 90% healthy individual have TTVs (reviewed in Hino 
and Miyata, 2007).  
 
Its genomic organization was different from that of the other well-known single-stranded DNA 
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viruses such as those of the family circovirus (TTV was originally classified in this family). 
Accordingly, the new family ―Anelloviridae,‖ from anellus, Latin for ring was created for TTV.   
 
1.1.2. TTMV Discovery 
In 2000, Takahashi et al. discovered the new small virus which had similar genomic structure to 
TTV and chicken anemia virus (CAV). TTV specific primers were used for the virus detection 
but the amplified virus was noticeably smaller than TTV. This virus was described as TTV-like 
mini virus (TTMV). TTMV is also negative sense single-strand closed circular DNA virus. Its 
particle size is estimated to be less than 30nm, and its genomic size 2.9 kb. TTMV genomic 
structures which have four predicted ORFs is similar to TTV, and TTMV had the GC-rich region 
and coding area (section 1.4.1.). TTMV was also discovered in chimpanzee and the genome size 
is 2785 nt. TTMV also showed the high genetic diversity.       
 
1.1.3. TTMDV and Small anellovirus (SAV) Discovery 
In 2007, Torque teno midivirus (TTMDV), a third group of the genus Anellovirus, was 
discovered in human serum (Ninomiya et al. 2007a) by using DNase-sequence independent 
single primer amplification (SISPA) and rolling circle amplification (RCA) method. TTMDV 
genome sizes were 3.242-3,253 nt and it is between those of TTV and TTMV. TTMDV possessed 
a genomic structure which contains four open reading frames (ORF1-4) with TTV characteristics, 
three Rep-motifs and putative stem-loop structures in GC-rich region.   
 
Before TTMDV discovery, small anelloviruses (SAV) were detected by using SISPA method. 
Two new TTV like viruses were detected from the patient of acute viral infection and these two 
viruses named small anellovirus 1 (SAV1) and small anellovirus 2 (SAV2). SAV1 genome size is 
2,249 nt with three putative ORFs. On the other hand, SAV2 had 2,635 nt genome length with 
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five putative ORFs (Jones et al., 2005). Furthermore, by using the RCA and SISPA, SAV related 
viruses but with even shorter genomes, were discovered (2,002 nt and 2,454 nt) and showed 40% 
sequence difference from SAVs (Biagini et al., 2007). SAV genomic sequence and structure is 
closely related to portions of TTMDV, and TTMDV was shown to be a complete virus. For this 
reason, SAVs were suspected to be the deleted form of TTMDV genomes or artifacts from the 
PCR and SAV and related viruses are not included in the current classification (Biagini et al., 
2009).  
 
TTMV and TTMDV are widely distributed in human population (Ninomiya et al. 2007b). 
Currently, human TTVs are categorized in three groups; TTV in the genus Alphatorquetenovirus, 
TTMV in the genus Betatorquetenovirus, and TTMDV in the genus Gammatorquetenovirus 
(intergenus ORF1 nucleotide divergence greater than 56%). In this classification, 29 TTVs, 9 
TTMVs, and 2 TTMDVs were classified as distinct species (previously known as genotypes) 
(Reviewed by Maggi and Bendinelli. 2010).  
 
It is also suggested that these smaller viruses may be the results of the intragenomic 
rearrangements of complete TTV genomes (Leppik et al., 2007). However, TTMV was clearly 
discovered as a complete virus not a satellite genome of TTVs. By the development of the new 
amplification method, additional TTV related virus may be discovered and further define the 
phylogeny of these viruses.  
 
1.1.4. Animal TTV Discovery 
TTV infection is not limited to human hosts. TTV was observed in a wide variety of species, 
including non-human primates (Okamoto et al., 2000a; Okamoto et al., 2000b; Okamoto et al., 
2001a; Abe et al., 2000; Cong et al., 2000, Romeo et al., 2000; Thom et al., 2003; Verschoor et 
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al., 1999), pets (Okamoto et al.,2002), farm animals (McKeown et al., 2004; Leary et al., 1999; 
Brassard et al., 2008) and wild animals (wild boar) (Martinez et al., 2006). Entire sequences of 
species specific TTVs have been found in chimpanzee (Inami et al., 2000), Japanese macaque 
(Okamoto et al., 2000), cotton-top tamarin (Okamoto et al., 2000), douroucouli (Okamoto et al., 
2000), tupaia (Okamoto et al., 2001), as well as domestic animals including pig (Niel et al., 
2005), cat (Biagini et al., 2007), and dog (Okamoto et al., 2002). Although these TTV genomes 
shared the similar genomic structures, the genomic sizes were variable depending on the animal 
order. For example, TTV genome sizes of the higher animals such as a human and primates are 
3.7-3.8 kb, but the genome sizes become smaller (2.8 kb) in the lower animals such as a swine 
and canine TTV genomes. Finally rodents which are one of the lowest mammals showed the 
smallest genome of TTV (2.2 kb) in current study (section 3.4). In this theory, feline TTV is the 
only exception because feline genome size is only 2 kb and it is the smallest genome of TTV 
(Okamoto et al., 2002). These compete genomes are currently classified in 11 genera depending 
on the host species (Alphatorquetenovirus; Torque teno virus, Betatorquetenovirus; Torque teno 
mini virus, Deltatorquetenovirus; Torque teno tupaia virus, Epsilontorquetenovirus; Torque teno 
tamarin virus, Etatorquetenovirus; Torque teno felis virus, Gammatorquetenovirus; Torque teno 
midi virus, Iotatorquetenovirus and Kappatorquetenovirus; Torque teno sus virus, 
Lambdatorquetenovirus; Torque teno zalophus virus; Thetatorquetenovirus; Torque teno canis 
virus; Zetatorquetenovirus; Torque teno douroucouli virus  (http://www.ICTVdb.org/). TTMV 
was also discovered in chimpanzee and is related to human TTMV, and the cross-species 
infection occurred between human and chimpanzee. This indicates that TTV may be zoonotic in 
origin (Okamoto et al., 2000; Thom et al., 2003).    
 
Human TTVs and animal TTV share many characteristic including the genomic structure, wide-
spread infection, and high genetic diversity. In principle, animal TTV is host species specific and 
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animal TTVs mentioned above, were observed only in the specific host. Human TTV is also 
known to infect only a human and it is very difficult to have TTV infection into other animals 
like mice (Isaeva et al., 2002). Animal TTV genetic diversity was also found. Although the 
animal TTVs have not been as well studied as human TTVs, two to three genotypes were 
discovered in each animal. Chimpanzee has TTV and TTMV similar to human anellovirus family 
(Okamoto et al., 2000). The genomic structures and predicted transcriptional profiles of animal 
TTVs were similar to those of human TTV and it is thought that co-evolution of TTVs with the 
hosts may be a key factor for the development of species specificity and genetic diversity (Fig. 
1.3.2.). Co-infection with different sequences and genotypes of anellovirus in the same individual 
is common in human and animal TTV infection (Maggie and Bendinelli., 2010).  
 
1.1.4.1. TTV Infection in Nonhuman Primates  
In the chimpanzee, TTV infection is extremely common and 98% (102/104) infectious 
prevalence was observed in chimpanzee sera (Okamoto et al., 2000; Inami et al., 2000). Two 
chimpanzee's TTVs consisting of 3,690nt and 3,899nt were isolated and they showed 43% 
sequence difference from each other (Okamoto et al., 2000; Inami et al., 2000). Unlike most 
anelloviruses, Chimpanzee TTV shows interspecies infection (Mushahwar et al., 1999). Due to 
the faecal-oral transmission route, TTV is predicted to contaminate and spread easily. 
Interestingly, human TTV genotype 1a was detected in one chimpanzee in Africa and the cross-
species infection was also confirmed by Mushahwar et al., (1999) and Tawara et al., (2000). 
These chimpanzees had previously been used for the transmission research of human hepatitis 
virus and the tested 11/53 chimpanzees had an anti-human TTV genotype 1a antibody (Tusda et 
al., 1999). Because of the discovery of chimpanzee TTMV, it is predicted that chimpanzee would 
have TTMDV and the dual or triple infection could occur similar to human TTV infection 
(Okamoto et al., 2000; Ninomiya et al., 2008). Thus, human and chimpanzee are considered to 
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share the same or similar TTVs, and chimpanzee infectious experiment has been performed by 
using the sera from a hepatitis patients and hepatic disease developed in the chimpanzee liver 
(Tawara et al. 2000) (section 1.5.2.1.). In conclusion, chimpanzee TTV infection may give us the 
hints of understanding the origin, nature, and transmission route of human anelloviruses.  
 
1.1.4.2. TTV infection in farm animal  
TTV infection in the farm animal was reported by Leary et al., (1999). In the report, TTV 
infection in farm animals was observed including 19% of chicken, 20% of pigs, 25% of cows and 
30% of sheep by using PCR. Porcine anellovirus is well-studied as an animal model for human 
TTV infection (section 1.7.1.). According to the result, the cross-species infection between 
human and farm animal, was also suggested and it is possible that animals are the reservoir of 
TTVs. This story is also supported by the report showing human TTVs infection in the camels in 
the United Arab Emirates (AI-Moslih et al., 2007). However, other studies have not supported the 
results (Brassard et al., 2008; Okamoto et al., 2002; Thom et al., 2003). These cross-species 
infections are one of the most important topics because this result would influence the 
epidemiology of TTV infection in human. 
 
1.2. Genetic diversity 
After the discovery of TTV, the extremely high genetic heterogeneity was shown in the early 
stages of TTV research, both at the nucleotide level and at the amino acid level with 47-70% 
divergence among TTVs isolates (Biagini et al., 1999; Luo et al., 2002). The untranslated region 
(UTR) is relatively well-conserved and contains several motifs with greater than 90% identity 
(Erker et al., 1999; Suzuki et al. 2004). Conversely, the translated regions have extensive 
genomic variations (Tanaka et al., 2000; Biagini et al. 2004) in contrast to many other viruses. 
Until now, 5 large genogroups were found in human TTV (Biagini et al., 2004). The divergence 
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is extremely high in the middle of ORF1, and in the case of genotype 1, there are three 
hypervariable regions (HVRs) (HVR1, HVR2, and HVR3). These areas contain multiple codon 
insertion or deletions and they make up approximately 70% of the divergence at the amino acid 
level (Erker et al., 1999; Hijikata et al., 1999; Nishizawa et al., 1999; Takahashi et al., 1998).   
 
TTMV is also extremely divergent and the first three isolated TTMV had 42% nucleotide 
sequence difference and 67% amino acid sequence difference from each other (Takahashi et al., 
2000). The reasons for TTMV genetic divergence are still unknown but the recombination sites 
and patterns are similar to those of TTV (Biagini et al., 2001). In addition, TTMDV is highly 
variable with divergence of up to 33% over the entire nucleotide sequence and 61% amino acid 
level of ORF1(Ninomiya et al., 2007).   
 
The reasons for TTV high genetic variability are still unknown but several hypotheses have been 
suggested. One of the reasons would be high TTV mutation rate. Recently, virus evolutionary 
dynamics of ssDNA virus is well-studied, because ssDNA evolutionary rate is approaching that 
of RNA viruses. Indeed, ssDNA viruses including TTV show the relatively high genetic diversity 
(Lopez‑Bueno et al., 2006; Isnard et al., 1998). Although ssDNA viruses (especially those with  
genomes smaller than ~13kb) show high mutation rate, ssDNA viruses were originally thought to 
have low mutation rates because ssDNA viruses depend on the host DNA polymerase for 
replication (Flint et al., 2004). Host DNA polymerase has strong proofreading capacity unlike the 
reverse transcriptase coded and used by RNA viruses (Duffy et al., 2008). However, ssDNA 
showed high substitution rate and the mutation rate is also intermediate between RNA and DNA 
virus according to the canine parvovirus (CPV-2) (Shackelton et al., 2005), human parvovirus 
B19(Shackelton et al., 2006), anellovirus SEN-V(Umemura et al., 2002), and plant geminivirus 
(Duffy et al., 2008) research. It is also suggested that this high mutation rate is related to the 
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single stranded character of the genome and/or the coding capacity for the proteins involved in 
replication (Shackelton et al., 2006). TTV would be expected to have a similar mechanism to 
make a high mutation rate.  
 
According to the studies of virus evolution, TTV has many features contributory to the high 
mutation rates. It has been suggested that several factors decide the mutation and substitution 
rates. Firstly, TTV is ssDNA virus. ssDNA viruses have higher mutation rate compared to dsDNA 
viruses (Duffy, 2008). Secondly, TTV is a small (2.0-3.8kb) virus and smaller viruses like TTV 
tend to replicate faster which increase the chance for the virus mutation (Duffy, 2008). Thirdly, 
TTV is thought to use the direct infection not to use vector (Lin et al., 2000). Therefore, TTV has 
to infect a new host by themselves and it may be required to mutate to adjust the receptor or 
avoid the host defence system of a new host. Finally viruses which use the horizontal infection 
also have to set up the robust infection as soon as possible in new host species, thus these viruses 
mutate frequently, and their replication speed is faster than the viruses which infect vertically 
(Lin et al., 2000). Viruses infecting vertically sometimes become latent in the host genome and 
these viruses passed fewer generations compared to horizonal transmission viruses and show low 
mutation chances (Duffy, 2008).  
 
The amino acid changes of TTV usually occur in the HVR of ORF1 and TTV is thought to infect 
the individuals as quasispecies. By the mutation of HVRs, TTV could avoid the host immune 
responses and establish persistent infection (Jelcic et al., 2004). In TTV evolution, it was also 
suggested that a large number of viral particles would be produced but only a small number of 
these are competent and/or co-infection of different incompetent isolates made up the competent 
virus (Khudyakov et al., 2000; Luo et al., 2002). This replication system is also observed in other 
virus species. In the hepatitis B virus infection (HBV), HBV infected cells produce different 
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forms of virus related particles and only some particles can be infectious or make further virus 
particles (Hakami et al., 2013). Furthermore, Human Immunodeficiency Virus (HIV) produces a 
large number of virions after infection but not all virions are competent (Pierson et al., 2000).         
 
Virus recombination is considered as a common mechanism to create new variants of viruses and, 
in the case of TTV, it is also suggested to occur frequently (Manni et al., 2002; Worobey et al., 
2000). Taq polymerase has been shown to produce the recombinant molecules similar to the 
products of rolling circle DNA amplification of DNA virus. Actually, many incomplete virus 
genomes (shorter genome or nucleotide changes) were cloned from PCR amplicons and also 
TTV recombination might be a PCR artifact (Jelcic et al., 2004; Zaphiropoulos, P. G., 1998), but 
this idea has been challenged (Worobey et al., 2000). Recently, Leppik et al. found several 
fragments of transcripts of TTV in a Hodgkin’s lymphoma, and it may indicate that intragenomic 
rearrangement has occurred in the host cells. It is also believed that the genetic evolution and 
genomic rearrangement are related to TTV heterogeneity and pathogenicity (Hino and Miyata. 
2007; Leppik et al. 2007). TTV genetic variability makes TTV research difficult. Much effort has 
been spent to design primers able to amplify the variable TTVs and related viruses genome in 
TTV research (section 1.3.1) and the different TTVs may have different nature. For example, as 
high human TTV genotype 1 infectious prevalence in the patients, human TTV genotype 1 is 
considered to be more pathogenic than other TTVs (section 1.5.2.1.), and different TTVs may 
have different replication sites and pathogenesis (section 1.5.2.).  However, it could also be 
indicated that human TTV genotype 1 may be more commonly infected in healthy individuals 
and patients than other genotypes, and genotype 1 may be more detectable by PCR than other 
genotypes in the patients not to indicate that human TTV 1 is more pathogenic.  
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Despite this wide variation in sequence, the TTV UTR sequence is well conserved (Hino and 
Miyata. 2007; Suzuki et al., 2004; Kamada et al., 2004). Replicating TTVs reproduce the large 
number of virions, for example; 1.0 x 10
4
 -2.1 x 10
6
 copies/ml in hepatic carcinoma patient 
(Tokita et al., 2002). Due to the high replication, hypermutation or recombination could occur 
and it is speculated to contribute to the viral evolution (Duffy et al., 2008). However, these 
mutations have a certain level of limitation because the mutation may cause a functional 
deficiency for the replication in the host cells. Thus, TTV might need to conserve some 
sequences or structures and these areas may have an important role in TTV replication. 
Furthermore, virus should not turn to be excessive virulent virus. Successful viruses would 
cohabit with host for replicating efficiently. Therefore, TTV infectious prevalence is extremely 
high, but the fataling rate is very low.   
 
It is suggested that this TTV genetic diversity is thought to come from the host-virus co-evolution 
in different host species and it would take millions of years (Ball et al., 1999; Biagini et al., 1999; 
Hijikata et al., 1999; Prescotte et al., 1999; Gallian et al., 2000). This idea would be 
contradictory to the other researcher's ideas mentioned above, and some researchers believe that 
TTV evolution occurs very slowly (Khudyakov et al., 2000). One reason is TTV titre is usually 
very low in the host and this indicates that TTV replication speed is slow (Okamoto et al., 1999). 
Low replication rate would be predicted to lead to a low mutation rate because the virus has 
passed fewer generations and therefore, mutation chances. Also, it has been suggested that TTV 
primary genomic structure is highly stable and one study reveals that the TTV genome did not 
change over a 31 month observation time (Biagini et al., 1999; Khudyakov et al., 2000). This 
contradicts the hypothesis proposed by a huge number of TTV heterogeneity papers (Worobey et 
al., 2000). Thus, it is concluded that long history of human and animal infection of TTV makes 
the TTV heterogeneity (Khudyakov et al., 2000). In addition, it was suggested that multiple 
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infection of different TTV genotypes enhances mutation frequency (Manni et al., 2002). The 
mechanism of TTV divergence is still unknown but it is revealed that human TTV infection 
happens not only with one TTV species but with a large family of TTVs. Some viruses show 
multiple infections in the host cells and produce the different genotypes of virus to avoid the host 
immune system. For example, the multiple genomes of HIV-1 infect in the same cells, produce 
different genetical proviruses and HIV-1 produces the drug resistance virus via recombinantion 
(Dixit and Perelson, 2004; Christian et al., 2012). TTV multiple infection would induce the virus 
recombination to produce further genotypes.     
 
1.3. Epidemiology/Transmission 
1.3.1. Epidemiology       
After first identification of TTV, epidemiological research was performed to understand TTV 
infectious prevalence and TTV infection was shown in healthy individuals and various patients 
indicating the possible disease associations (section 1.5.). However, the result was not reliable 
and speculated to be low infectious prevalence compared to the actual infectious rate because the 
wide sequence variation was not known at the time (section 1.2.). The PCR conditions, especially 
primer design, has a large impact on the PCR results and some primers tend to detect fewer 
genotypes than others (Ali et al., 2002; Irving et al., 1999; Leary et al., 1999, Lopez-Alcorocho 
et al., 2000; Niel et al., 1999; Nishiguchi et al., 2000; Okamoto et al., 1999b; Pollicino et al., 
2003; Ukita et al., 2000). For the current method, based on the knowledge of the genomic 
variation, various primer combinations have been used to detect TTVs quantitively and 
qualitatively (Biagini et al., 2001a; Devalle et al., 2004; Hu et al., 2005; Maggi et al., 2003b; 
Moen et al., 2002b). However, it was still difficult to amplify the animal TTVs; for example, N22 
primers which were designed based on ORF1 used for TTV screening in early TTV studies, could 
not amplify animal TTV from any nonhuman primate serum (Okamoto et al., 2000). After the 
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study, taking advantage of the highly conserved UTR sequence, broader spectrum primers to 
detect various TTVs of animals were designed and many animal TTV species were discovered 
(Okamoto et al., 2001; Okamoto et al., 2002). Use of these primers extended the scope of TTV 
research and has played a key role in new TTV discovery, the understanding of TTV viral 
character, and the evolutionary relationship among TTVs. 
 
PCR has remained the standard for TTV detection but the result is influenced by the primer 
design. Sequence independent methods including Rolling circle amplification (RCA), have also 
been developed recently. This method has several advantages for amplification of circular viruses 
such as strand displacement activity, proof reading activity, generation of long synthesis products, 
and a relatively straightforward technique (30℃ overnight) (Reimer et al., 2009). In RCA, a 
random hexamer primer attaches to multiple sites of template circular DNA and from the sites, 
DNA is isothermally extended by phi 29 DNA polymerase (Garmendia et al., 1992; Esteban et 
al., 1993). By using this method, new circovirus (Johne et al., 2006), geminivirus (Haible et al., 
2006), and TTVs were detected (Niel et al., 2005; Macera et al., 2011). Furthermore, the 
combination of RCA and a new method, sequence independent single primer amplification 
(SISPA), were applied to detect TTVs in human plasma and cat saliva (Biagini et al., 2007). This 
method requires target DNA and asymmetric linkers or primers which contain restriction 
endonuclease sites (Reyes and Kim 1991; Allander et al., 2001). First the target DNA is digested 
by Mbo-I. Linkers which have the same restriction sites (Mbo-I) connect to the digested DNA 
and PCR is performed by using the linker primer. It has been suggested that this new technique, 
RCA and SISPA, would be useful tool for detecting more divergent viruses.  
 
By using PCR and new methods, TTV infectious prevalence is considered to be extremely high 
in human and animals. In terms of prevalence, it is indicated that TTV is one of the most 
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successful viruses in a number of species. TTV is found world-wide in the general population 
(Abe et al., 1999; Okamoto et al., 1999; Prescott et al., 1998; Viazov et al., 1998) and their level 
of infection increases with age regardless of gender, economical condition, and geological 
location (Hsieh et al., 1999; Saback et al., 1999; Umemura et al., 2001; Zhong et al., 2001). 
Although, Infectious prevalence varied depending on TTV detection methods and primer 
difference for the PCR (Leary et al., 1999), it has been demonstrated that TTV occurs all over the 
world including Brazil (Devalle et al., 2004; Niel et al., 1999), Turkey (Erensoy et al., 2002; 
Yazici et al., 2002), Norway (Huang et al., 2001), China (Zhong et al., 2001), but geographical 
differences in prevalence were not observed (Huang et al., 2001; Manni et al., 2002; Mushahwar 
et al., 1999; Pisani et al., 1999). Currently two-thirds or more of global populations have TTVs. 
TTMDV and TTMV are predicted to show the same level of infection. Furthermore, multiple 
infection of TTV and TTV-related small virus is common (Bendinelli et al., 2001; Moen et al., 
2002; Maggi et al., 2005; Biagini et al., 2006a; Biagini et al., 2006b; Ninomiya et al., 2008). 
Although the prevalence would change over the time depending on the technological 
development, it is considered TTV and TTV-related small virus showed the extremely high 
infectious prevalence.  
 
Epidemiology of TTMV and TTMDV 
TTMV is also distributed worldwide among healthy individuals (Biagini et al., 2001; Niel et al., 
2001). TTMV DNA prevalence in the blood donors was studied to be 48-76.9% in different 
counties such as 62% in France (Biagini et al., 2006), 67-72% in Brazil (Devalle et al., 2004; 
Niel and Lampe, 2001), 48% in the Norway (Moen et al., 2002), and 76.9% in Japanese pregnant 
woman (Matsubara et al., 2001). Furthermore, TTMV isolates were also found in various tissues 
such as serum/plasma, PBMC, faeces, saliva, bone marrow, spleen, and cervical swabs with 




) (Biagini et al., 2001; Fornai et al., 2001; Thom et al., 2003; 
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Vasconcelos et al., 2002).  
 
TTMDV infectious prevalence is still required to be studied by using accurate methods, and 
TTMDV is also predicted to spread in general populations according to several reports studied 
about TTMDV infectious prevalence in plasma samples from European and Japanese blood 
donors (Jones et al., 2005; Ninomiya et al., 2008; Andreoli et al., 2006; Biagini et al,2006). 
Studies have been performed on SAV which is suspected to be related to, or a laboratory aritifact 
of TTMDV. SAV is distributed in systemic organ and body fluid including saliva, PBMC (Biagini 
et al., 2006), and nasopharyngeal aspirates (Chung et al., 2007). SAV is also common in the 
healthy individuals and it was observed in 20% of French blood donors (Biagini et al., 2006) and 
34.5% of Korean children (Chung et al., 2007). TTMDV and SAV have not been as well studied 
as TTV and these infectious prevalence measurements could be changed depending on the primer 
design mentioned above. Accordingly, it is predicted that TTMV and SAV infect ubiquitously 
similar to TTV infection. In addition, most infected people have more than one genotype of TTV 
or/and the related smaller genome viruses (Maggi et al., 2005).  
 
1.3.2. Transmission    
1.3.2.1. Vertical transmission 
Anellovirus infections are generally thought to occur in the early stages of life. A report which 
studied TTV infection in cord blood samples and serum samples from children 1 year and older, 
showed anellovirus was negative in cord blood samples but within 2 years TTV infectious 
prevalence rose to 100% (Ninomiya et al., 2008). Based on these studies, TTV transplacental 
transmission has only a minor role in TTV infection (Mutlu et al., 2007; Ninomiya et al., 2008). 
However, it is very difficult definitively to prove a lack of TTV because of the issue surrounding 
PCR sensitivity and low virus titer. When TTV sequence was compared between mother and 
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children, children showed TTV sequences consistent with both vertical and environmental 
transmission (Davidson et al., 1999; Sugiyama et al., 1999; Bagaglio et al., 2002; Lin et al., 
2002; Ohto et al., 2002). Therefore, mother-to-fetus transmission may explain some parts of TTV 
high and persistent infectious character (Morrica et al., 2000).  
 
1.3.2.2. Horizonal transmission 
TTV infections are believed to be predominantly transmitted via the horizonal route. TTV and 
other anellovirus genomes have been found in the faceces (Biagini et al., 2001; Okamoto et al., 
1998), saliva (Biagini et al., 2001; Deng et al., 2000; Gallian et al., 2000; Goto et al., 2000; 
Ishikawa et al., 1999; Vasconcelos et al., 2002) breast milk(Gerner et al., 2000; Goto et al., 2000; 
Schröter et al., 2000), genital secretion (Reviewed by Bendinelli et al., 2001), tears (Emre et al., 
2007), skin and hair follicles (Osiowy et al., 2000), suggesting several potential sources for 
transmission of TTV. Several papers investigated the possible transmission routes of TTV.  
 
Parenteral infection 
TTV is frequently referred to as a transfusion transmitted disease because TTV is found in a 
myriad of tissues and body fluids and it can be transmitted by blood transfusion. TTV was 
discovered in post-transfusion hepatitis patient. For this reason, blood and blood products have 
been vigorously studied. TTV DNA prevalence is higher in patients who have several blood 
transfusions (Viazov et al., 1998; Simmonds et al., 1998; Forns et al., 1999; Gallian et al., 1999; 
Kanda et al., 1999; Takayama et al., 1999; Prati et al., 1999; Maeda et al., 2000; Amarante et al., 
2007), although some researchers have found the opposite (Schröter et al., 1998; Rubinstein et 
al., 2000). Furthermore, TTV was detected in blood products such as commercial human plasma 
(Pisani et al., 1999; Simmonds et al., 1998; Yokozaki et al., 1999), first-generation recombinant 
factor VIII concentrates, factor IX concentrates (Azzi et al., 2001; Simmonds et al., 1998; 
Chapter I                                                                                                      Introduction 
18 
 
Yokozaki et al., 1999; Chen et al., 1999), and intramuscular immunoglobulin (Ig) preparations 
(Pisani et al., 1999; Simmonds et al., 1998). However, TTV infectious prevalence is too high in 
human and animal populations to be explained infecting solely using blood transfusion. Thus, the 
name, transfusion transmitted virus is misleading because it is likely that other infectious routes 
are more important for TTV infection.       
 
Faecal-Oral transmission  
Faeces contains TTV(Okamoto et al., 1998; Ross et al., 1999; Ukita et al., 1999; Lin et al., 2000) 
and some reports have shown that this faeces is infectious in cell culture (Maggi et al., 2001) and 
non-human primates (Luo et al.,2000) suggesting faecal-oral route as a most common 
transmission route. TTV exhibits high resistance of virions to environmental inactivation. By 
comparing to the structurally similar virus (Porcine circovirus 2 (PCV-2) and CAV), TTV should 
be resistant to physicochemical agent (Welch et al., 2006) and TTV can survive the depth 
filtration procedure (Azzi et al., 2006). Also, TTV is widespread in the environment and it was 
already investigated that TTV is detectable in river water (Hiramoto etal., 2005; Verani et al., 
2006; Hiramoto et al., 2010), sewage (Vaidya et al., 2002; Hiramoto et al., 2005; Hiramoto et al., 
2008), polluted superficial waters (Hiramoto et al., 2008; Diniz-Mendes et al., 2008), and 
drinking water (Griffin et al., 2008). Furthermore, TTV and TTMV were found in 8% of 
Norwegian shellfish (Myrmel et al., 2004) suggesting that TTV could infect using food borne 
transmission. Therefore, it is thought that faecal-oral route is main route of TTV infection.  
  
Respiratory infection  
Another potential route of TTV infection is through the respiratory tract as TTV replication is 
predicted in this site (Maggi et al., 2003a; Maggi et al., 2003b; Maggi et al, 2004; Bando et al., 
2008). This idea is also supported by the studies about TTV infection in respiratory disease 
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patients (section 1.5.2.2.) (Bando et al., 2001; Pifferi et al., 2005; Pifferi et al., 2006; Chung et 
al., 2006). Recently, exhaled breath was studied for airborne TTV infection, and it showed the 
possibility to transmit by the breath in the same room (Chikasue et al., 2012).  
 
Sexual transmission 
Sexual transmission has also been studied as another potential infectious route of TTV to spread 
in the adult population. TTV was detected in cervical swabs (Calcaterra et al., 2001; Chen et al., 
2001; Fornai et al., 2001) and in semen (Inami et al., 2000; Martinez et al., 2000) indicating that 
sexual transmission is possible.  
 
1.4. TTV structure and coding      
1.4.1. Genome structure 
At the end of 1999, the genome structure of TTV was shown in two papers and complete genome 
sequences from 10 TTV isolates which have genome sizes between 3,808 nt (SANBAN isolate) 
and 3,853 nt(isolates TA278 and JA20) were studied (Miyata et al., 1999; Erker et al., 1999). 
Although, the described genomic sequences were variable, some parts of genome were 
conserved. Based on the sequence results which had well-conserved area among the sequenced 
isolates, TTV genome is divided into a potential coding region of ~2.6kb and an untranslated 
region of ~1.2kb (Fig. 1.4.1.1.) (Miyata et al., 1999; Kamada et al., 2004; reviewed in Beninelli 
et al., 2001). The former region contains two major partially overlapping protein –coding genes; 
open reading frame 1 (ORF1) and ORF2 and it was also predicted to encode the further potential 
ORFs. Prototype TA278 sequence, ORF1 spans nt 589 to 2898 and ORF2 spans nt 107 to 712, 
but the sequence variation at the nucleotide level is quite high among TTV genotypes. A small 
additional ORF3 was also discovered downstream of ORF1 and is well conserved (Fig. 1.4.1.1). 
In addition, there are several conserved structures in the TTV genome. For example, TTV 
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genome contained unique stem loop structures in a GC-rich region (GC contents; 89%-90.6%) 
which have around 100 nucleotides (Miyata et al., 1999; Hallett et al., 2000; Heller et al., 2001; 
Peng et al., 2002). A poly-A sequence downstream and a TATA-box upstream of the coding 
region are also well-conserved (Erker et al., 1999; Hallett et al., 2000; Okamoto et al., 2000; 
Heller et al., 2001; Mueller et al., 2008). At the nucleotide level, the untranslated region (UTR) is 
more conserved than the coding area, and it contained the basal promoter and enhance elements 
for transcriptional regulation (Suzuki et al., 2004; Kamada., 2004). Therefore, PCR primers for 
screening TTV in human and animals are most commonly designed based on the UTR (Okamoto 
et al., 2000; Okamoto et al., 2001; Okamoto et al., 2002; Thom et al., 2003).    
 
TTV was historically classified as a member of the circovirus family because the TTV genomic 
structure is similar to that of chicken anemia virus (CAV) in circovirus family (Kooistra et al. 
2004). CAV is currently the only virus in the genus Gyrovirus of the Circoviridae because CAV is 
different from the other circovirues in a few aspects. Circoviruses have an ambisense genomes 
but CAV has a unidirectional genome which is also seen in TTV. CAV also lacks the potential 
stem-loop structure which is common in Circoviruses. Furthermore, configurations of ORFs 
which have partially overlapping ORF2 and ORF1 in CAV and TTV are similar. A non-coding 
region with GC-rich sequence was conserved in TTVs and CAV. Also, a 36-nt region (nt 3816 to 
3851) of TTV was 80.6% identical with that of CAV (Miyata et al., 1999; reviewed in Hino and 
Miyata., 2007). However, no other parts of CAV and TTV structure were similar, and in 
particular TTV does not have the CAV unique region which was shown as four or five near-
perfect directs repeats of 21bp (Noteborn et al., 1994). Thus, CAV is currently classified into 
"Circoviridae, Gyrovius" (http://www.ictvonline.org/virusTaxonomy.asp) but possibly could be 
re-classified into Anelloviridae due to its similarities to TTVs. Transcription profiles with spliced 
transcripts of CAV were similar to those of TTVs (Kamada et al., 2006) and some protein 
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Figure 1.4.1.1. Genomic organization of TTV in the prototype TA278 (Accession number: 
AB017610) sequence showing single strand circular DNA of negative polarity encapsidated into 
the virion. 
 
Finally, the UTR is known to function in transcriptional control because of the presence of 
transcription factor binding sites in the region (Miyata et al., 1999). Moreover, the promoter and 
enhancer elements have mapped to the UTR (Kamida et al., 2004; Suzuki et al., 2004). The 
promoter/enhance activity of the different TTV genotypes was variable depending on the types of 
cells. This may be related to the cell tropism of TTV infection and different genotypes may have 
different transcriptional regulation activity (Kamada et al., 2004). In addition, not all enhance 
motifs in the UTR were conserved. This indicates that different host cells and TTV genotypes 
have different transcriptional regulation system (Kamada et al., 2004).  
 
 1.4.2. Transcriptional Profile 
According to the complete genome analysis of original clone (TA278) (Fig. 1.4.1.1.), 2-3 
predicted open reading frames (ORFs) were observed (reviewed in Hino and Miyata., 2007). 
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However, it does not mean that these ORFs were actually transcribed. Due to the lack of a cell 
culture system, TTV transcription profile has largely come from the cells transfected with human 
TTV complete genome. Using the strategy, transcriptional profiles from Genotype 1a transfected 
Huh7 and Cos-1 cells and Genotype 6 293 cells clones have been published (Kamahora et al., 
2000; Qiu et al., 2005; Mueller et al., 2008). 
 
TTV genotype 1a complete genome was transfected in the monkey kidney cell line Cos-1 and 
three clone-derived mRNAs; 3.0, 1.2 and 1.0 kb in length were detected in the transfected cells 
(Kamahora et al., 2000). In addition, the shortest mRNA of 0.6 kb in length was discovered later 
(Mueller et al., 2008). The 5'-end and 3' end of the larger three mRNAs are identical (Qiu et al., 
2005). The transcripts share the same poly-A at the end of coding region and started between 
predicted TATA box and first methionine of ORF2. All the transcripts showed the same splicing 
site toward 5' end of the mRNA. The 3.0kb transcripts contained the complete ORF1 (frame 1) 
and ORF2 (frame 2) coding sequences. The 1.2kb mRNA had a second splicing site and ORF2 
(frame 2) connected to a downstream ORF (frame 2) to create the new ORF (ORF2/2) in the 
same reading frame and ORF1 (frame 1) spliced and connected same ORF1 to construct shorter 
ORF1 (ORF1/1). The 1.0 kb mRNA also had a second splicing site but this time introduces a 
frame sift and that ORF2 (frame 2) connected to a downstream ORF (frame 3) to construct the 
new ORF, ORF3 and ORF1 (frame 1) connected an ORF in frame 2 to make ORF1/2 (Mueller et 
al., 2008). Recently, a small 0.6 kb small mRNA which had a second splicing site was found and 
ORF2 (frame 2) connected to a downstream of ORF (frame 3) to create the new ORF (ORF4) 
(Mueller et al., 2008). The transfection was also performed in 293 (human embryonic kidney 
cells) and L428 cells (nodular sclerosing Hodgkin's lymphoma), and the three larger of mRNAs 
were also detected in these cell types (Kamahara et al., 2000; Okamoto et al., 2000; Qiu et al., 
2005; Leppik et al., 2007). Similar results were shown in bone marrow cells from a patient who 
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was infected by TTV (Okamoto et al., 2000). An additional splicing site was discovered in L428 
Hodgkin's lymphoma cells which were transfected with tth7 and tth8 isolates (Jelcic et al., 2004). 
The transcription map of genotype 1 (P/1C1 clone) TTV generated by TTV transfected Huh7 
cells is shown in Fig. 1.4.2.1. In all, seven possible proteins (six predicted proteins from the three 
large transcripts in Qiu et al., 2005 and one newly described in Mueller et al., 2008) are encoded 
by this virus.   



















Figure 1.4.2.1. Summary of TTV genotype 1 transcripts. Genetic map of TTV is shown in 
the top and initiation site, all splicing site, and polyadenylation cleavage site were indicated. 
Seven potential ORFs expressions are diagrammed in the map below. (Reproduced from 
Mueller et al., 2008) 
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 1.4.3. Proteins 
As documented in section 1.4.2., by variable splicing and alternative initiation up to 7 predicted 
proteins can be encoded by the overlapping ORFs of TTV. However, the functions of the proteins 
of TTV are poorly understood due to the lack of a cell culture system.  
 
Protein localisation 
The proteins from their transcripts from P/1C1 genotype1 were expressed in human 293, Huh and 
Hela cells, and ORF1/1 and ORF1/2 proteins were found in the nucleoli (Mueller et al., 2008). 
ORF2 was distributed in a reticular structure of the cytoplasm (Mueller et al., 2008). ORF2/2 was 
demonstrated in nucleoli or in the nucleoplasm. ORF2/3 and ORF4 (Fig. 1.4.2.1.) were detected 
in the nucleoplasm (Mueller et al., 2008). However, the location of ORF1 protein was different 
between an older report of genotype 6 and a more recent report of P/1C1 genotype1. Genotype 6 
ORF1 was located in the cytoplasm (Qiu et al ., 2005), but P/1C1 genotype1 ORF1 was 
expressed in the nucleoli (Mueller et al., 2008).  
 
ORF1: The longest ORF in all anellovirus is named ORF1. In human TTV, ORF1 is believed to 
contain a structural protein related to a capsid protein (Takahashi et al., 1998) and the predicted 
length of the ORF1 encoded protein was variable around 719-770 amino acids (Erker et al., 
1999; Heller et al., 2001., Tanaka et al., 2000; Ukita et al., 2000). In some isolates, premature 
stop codons in the middle of TTV ORF1 were observed suggesting the production of the 
defective TTV genomes (Erker et al., 1999; Luo et al., 2000; Khudyakov et al., 2000; Pollicino et 
al., 2003; Jelcic et al., 2004) or full length ORF1 might not be necessary for virus replication. 
Furthermore, in the same genotype, nonsynonymous changes can be observed in ORF1 
(Mushahwar et al. 1999; Ukita et al., 2000). Therefore, TTV is considered to have a quasispecies 
nature and in this, the ORF1 change would play an important role in the evasion of the host 
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immune surveillance and establishment of persistent infection. This quasispecies nature is also 
observed in HCV and HIV-1 and the hyper variable region (HVRs) of human TTV genome 
which contains aa 286 to 403 (TA278, SANBAN, and TUS01), worked similar to HVRs of 
hepatitis C virus (HCV) (HVRs in the E2 region), HIV-1 (V3 loop) (Hijikata et al., 1991; 
Meyerhans et al., 1989; Yamaguchi and Gojobori et al., 1997; McAllister et al., 1998; Nishizawa 
et al., 1999; Umemura et al., 2002), or human T-cell leukemia virus-1 (the tax gene) (Umemura 
et al., 2002). The TTV ORF1 HVRs are sites of high frequency nonsynonymous nucleotide 
changes which cause amino acid changes, some of which are removed by host immunity leaving 
persistent variants remaining (positive selection). On the contrary, the most conserved area in 
ORF1 is first 65aa which have an arginine-rich region and this area has a homology of 56.5-70% 
among TTVs. It has also been suggested that ORF1 protein is associated with TTV replication 
and contains two rolling circle replication motifs (Rep-motifs) which are conserved among the 
various isolates (Bendinelli et al. 2001; Takahashi et al. 1998). Viral protein (VP) 1, the capsid 
protein of CAV also has Rep-motifs and an arginine-rich N-terminus similar to TTV ORF1, and 
could function as a replication associated protein (Takahashi et al., 1998; Niagro et al., 1998). 
Interestingly, the expression of TTV ORF1 in transgenic mice caused renal epithelial cell change 
(Yokoyama et al. 2002). This indicate that TTV ORF1 could relate to renal pathogenicity.  
       
ORF2: ORF2 is also observed in all human and animal TTV (Okamoto et al., 2009) and is 
located upstream of ORF1 with an overlapping region (Takahashi et al., 1998). This structure 
was also found in CAV genome structure (Takahashi et al., 1998). ORF2 is assumed to code for a 
nonstructural protein involved in viral replication (Okamoto et al., 1998. Reviewed in Bendinelli 
et al., 2001), and in the some clones, the stop codon was observed in the middle of ORF2 and the 
subsequent ATG codon starts translation downstream. Accordingly, ORF2 was divided in two 
smaller protein coding areas, ORF2a and ORF2b (Tanaka et al., 2000). ORF2a is well conserved 
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(more that 85-90%) compared to ORF2b (less than 70%) (Tanaka et al., 2000; Ukita et al., 2000). 
TTV ORF2 coding sequence of genotype 3(SANBAN) have a high amino acid similarity (53-
55%) with CAV VP2. This TTV and CAV ORF2 similarity is also observed in Sanban, Yonban, 
and TTMV, and these anelloviruses have the same WX7HX3CXCX5H sequence as CAV VP2 
(Peng et al., 2002; Peter et al., 2002). The CAV VP2 has protein-tyrosine phosphatase (PTPase) 
activity and regulates the cellular and/or viral protein in the infection (Peter et al., 2002). TTV 
may have similar host immune regulation system like CAV. In a recent report, TTV ORF2 protein 
(SANBAN isolate) was found to suppress both canonical and noncanonical NF-κB activity. That 
fact indicates that the TTV ORF2 may indirectly decrease the expression of inflammatory 
cytokine and contribute to TTV pathogenesis (Zheng et al. 2007). 
 
Other ORFs: The other TTV ORFs are created by the splicing and the nomenclature is not 
constant and varies among the publications. The expressed ORF2/2 and ORF3 (OR2/3) proteins 
of genotype6 from 293 cells (corresponding to the ORF2-4 and ORF2-5 proteins of genotype 1 
respectively; Kamahara et al., 2000) were located in the nucleus (Asabe et al., 2001; Qiu et al., 
2005) and they may be indicated to have functions in genome expression and replication. The 
ORF2/2 is approximately 280 amino acids (nt 347 to 705 and nt 2308 to 2803) and has a serine-
rich domain (Fig. 1.4.2.1.) (Asabe et al., 2001; Tanaka et al., 2001; Peng et al., 2002). This 
ORF2/2 of genotype 1a had a similar genomic sequence to hepatitis C virus(HCV) nonstructural 
5A (NS5A) protein which is phosphoprotein and it is believed to be associated with various 
cellular proteins (Asabe et al., 2001). In the COS-1 cells, TTV ORF2/2 protein could be 
phosphorylated and its genome produced two forms of protein with different level of 
phosphorylation. It has been suggested that TTV ORF2/2 has similar functions to HCV NS5A 
and regulates viral replication and cellular replication (Asabe et al., 2001). However, the actual 
function of viral protein in TTV infection cycle was still unknown.        
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 ORF4 encodes a protein with approximately 280 amino acids (nt 347 to 393 and 2501 to 2975). 
ORF4 is also predicted to have a function to regulate TTV transcription because it has similarity 
to proteins with transcription-factor activity (Kamahora et al., 2000). Also, ORF4 is conserved at 
the amino acid level among TTVs but the function is still unknown (Okamoto et al., 2000; Peng 
et al., 2002).  
 
The genomic organization of TTV is quite similar to that of chicken anemia virus (CAV). TTV 
putative protein from ORF2 is quite similar to that of the CAV VP3 protein. CAV VP3 protein 
induces p53 independent type of apoptosis in cancer cell line. This TTV protein named TTV-
derived apoptosis inducing protein (TAIP), has been shown to induce apoptosis in hepatocellular 
carcinoma cells (Kooistra et al. 2004). However, it is still not clear whether ORF2 coded by other 
genotypes express this protein.  
 
Furthermore, there are possibilities that other TTV proteins in addition to the proteins shown 
above exist. Recently TTV intragenomic rearrangement was suggested from TTV transfected into 
the Hodgkins-lymphoma cells and it makes another splicing site to create new ORFs. Thus, 
further variation of TTV coding capacity was predicted (Leppik et al., 2007).       
 
1.4.4. Genomic structure and predicted proteins of TTMV, TTMDV and SAV 
TTMV has also long ORF1 preceded by a short ORF2 and GC-rich region, the coding areas of 
which were similar to those of TTV. As shown in CAV VP2 protein research, the ORF2 protein of 
TTMV had a function to act as a dual-specificity phosphatase (Peters et al., 2002). Moreover, 
TTMV and CAV have an additional ORF3 (Takahashi, et al. 2000). This ORF3 was indicated to 
have a serine-rich C-terminus and it is corresponding to TTV ORF3 having function like DNA 
topoisomerase I. This protein is known to catalyze breakage of single stranded DNA and plays 
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important role of ssDNA virus replication (Peters et al., 2002). The ORF1 TTMV also had an 
arginine-rich N-terminus and Rep-motifs similar to TTV. The untranslated region of TTMV was 
similar to that of CAV in that both viruses had direct repeat sequence which are absent from TTV 
although the repeated sequence units are different (section 1.4.1.) (Takahashi et al., 2000). A 
chicken anemia virus (CAV) like motif in the ORF2 region (WX7HX3CXCX5H) was also 
observed (Takahashi et al., 2000). Four sequence motifs were predicted in many TTMV isolates 
and conserved motifs 1 (FTL/FxTL), 2(HxH), and 3(YxxK) were identified in ORF1 but motif 
4(GxxxxGK5) and the P-loop (putative ATP/GTP-binding motif), which were observed in TTV 
and CAV, were not found (Biagini et al., 2001). These features indicated that TTMV has an 
intermediate structure between TTV and CAV (Biagini et al., 2001; Biagini et al., 2007; Okamoto 
et al., 2000; Takahashi et al., 2000).  
 
The transcriptional profile of small anellovirus and TTMDV has not been studied yet but it is 
known that SAV and TTMDV genomic structures are closely related. SAVs had similar structure 
of TTVs and TTMV; a largest ORF (ORF1), a GC-rich region and ORF2 which had CAV like 
motif (Andreoli et al., 2006).  
 
1.5. Replication and Pathogenesis  
1.5.1. Replication mechanism 
The exact mechanism of TTV replication system is still unknown, but some researchers have 
predicted the TTV replication system based on other small DNA viruses. Most small DNA 
viruses utilize the host cell replication system for virus replication. TTV is not predicted to 
encode a DNA polymerase based on the genomic analysis. Viruses requiring a host polymerase 
either infect highly replicating cells or induce their host cells into S-phase (Kakkola et al., 2007). 
In aphidicolin (an inhibitor of eukaryotic nuclear replication) treated 293 T cells, DNA 
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replication of TTV was totally blocked by the drug indicating that TTV depends on cellular 
replication machinery (Kakkola et al., 2007). Also the virus replication process is predicted to 
depend on the host cell topoisomerase or helicase to gain the local binding and/or unwinding 
function in the virus replication. This replication method was observed in rolling circle DNA 
replication mechanism of bacteriophage 8X-174 and other viruses (Niagro et al., 1998; Iiyama et 
al., 1992). It is predicted that CAV and TTV would apply the similar replication mechanism.    
 
TTV, like the other circular ssDNA viruses, is predicted to use the rolling circle replication 
system (Erker et al. 1999; Mushahwar etb al., 1999; Okamoto et al., 2000). Based on the TTV-
related circovirus and geminivirus replication system, TTV viral proteins would be required to 
cooperate with cellular proteins for the initiation of replication (Mankertz et al., 1998; Nigro et 
al., 1998). For circovirus replication, circovirus encodes replication-associated proteins with 
specific Rep-motifs which bind to the replication initiation site (Mankertz et al. 1998) and, 
according to the amino acid sequences, TTV ORF1 is predicted to contain similar Rep-motifs 
(Mushahwar et al. 1999; Mushahwar et al., 1999; Tanaka et al., 2001). Animal circoviruses have 
a conserved rep-protein (replication associated protein) coding sequence and genomic structures 
(stem-loop structure) which interact for virus replication (Niagro et al., 1998; Mankertz et al., 
2001; Mankertz et al., 2001; Todd et al., 2004), and TTVs also contain the similar sequence and 
form the similar structure (stem-loop structures were located in the GC-rich region and rep-
protein was made in ORF1.) (Hijikata et al., 1999; Mushahwar et al. 1999; Peng et al., 2002). 
However, it is still unknown whether these similar structures and proteins are actually functional 
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1.5.2. Replication site and Pathogenicity of TTV  
TTV DNA can be detected in several organs, indicating a wide range of cell tropism (Reviewed 
by Hino and Miyata. 2007). Although TTV viral load is higher in bone marrow, lung, spleen, and 
liver than any other organs in TTV infected individuals, the host cell and details of replication in 
the cells during TTV infection are still unknown. In addition, virus replication would not 
necessarily produce a lesion because the cells in which TTV is actively replicating did not show 
any pathologic change (Cheng et al., 2000; Jiang et al., 2000).   
 
TTV is widespread in general human population so that some researchers suggest that TTV does 
not have any pathogenic effect. However, TTV, TTMDV, and TTMV have possible disease 
associations and the lesion of TTV may be shown in the different place from the past studies or 
require other pathogens to develop. In many cases, viral replication is known to cause cell lysis to 
spread progeny virions. Viral infection may induce apoptosis to prevent further virus replication, 
the immune response may destroy infected cells, and viral infection may lead to carcinogenesis. 
TTV and disease relationships have been described in several cases such as a liver disease 
(section 1.5.2.1.), respiratory disease (section 1.5.2.2.), multiple sclerosis (MS) (Sospedra et al., 
2005), systemic lupus erythematosis (SLE) (section 1.5.2.4.), diabetes mellitus (Guney et al., 
2005), laryngeal cancer (section 1.5.2.3.), pancreatic cancer (Tomasiewics et al., 2005), cancer in 
general (section 1.5.2.3.), periodontal disease (Rotundo et al., 2004), certain rheumatic disease 
(section 1.5.2.4.) and CNS disease (Maggi et al., 2010).    
 
1.5.2.1. Virus replication in liver and hepatic disease 
As TTV was originally discovered in a hepatitis patient, the liver was the original presumed 
target organ of TTV replication (Nishizawa et al., 1997). In experimental infection of Rhesus 
monkeys, viral DNA was observed in various organs, but double-strand circular DNA which 
Chapter I                                                                                                      Introduction 
32 
 
indicates potential replication was detected only in liver, bone marrow, and the small intestine 
(Xiao et al. 2002). The double stranded circular genome was also observed in human liver 
(Okamoto et al., 2000). Furthermore, high TTV titer was found in bile (Ukita et al., 1999; Itoh et 
al., 2001), and TTV can be detected by in situ hybridization method in nucleus and/or the 
cytoplasm of liver cells in patients who have liver disease (Cheng et al., 2000; Jiang et al., 2000). 
However, TTV infected cells did not show any pathological change. In recent years, there has 
been increasing recognition that the liver is most likely not the main replication site of TTV 
(Viazov et al., 1998; Kikuchi et al., 2000; Nakagawa et al., 2000). The double stranded 
replication form of TTV genomic material has also been found in almost every organ; lung 
(Bando et al., 2001), stimulated peripheral blood mononuclear cells (PBMC) (Mariscal et al., 
2002), bone marrow (Okamoto et al., 2000b), liver (Okamoto et al., 2000a), lymph node, thyroid 
gland, spleen, pancreas, and kidney (Okamoto et al., 2001). About these results, some researchers 
proposed that TTV is present in immune cells and they might migrate into the various organs by 
using these cells. Thus, TTV replication mechanism has to be carefully studied (Takahashi et al., 
2002).    
 
As the discovery of TTV from a patient with non-A to non-E hepatitis (Nishizawa et al., 1997), 
TTV research has concentrated on liver disease and many studies focused on connecting TTV 
and liver disease such as non-A to E hepatitis, transfusion associated hepatitis, cryptogenic 
chronic liver disease (Ergünay et al., 2008), liver chirrosis (Zein et al., 1999), hepatitis-associated 
aplastic anemia (Ishimura et al. 2010), fulminant hepatitis (Shibata et al., 2000), hepatocellular 
carcinoma (Tokita et al., 2002) and alcohol related liver disease (Tokita et al., 2001). 
 
Early studies of TTV concentrated on establishing the relationship between TTV prevalence/virus 
titer and various hepatic diseases (Charlton et al., 1998; Ikeda et al., 1999; Kanda et al., 1999; 
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Nishizawa et al., 1997; Okamura et al., 2000; Tanaka et al., 1998). It has been suggested that 
TTV is a potential cause of liver damage in children (Nobili et al., 2005) and persistent TTV 
infection in the patient could cause hepatic failure (Takayama et al., 1999). Furthermore, TTV 
hepatitis-associated aplastic anemia was also reported in a 12 year old Japanese boy (Ishimura et 
al., 2010). TTV related liver disease was also studied by experimental infection using 
chimpanzees. A serum sample from an 11-month-old infant with acute hepatitis which contained 
TTV genotype 1 (10
5
 copies/ml) was inoculated into a naive chimpanzee intravenously. The 
chimpanzee showed several symptoms; a histological change (ballooning degeneration of 
hepatocytes), increasing TTV DNA at 5-15 weeks after inoculation, an elevation of the serum α-
glutathione-S-transferase level, and mild elevation of ALT level (Tawara et al. 2000). 
Subsequently, TTV DNA level decreased depending on immunoglobulin (Ig)M-class and IgG-
class anti-TTV (genotype 1) antibody suggesting TTV genotype 1 has hepatitis inducing capacity. 
However, co-infection of other pathogens or host species difference between human and 
chimpanzee could have influenced this study and also the number of samples is too low to 
indicate the TTV related disease. In addition, genotype 1 TTV protein may be pathogenic in liver 
cells. TTV has an Apoptin-like protein (Apoptin is the main apoptosis-inducing agent of CAV) 
called TTV-derived apoptosis-inducing protein (TAIP), and it is selective to induce apoptosis in 
hepatocellular carcinoma (Kooistra, et al. 2004). These diseases were more frequently observed 
with Human TTV genotype 1. Hence, several studies suggested that human TTV genotype 1 has 
hepatitis inducing capacity and may be more pathogenic than other genotypes of TTV (Okamoto. 
2009). However, contradictory results have been reported and indicate that TTV is not associated 
with ALT levels with any form of hepatitis (Hijikata et al., 1999; Hsieh et al., 1999; Nakano et 
al., 1999; Naoumov et al., 1998; Niel et al., 1999; Prati et al., 1999; Viazov et al., 1998; 
Yamamoto et al., 1998). Therefore, in current situation, it has been found that the higher level of 
TTV viremia is observed in hepatitis patient (Pistello et al., 2001), but it was not clear whether 
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this high TTV viremia is a cause or a consequence of hepatitis (Nobili et al., 2005).  
 
Other candidate genotypes of TTV related hepatitis disease are genotype 12 and 16, which are 
described as SENV-D and SENV-H respectively. These two genotypes have been more frequently 
found in transfusion-associated non-A to -E hepatitis patients than among the transfused patient 
without hepatitis (Umemura et al., 2001). However, some contradicted papers were also 
published and they indicated that SENV infection is not related to hepatitis and other liver 
disease (Akiba et al., 2005; Kao et al., 2002; Schroter et al., 2003). 
 
Most studies have not described a significant role for TTV in hepatitis. Hence, co-infection with 
other hepatitis viruses is another approach in TTV hepatitis research. Co-infection study has been 
focused on HCV and HBV infections due to the original assumption of TTV as a hepatitis virus. 
In the chronic stage of TTV infection, the patients infected with HCV and TTV showed a higher 
histological change compared to the patient infected with HCV only (Sampietro et al., 2001). In 
the hepatitis B patients, there were no significant differences in ALT level or HBV titer between 
TTV infected and noninfected children, but the total histological score of disease severity was 
significant higher in TTV infected patients (Kasirga et al., 2005). However, there is still no clear 
proof that TTV is a co-factor, disease maker or complicating factor. Also, many papers mentioned 
that co-infection does not have any effects on hepatitis and other diseases (Campo et al., 2000; 
He et al., 2003; Hsu et al., 2003; Kato et al., 2000; Schroter et al., 2003; Tuveri et al., 2000; 
Umemura et al., 2001).  
 
In conclusion, TTV related liver disease has been well studied because of the discovery of TTV 
in a hepatitis patient. However, these hypotheses have not been supported by further investigation 
even by the same group of researchers. Overall, TTV is almost ruled out as an important cause of 
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clinical liver disease.         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
1.5.2.2. Virus replication in respiratory tract and pulmonary disease 
TTV replication is considered to occur in the respiratory tract. TTV replication in epidermal cells 
of entodermal origin has also been suggested because high TTV viral titer was shown in nasal 
secretions (Maggi et al., 2003; Deng et al., 2000). In addition, it has been suggested that TTV 
infection has a potential role in pulmonary disease, because TTV replication was observed in 
pulmonary epithelium of 1 to 24-month-old children with acute respiratory disease, and group 4 
TTV was frequently observed in bronchopneumonia patients (Bando et al. 2001; Maggi et al. 
2003a; Okamoto et al., 2001). It was reported that high TTV loads were found in the swabs of 
severe acute respiratory disease patients and the prevalence of SAV showed the same result 
(Chung et al., 2007). Interestingly, active TTV replication was observed in the respiratory tract. 





 T cells) (Maggi et al. 2003b; Maggi et al. 2004) and might skew the immune 
response towards a Th2 response (Pifferi, et al. 2005). The inbalance of Th2 response is thought 
of as critical to the pathogenesis of asthma (Umetsu et al. 2002). In addition, in children with 
asthma, the three important lung functions (force expiratory flow; FEF in which 25% and 75% of 
force vital capacity (FVC) is expired (FEF25%-75%), force expiratory volume (FEV), and FEF25%-
75%/ FVC) decreased and inversely correlated with nasal viral load. This might indicate that TTV 
affects lung function. Bando et al. reported that idiopathic pulmonary fibrosis (IPF) may be 
related to TTV infection because TTV infected IPF patient showed poor survival rate and there 
was an association with lung cancer development in IPF patients (Bando et al. 2001; Bando et al. 
2008). In one study, a newborn showed benign viral rhinitis with TTV infection. The oral swab 
samples collected in the several times from mother, father, and new born child, and TTV was 
detected from mother only before the date of newborn delivery. In day 4, new born child showed 
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TTV infection and the TTV sequence was identical to that of mother samples of 25 days before 
the newborn delivery. Accordingly, the virus was predicted to come from mother which had high 
TTV load in saliva (Biagini et al., 2003).    
 
1.5.2.3. Cancer 
There are several reports investigating the association between TTV infection and cancer. These 
are primary focused on four major cancers; hepatocellular carcinoma (HCC) (Michitaka and Onji 
2003), lymphoma (zur Hausen and de Villiers 2005), laryngeal carcinoma (Szladek et al. 2004), 
and pancreatic cancer (Tomasiewicz et al., 2005).  
 
Due to the discovery of TTV in a hepatitis patient, it was thought that it may account for the 5 to 
10% HCC patients who are hepatitis B virus (HBV) and hepatitis C virus (HCV) negative. In the 
HBV carcinogenesis, HBV DNA is known to integrate into the hepatocyte DNA during persistent 
infection and this is involved in the process of hepatocarcinogenesis. TTV was also predicted to 
show the similar mechanism, but TTV DNA was confirmed not to integrate into host hepatocyte 
DNA (Yamamoto et al. 1998). This would indicate that TTV may use a different mechanism from 
HBV and HCV. As an alternative, TTV may have some role in carcinogenesis in HBV or HCV 
infection (Tokita et al. 2002).  
 
The etiology of some lymphomas and leukemias is still unknown and chromosomal 
translocations have been identified in these tumour cells. As the cause of chromosomal 
translocation, infectious agents have been suspected as the factors related to lymphomas and 
leukemias development. Epstein-barr virus (EBV), human herpes virus type 8, and human T-cell 
Lymphotropic virus (HTLV-1) have been reported as viruses inducing lymphomas and leukemias 
(zur Hausen and de Villers. 2005). In the TTV studies, TTV DNA was frequently found in 
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various types of lymphoma and it is suggested that TTV may contribute to a number of 
lymphoproliferative disorders (Garbuglia et al. 2003). Furthermore, TTV-like viruses were found 
in 2 cell lines of lymphatic origin and they were Epstein-barr virus (EVB) negative (zur Hausen 
and de Villers. 2005). Based on this finding, it is assumed that TTV-like virus increases the risk 
of chromosomal translocation, and this risk would be increased depending on the viral load (zur 
Hausen and de Villers. 2005).  
 
It is also reported that laryngeal carcinoma patients showed co-infection of genotype 1 TTV and 
human papillomavirus. The patients infected either human papillomavirus or TTV did not show 
the papilloma with malignant transformation. Therefore, co-infection of genotype 1 TTV and 
human papillomavirus might cause poor clinical outcome in laryngeal carcinoma (Szladek et al. 
2004).  
In another study, two hepatitis patients developed pancreatic cancer and serological and 
virological markers were used for screening the causative factors. However, only TTV was 
detected in their serum and it is predicted that TTV was the only detectable causative agent for 
this cancer development. However, it was very difficult to confirm the relationship between TTV 
and pancreatic cancer (Tomasiewicz et al., 2005).  
 
Furthermore, TTV may be associated with the development of classical Kaposi's sarcoma. 
Human herpes virus 8 infection is nessesory but not sufficient for the development of Kaposi's 
sarcoma. TTV infectious rate in the sera of patients with Kaposi's sarcoma was much higher than 
that in sera of healthy patient. In addition, TTV DNA was detected in cutaneous samples from 
Kaposi's sarcoma but not observed in control sample from the healthy skin. It was predicted that 
TTV may play an important role for the development of Kaposi's sarcoma, for example, 
immunosuppression and/or sharing the common transmission pathway (Girard et al., 2007).  
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In cancer patients, 100 times higher virus load was observed in the Peripheral blood mononuclear 
cells (PBMC) compared to those of healthy controls. PBMCs are thought of as the one of the 
important predicted replication cells and TTV replication was predicted to be related to cancer 
development. However, still it is not certain TTV is a cause of cancer or shared among the 
patients with other pathogen (Zhong et al., 2001).  
 
Many cancers have been reported as being TTV associated but two factors have to be considered 
in the cancer research of TTV infection. 1) TTV carcinogenesis cases may be caused by tissue 
inflammation. Cancer frequently induces the inflammation and the inflammation encourages 
TTV to replicate and mutate (de Villiers et al. 2007). It may mislead that TTV is related to 
carcinogenesis of these tumour. 2) It was uncertain whether the high TTV titer in cancer is the 
cause or result of cancer development. TTV is predicted to infect highly replicating cells (section 
1.5.1.).      
 
1.5.2.4. Autoimmune disorders 
Autoimmune rheumatic diseases are predicted to have a complex mechanism for development 
and it is known that at least some cases may have a viral aetiology. It is thought that molecular 
similarity of virus proteins and autoantigens can cause T and B cell dysfunctions (Gergely et al., 
2006). Early in TTV research, some epidemiological studies were published on the association of 
rheumatic disease and TTV infection (Hirata et al., 1998). Lower TTV infectious prevalence was 
observed in the rheumatic arthritis patients compared to those of the control patients with other 
unselected pathology (Maggi et al., 1999 ; Seemayer et al., 2001), although the contradictory 
results have also been reported (Hirata et al., 1998).  
 
HTLV I-related retrovirus element (HRES-1/ p28) autoantigen has been suggested as a common 
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autoantibody-generating epitope in systemic lupus erythematosus (SLE). Anti-HRES-1/ p28 
antibody were detected in 21-50% of SLE patients in contrast to normal donors or HIV-infected 
patients (Perl et al., 1995). HRES-1/ p28 is a human endogenous retrovirus-encoded nuclear 
protein expressed in a tissue specific manner (Banki et al., 1992) and it resembled the peptides 
from TTV ORF1 and ORF2. HRES-1/ p28 reactive serum has been shown to recognise at least 
one TTV peptide in TTV infected patients (Gergely et al., 2005). In addition, TTV titer was much 
higher in SLE patients than in healthy relatives. Genetic factors are thought to be an important 
risk factor for SLE and TTV infection may skew the genetic factor of SLE (Gergely et al., 2006). 
However, it is not clear whether TTV enhances generation of autoantibody or the patients who 
have a immunological dysfunction tend to be more likely to harbour TTV infection than healthy 
individuals (Gergely et al., 2005).  
 
Multiple sclerosis is also a candidate TTV related disease. In one study, CD4
+
T cells taken from a 
patient with multiple sclerosis responded against the poly arginine motif of TTV ORF1 N-
terminus. It is predicted that these T cell clones were stimulated repeatedly by arginine rich 
protein and the T cells starts to recognise multiple autoantigens. Finally, the combination of the 
stimulation from TTV and other genetic and microbial factors could have a role of disease 
development (Sospedra et al., 2005). Moreover, TTV has been detected in patients with 
rheumatoid arthritis (Gergely et al., 2005; Hirata et al., 1998) and idiopathic inflammatory 
myopathy (IMM) (Gergely et al., 2005). As genotype 4 was frequently observed in the 
rheumatoid arthritis patients, it is also suggested that the specific genotype such as TTV genotype 
4 caused the rheumatoid arthritis (Maggi et al., 2007). However, the elevation of TTV load was 
not observed in the rheumatoid arthritis patients but was in patients with SLE and psoriatic 
arthritis (PsA). Finally, the authors suggested that the stimulation of TTV replication and 
autoimmune reactivity may be related but the actual causality is not confirmed (Maggi et al., 
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2007).     
 
1.5.2.5. Virus replication in bone marrow cells and haematological disorder 
In humans, double stranded circular TTV DNA is found in the bone marrow of infected 
individuals suggesting TTV replication (Okamoto et al. 2000). TTV has also been detected in 
granulocytes (Takahashi et al. 2002) and TTV replication was observed in phytohaemagglutinin 
(PHA) stimulated peripheral blood mononuclear cells (PBMC) in humans (Mariscal et al. 2002; 
Maggi et al. 2001) although virus replication was only for a short period of time and the copy 
numbers were low. This virus replication in PBMC was also confirmed by fluorescent in situ 
hybridization (Lopez-Alcorocho et al., 2000; Mariscal et al., 2002; Zhong et al., 2002) and it has 
also been speculated that virus heterogeneity may cause a preference for PBMC or other organs 
(Chan et al., 2001; Okamoto et al., 1999; Okamoto et al., 2000). Also, the erythroid linage may 
be ideal for TTV replication, because the promoter activity of TTV was strongest in K562 cells of 
erythroid origin (Kamada et al., 2004). Cells of the megakaryocyte linage could also be a 
possible replication site as thrombocytopaenia was reported in TTV infected patients (Tokita et 
al., 2002). In patients under myelosuppression, TTV DNA expression levels were decreased 
suggesting that TTV was sustained by bone marrow cells (Yu et al., 2002; Zhong et al., 2002), 
and TTV was also cleared after bone marrow transplantation (Chan et al., 2001) However, it is 
also possible that unidentified cells may be the host of TTV, or TTV different genotypes could 
show different host cell tropism.  
 
As TTV replication in bone marrow cells has been shown, links between individuals and 
haematological disorders have also been studied well. Hepatitis-associated aplastic anemia 
(HAAA) is known to occur after non-A, non-B and non-C hepatitis (Brown et al., 1997). TTV 
infection has been suggested as a contributory factor because a high level of TTV replication was 
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observed in the bone marrow of the HAAA patients (Kikuchi et al., 2000; Ishimura et al. 2010; 
Miyamoto et al., 2000). However, contradictory reports have also been published showing no 
TTV detection in HAAA patients in the epidemiological study (Poovorawan et al., 2001; Safadi 
et al., 2001). As previously discussed in section 1.2.3., TTV DNA was detected in the lymph 
nodes of patients with B-cell lymphoma and those with Hodgkin`s disease (Garbuglia et al., 
2003). It is predicted that TTV may affect the infected T cells and play the role of lymphoma 
development.     
 
1.5.2.6. Co-infections with other pathogen 
It is hypothesized that co-infection is another important factor for the development of TTV 
associated disease. Co-infection with human papillomavirus (HPV) was frequently observed in 
TTV infected women patients, and the patients with HPV infection showed higher TTV titer, 
although no cancer development was observed (Calcaterra et al., 2001). Also, in the case of 
laryngeal cancer, TTV genotype 1 and HPV co-infected patients showed the malignant 
transformation of papillomatosis and the poor clinical outcome (Szladek et al., 2005). Following 
the report, oral squamous cell carcinoma and cervical cancer were studied and showed the similar 
result (Feher et al., 2009). Higher TTV loads were observed in the gastritis patients with 
Helicobacter pylori and it is suggested that TTV may have some role in the development of 
gastritis (Maggi et al., 2003). 
 
1.5.2.7. Immunocompromised patients 
It is predicted that TTV viral titer may depend on the immunological status of host. HIV infected 
patients are more likely to have some TTV genotypes compared to the healthy individuals 
(Shibayama et al., 2001). HIV positive patients receiving highly active antiretroviral therapy 
(HAART), decreased TTV virus titer probably because of the recovery of immune system even in 
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the absence of CD4
+
 T cell number improvement (Madsen et al., 2002). Other studies have 
shown that TTV viral load is increased in HIV patients progressing toward acquired 
immunodeficiency syndrome (AIDS) and it was related to a low CD4
+
 cell count (Christensen et 
al., 2000; Sagir et al., 2004; Sagir et al., 2005; Shibayama et al., 2001; Thom et al., 2007; 
Touinssi et al., 2001). However, these studies have not established the consequence of TTV 
infection on HIV disease progression. 
 
1.6. Immunology of TTV 
Anellovirus spread in a variety of host species and show wide genetic diversity (section 1.1.4. 
and 1.2.). These facts indicate that anelloviruses have established a highly successful interaction 
with the host immune system and have thrived in the hosts leading to the presence of numerous 
genotypes. However, because of the lack of the investigational tool including sufficiently 
efficient in vitro cell culture system and easy-to-handle experimental animals (section 1.7.), 
anellovirus immunological properties are still poorly understood. Although the information of 
anellovirus related host immunological reactions are limited, we review the recent studies of the 
innate, adaptive and cell-mediated immunity. 
 
1.6.1. Innate immunity 
The first possible defense system of TTV infection is predicted to be the ciliated cells in the 
respiratory epithelium because the ciliated cells have non-specific defence function of 
continuously sweeping pathogens by using mucous secretions. It was shown that the respiratory 
tract, especially the upper tract, was continuously exposed to TTV and is predicted to be an 
important route and primary replication site of TTV infection (Maggi et al., 2003). The cell type 
of TTV replication has not shown but the ciliated cells showed the abundant TTV titers according 
to the study by using laser micro-dissected epithelial cells. Furthermore, it was shown that high 
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TTV viral load was related to the disfunction of the"mucociliary escalator" system (Pifferi et al., 
2008). This may indicate that TTV disturbed the defense system of respiratory tracts.  
 
Specific TTV proteins may function to disturb the host immune system. ORF2 of genotype 3 
TTV SANBAN strain was shown to have the potential to interfere with the activity of NF-қB. 
NF-қB is well-characterised intracellular signal transcriptional factor and NF-қB activity 
promotes virus related inflammation (Zheng et al., 2007). 
 
TTV infection is a suspected cause of asthma and acute respiratory disease (section 1.5.2.2.). 
TTV viral load had a positive correlation with the concentration of Eosinophil Cationic Protein 
(ECP) in children with acute respiratory disease (Maggi et al., 2004) and TTV load in nasal fluid 
and exhaled Nitric Oxide (eNO) also showed the positive relationship (Maggi and Bendinelli. 
2009). ECP and eNO have a complex function related to respiratory disease and have a key role 
of respiratory inflammation (Maggi et al., 2004; Pifferi et al., 2011). ECP is thought to be a 
reliable indicator of the inflammation in the clinics. Moreover, these immunological disturbances 
would be directly connected to the virus replication and produce the abundant virus-immune 
complexes.  
 
1.6.2. Adaptive Immunity  
Antibodies against TTV were detected using various methods. When TTV from faecal 
supernatants and the patient serum were mixed together, immunoprecipitation was observed. 
These precipitated pellets showed higher TTV PCR signal and the presence of TTV-specific 
antibodies were confirmed in the serum. This study showed that regardless of the presence of 
TTV DNA or not, the patients could have anti-TTV IgG antibodies (Tsuda et al., 1999).  
In spite of the many limitations of TTV research, there are several attempts to reveal the kinetics 
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of antibody production in primary infection. Sequential examination of the patients who were 
accidentally infected with TTV and chimpanzees used in TTV infectious experiments showed 
that the antibody elevation was slow similar to hepatitis C virus infection (Tsuda et al., 1999; 
Tsuda et al., 2001; Tawara et al., 2000; Ott et al., 2000). TTV-specific IgM was detected in serum 
10-21 weeks after the inoculation. This was 2-7 weeks after the appearance of TTV DNA in 
blood. Usually IgM decreased within 5-11 weeks (Tsuda et al., 2001; Kakkola et al., 2002). IgG 
appeared after IgM and lasted longer to retain a relatively constant titer. Most of these results 
came from TTV genotype-1 infection, and it is uncertain whether TTV genotype influences the 
serotypes produced, kinetics, and cross-reactivity after antibody response.          
 
The relationship between TTV ORF1 and ORF2 proteins and autoimmune disease was discussed 
in section 1.5.2.4.. Kakkola et al. (2002) provided the evidence to support TTV ORF2 
immunogenicity. TTV ORF2 can be divided into ORF2a and ORF2b (section 1.4.3.) and these 
two proteins can be produced separately by using the prokaryotes. The presence of anti-ORF2 
antibodies in the sera of 89 healthy individuals was screened using these two ORF2 proteins, and 
IgM and IgG were detected in 9% and 10% of samples respectively. In a subsequent study, 
Gergely et al. (2005) found anti-ORF2 IgG in nearly 90% of SLE patients. These results indicate 
that TTV ORF2 is immunogenic and could be associated with the development of autoimmune 
disease as discussed in section 1.5.2.4. 
 
The putative TTV capsid protein, ORF1 was also expressed by two research groups, with one 
group succeeding with production of the N-terminus (amino acid 1-411) (Handa et al., 2000) and 
the other group reporting the expression of the C-terminus (Ott et al., 2000). Both proteins were 
expressed as His-tagged fusion in E. coli. and the proteins were used to detect TTV specific 
antibody. The antibodies against N-terminus of ORF1 were detected in 38% U.S. blood donor 
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and the majority of antibody positive individuals were TTV DNA positive suggesting that the 
antibodies were not effective in preventing TTV infection or may be a marker of chronic 
infection (Handa et al., 2000). On the other hand, antibodies (IgG+IgA+IgM) against the C-
terminus of ORF1 were detected in 98.6% of sera. In the same samples, TTV-DNA was found in 
76.1% (Ott et al., 2000). However, no antibodies were detected by using the protein from N22 
region of ORF1 (120 amino acid) indicating that the immunogenesis may be region dependent 
(Lo et al., 1999).  
 
TTV particles containing immune complexes were observed in the sera of infected individuals 
(Itoh et al., 2000; Maggi et al., 2006; Tsuda et al., 1999) and the number of virions decreased 
every day (Maggi et al., 1999). These immune complexes were common in chronic viral 
infections such as HCV and HIV, however in acute infection these immune complexes were not 
observed (Nishizawa et al., 1999). It has been reported that superinfection including a genogroup 
2 TTV (ViPi04 strain which is uncommon starain in genogroup 2) and three different genotypes 
of TTV developed the rapid increase of total plasma viremia and the decrease of 
immunocomplexes in TTV infected patients. After superinfection, the immune complexes were 
recovered and it may suggest that the antibody response is effective in the acute phase of TTV 
infection (Maggi et al., 2006). 
 
1.6.3. Cell-mediated immunity             
It has been shown that there is a relationship between high TTV viral load and immune 
suppression in individuals such as the transplant recipients (Moen et al., 2003) and HIV infected 
patients (Sagir et al., 2005a; Touiness et al., 2001). CD4
+
 T cell is predicted to be inversely 




showed higher TTV level 
(Christensen et al., 2000; Sagir et al., 2005b; Thom et al., 2007) indicating that TTV viral load 
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seems to influence, or be influenced by, host immune status (Madsen et al., 2002; Sagir et al., 
2005a; Shibayama et al., 2001). Similar balance of TTV and lymphocytes was observed in 
children with acute respiratory disease (section 1.5.2.2.) and in this disease, high B cell number 
was positively related to TTV viral load but T cell number was decreasd (Maggi et al. 2003b; 
Maggi et al. 2004) . Patients with HIV related immunedeficiency alone did not show a significant 
TTV and TTMV elevation and it was not correlated to the number of CD4
+
 cells. Furthermore, 
the patients who had HAART (highly active antiretroviral therapy) decreased TTV viral load 
even without increase CD4
+
 cell number indicating that the other immunological mechanism may 
influence the viremia (Madsen et al., 2002; Moen et al., 2002).  
 
Interferon is widely used for the treatment of chronic hepatitis B and C infection. The effects of 
interferon treatment on TTV infection were also studied, and several studies showed that TTV 
and TTMV level decreased depending on the interferon treatment regimen indicating a 
suppression of TTV replication (Akahane et al., 1999; Ali et al., 2002: Chayama et al., 1999; Kao 
et al., 2003; Maggi et al., 2001; Tokita et al., 2001; Umemura et al., 2002; Watanabe et al., 
2000). Interferon was thought not to eradicate TTV because genetically identical virus reappeared 
in the patients following removal of interferon treatment. Furthermore, novel strains also 
appeared after the removal of interferon treatment indicating re-infection (Moen et al., 2003). It 
was also predicted that some specific genotypes are more resistant to interferon treatment 
(Chayama et al., 1999).       
 
1.7. Model of TTV infection 
1.7.1. Cell culture system of TTV 
One of the major TTV research problems is the lack of a suitable cell culture system. Although 
various cell lines and primary cells have been tested for their ability to support TTV replication, 
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TTV infection in these cells was not sufficient to reliably produce infectious virus. Reproductive 
form of TTV was found in bone marrow, peripheral blood mononuclear cells (PBMC) and liver 
cells (section 1.5.2.1.). As a result, the cell culture study has concentrated on using 
haematopoietic cell lines and liver cell lines. In the early experiment, the PBMC from TTV-DNA 
negative healthy individual was used in an in vitro experiment. In an experiment comparing 
stimulated PBMC and unstimulated PBMC, TTV-DNA and mRNA were detected in only 
stimulated PBMC (Mariscal et al. 2002). Accordingly, it was demonstrated that TTV could 
replicate in stimulated PBMC (Maggi et al., 2001; Mariscal et al. 2002), although virus titer is 
low. The liver also had been thought as the main site of TTV replication because TTVs were 
originally discovered from hepatitis patient (Nishizawa et al., 1997). It was reported that the clear 
morphological change such as clumping and granular degeneration was observed in the Chang 
Liver cell line (Desai et al. 2005) upon infection with TTV. TTV replication was seen in the Raji 
cell line, B-cell line (Desai et al., 2005), 293 cell human embryonic kidney, Huh7 
hepatocarcinoma cell line, and UT7/Epo-S1 myeloid cell line; (Kakkola et al. 2007) but these 
studies showed only low-level infectivity. Also, these TTV replications stopped within a short 
period of time and virus propagation was not observed in these reports (Mariscal et al. 2002., 
Desai et al. 2005., Kakkola et al. 2007., Leppik et al. 2007). Recently, human TTV subviral 
molecules were observed in the medium of TTV complete genome transfected 293TT cells and 
the subviral molecules transfected 293TT cells also produced the subviral molecules (de Villiers 
et al., 2011). However, these subviral molecules were not infectious and the copy number 
decreased over time (de Villiers et al., 2011).  
 
1.7.2. Animal model of TTV 
Another difficulty in TTV research has been the lack of a suitable animal model. Animal 
experimentation in TTV has been conducted in chimpanzee, pig and transgenic mouse.  




The first attempt to make an animal model of TTV infection was using chimpanzees. In this 
study, human TTV genotype 1 from human faecal supernatant or serum was inoculated 
intravenously into chimpanzees and they showed mild biochemical and histological change in 
liver (Tawara et al. 2000).  
 
The best animal model to date has been the infection of pigs. The international Committee on 
taxonomy of virus (ICTV) has grouped TTVs in nine genera depending on the host species. 
There are currently 2 recognised genera of anellovirus that infect pigs; Torque teno sus virus 1 
(TTSuV1), genus Iotatorquetenovirus and Torque teno virus 2 (TTSuV2), genus 
Kappatorquetenovirus. Porcine TTV also showed the high genetic diversity similar to human 
TTV infection and one individual can have at least two genotypes or subtypes in the same species 
(Gallei et al., 2010; Huang et al., 2010). TTSuV1 and TTSuV2 shared very low level of 
nucleotide identities about 50% (Huang et al., 2010; Cortey et al., 2011) and even in the same 
species, TTSuV1 and TTSuV2 showed high intraspecies variation (>30% in TTSuV1 and >15% 
in TTSuV2) (Huang et al., 2010; Cortey et al., 2011). The epidemiological character of TTSuV 
infection is similar to that of human TTV infection. TTSuV infection has been detected in swine 
serum worldwide and its infectious rate ranged from 24% to 100% (McKeown et al., 2004; 
Bigarre et al., 2005; Kekarainen et al., 2006; Taira et al., 2009; Gallei et al., 2010). Transmission 
routes are considered to be same as other TTV; faecal-oral and vertical transmission and early 
acquisition of TTSuV was observed from one year old (Martinez-Guino et al., 2009; Martinez-
Guino et al., 2010; Pozzuto et al., 2009; Sibila et al., 2009).  
 
Pigs inoculated intraperitoneally with porcine TTV genotype 1 serum  showed histological 
change such as interstitial pneumonia, transient thymic atrophy, membranous 
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glomerulonephropathy and modest lymphocytic to histiocytic infiltrates in the liver (Krakowka et 
al., 2008a; Krakowka et al., 2008b).  
 
Most TTSuV infected pigs are apparently healthy (Sibila et al., 2009b), but it is believed that 
TTSuV can be one of the key factors in the development of some diseases. Co-infection with 
PCV-2 has mainly been studied and TTSuV is considered to be related with the occurrence of 
porcine circovirus associated disease (PCVDs) such as post-weaning multisystemic wasting 
syndrome (PMWS) (Aramouni et al., 2011; Ellis et al., 2008; Kekarainen et al., 2006; Nieto et 
al., 2011) and a porcine dermatitis and nephropathy syndrome (PDNS)-like condition (Krakowka 
et al., 2008). TTSuV 2 viral titer was significantly higher in PMWS compared to healthy or 
PDNS infected pigs, but TTSuV 1 viral titer showed no difference between PCV-2 infected pigs 
and healthy pigs (Aramouni et al., 2011). However, the contradictory results have shown that 
TTSuV were not involved in PCV-2 related disease (Gauger et al., 2011; Lee et al., 2010). Also, 
TTSuV 1, but not TTSuV 2 was detected frequently from porcine respiratory disease complex 
(PRDC) affected pigs and it was concluded that TTSuV was strongly related to clinical 
multietiological condition (Rammohan et al., 2012).  
 
In addition to its role in co-infection, there were several attempts to reveal the pathogenesis of 
TTSuV single infection. Krakowka and Ellis (2008) showed the development of mild lesions by 
inoculating TTSuV containing plasma into gnotobiotic pigs. TTSuV infected pigs showed 
transient thymic atrophy, membranous glomerulonephropathy, modest lymphohistiocytic 
infiltrates in the liver and mild interstitial pneumonia (Krakowka and Ellis. 2008). Similar results 
were also observed in TTSuV2 infectious experiment by inoculating liver homogenate with 
TTSuV2 into specific-pathogen free pigs (Mei et al., 2011). Recently, a new approach was 
carried out using the porcine TTV infection system. In this method, porcine TTV concatemerised 
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DNA was directly inoculated into the piglets and virus replication was observed (Huang et al., 
2012). By using this method, TTV was not needed to be isolated in the cell culture and it is 
expected to be used in pathogenesis and biology of TTVs.  
 
Because of the lack of cell culture system (section 1.7.1.), TTVs have not been isolated and these 
experiments were performed by using the serum, faecal supernatant and liver homogenate 
(Tawara et al. 2000; Krakowka and Ellis. 2008; Mei et al., 2011). Also, even though injection of 
concatemerised TTSuV2 genome worked in vivo, it did not work for in vitro studies (Huang et 
al., 2012).   
 
The transcription profiles of TTSuV were also studied and the protein expression was performed. 
TTSuV 1 showed two transcripts encoding three predicted proteins and TTSuV 2 had two 
transcripts encoding six predicted proteins using in vitro transfection of TTSuV complete genome 
(Martinez-Guino et al., 2011; Huang et al., 2011). These predicted proteins were expressed in the 
porcine kidney cell lines. ORF1 and ORF3 expressions were located in the nucleoli and ORF2 
was expressed in the cytoplasm and nucleus excluding the nucleoli. These expressions were 
similar to those of the homologous proteins from human TTV (Martinez-Guino et al., 2011).   
 
To gain the ideal animal model, there was an attempt to infect mice with human TTV. Generally, 
human TTV does not infect mouse, and as a result, Tawara and coworkers produced the 
transgenic mice which contained TTV ORF1. These mice developed renal failure with severe 
renal epithelial cells abnormalities (Yokoyama et al. 2002).  
 
TTSuV is widely distributed in pig population and the body size and physiology of the pig are 
relatively similar to those of the human (Lunney et al., 2007). As a consequence, it is believed 
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that the pig may provide a suitable animal model system in TTV research (Kekarainen and 
Segales 2009). However, a mouse animal model would be more useful because the mice are 
small, generally easy and economic to maintain and breed prolifically. In addition, there are many 
reagents and transgenic to study pathogenesis in mice. Human TTV infection in mice is difficult 
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1.8. Project outline 
Recently, in our laboratory, rodent TTV was found in wood mouse by using RCA. In this project, 
I aim to investigate the possibility of rodent TTV as a human TTV animal model to study the 
pathogenesis of TTV. I would like to focus on the following areas.  
 
(1) Characterisation of rodent torque teno virus in wild rodent population 
(2) Transcripts identification and protein expression of rodent torque teno virus  
(3) Torque teno virus replication in vitro 
(4) In vivo experiment of Torque teno virus infection in wood mice and type I IFN receptor KO 
mice 
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2.1. Tissue samples 
Wild rodents (n=266) captured by humane traps in the United Kingdom, and laboratory mice 
(n=3) were euthanized by cervical dislocation. These rodents were provided by Anna Meredith 
and Darren Shaw (R(D)SVS, University of Edinburgh)/James Stewart (University of Liverpool). 
In addition, pet shop feeder dead mice (n=25) which were sold as snake food were used for the 
samples. Sixty-four spleen and 208 liver samples were taken from wild mice, and 4 spleen and 28 
liver samples were obtained from laboratory mice and feeder mice respectively.  
 
2.2. DNA extraction 
2.2.1. DNA extraction 
Spleen and liver samples were digested by Proteinase K (final concentration 2mg/ml) in 10 
volumes of lysis buffer (4% SDS, 0.5M Tris, 0.25M EDTA, 2.5M NaCl) at 53 ℃ overnight. 
Then, DNA purification was performed. Firstly, the digested samples were added to an equivalent 
volume of phenol:choloroform:isoamyl alcohol (IAA) (50:49:1) and vortexed vigorously. 
Secondly, the mixture was centrifuged >15,000xg for 4 minutes to separate the organic and 
aqueous phase. The aqueous phase was transferred into a fresh 1.5ml microcentrifuge tube 
(Eppendorf, UK) and repeatedly extracted with phenol:chloroform:IAA until no protein was 
visible. Thirdly, the aqueous phase was totally mixed and purified with the chloroform only and 
centrifuged >15,000xg for 4 minutes and carefully removed into a fresh 1.5ml microcentrifuge 
tube (Eppendorf, UK). Finally, the DNA was concentrated by ethanol precipitation. The aqueous 
phase in the 1.5ml microcentrifuge tube (Eppendorf, UK) was added to 1/10 volume of 3M 
sodium acetate (ph5.2) and 2.5x volume of cold 95% ethanol (v/v), mixed and precipitated at -
20°C for at least 2 hours and the mixture was centrifuged at >14,000xg for 30 minutes. The 
supernatant was discarded and the DNA pellet was washed with 70% (v/v) ethanol and 
resuspended in DNase-RNase free water.  
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In order to extract DNA from faeces, DNA was extracted by using QIAamp
® 
DNA Blood Mini 
kit (QIAGEN). Faeces were mixed with PBS and centrifuged at 15,000xg for 5 minutes. The 
supernatant was taken for DNA extraction. DNA extraction was performed following the 
manufacturer's instructions. Briefly, 20µl proteinase K, 200ul faecal supernatant 200AL Buffer 
were mixed together and incubated in 56℃ 10 minutes. After that, 200µl 96-100% ethanol (v/v) 
was added to the digested samples and these sample mixtures were applied in QIAmp spin 
column and centrifuged at 6000xg for 1 minute. QIAmp spin column was washed by using AW1 
and AW2 Buffer. DNA was eluted by using 50µl AE buffer.  
    
2.2.2. Quantification of DNA 
DNA quantification was performed by the Nanodrop ND-1000 spectrometer (Nanodrop 
Technologies, Inc). A 2µl aliquot of distilled water was used for blank measurement. Then, 2µl 
DNA sample was applied to measure DNA concentration and purity. For screening PCR analysis, 
DNA was diluted with DNase-RNase free water to give a concentration of 250 mg/ml.  
 
2.3. RNA methods 
2.3.1. Tissue collection and storage 
For RNA work, wild wood mice were captured by humane trap and euthanized by cervical 
dislocation. They were dissected and lung, kidney, liver, spleen, and bone marrow were taken. 
These tissues were cut finely and fixed in RNA later
TM
 (Ambion) 4℃ overnight. After that, these 
tissues were stored in -20℃ freezer.  
     
2.3.2. RNA extraction 
DNA and RNA from infected wild mice were extracted by using All Prep mini kit (QIAGEN) 
according to the manufacturer's instructions. Briefly, up to 30mg tissue was homogenised using a 
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sterile plastic pestle (Sigma) in Buffer ALT. The viscous lysates were put into an All prep DNA 
spin column and centrifuged for 30s at ≥ 8000 x g (≥10,000 rpm).  
 
For the RNA extraction, 96-100% ethanol (v/v) was added to the flow-through from the previous 
step, applied to an RNeasy spin column, and loaded on the column by centrifugation. Then, the 
RNeasy spin column was washed with using RW1 and Buffer RPE. After RW1 wash, on-column 
DNase digestion was carried on. Finally, 50µl RNase-free water was applied in the spin column 
membrane to elute the RNA.  
 
For the DNA extraction, the All prep DNA spin column washed with 500ul of buffer AW1 and 
AW2. The All prep DNA spin column was then centrifuged at full speed for 2 minutes to remove 
the buffer. Finally, DNA was eluted by 50µl of Buffer EB.   
  
2.3.3 DNAse digestion of mouse total RNA using TURBO DNA-free
TM
Procedure. 
During the RNA extraction, on-column DNase digestion was performed. However, by this 
method, the TTV genome DNA concentration was too high to be removed completely from 
mouse total RNA. For this reason, TURBO DNA
TM
 DNase (Life technologies, UK.) treatment 
was used for DNA digestion. In the ABgene 0.2ml strip tube (Thermo scientific, UK.), 8µl total 
RNA, 1-2µl 1X TURBO Dnase (2U), and 1µl 10X TURBO Dnase Buffer were mixed together 
and incubated in 37℃ 30 minutes. Afterwards, 2µl DNase inactivation Buffer was added to 
remove DNase.   
2.3.4. Measurement of quality and quantity of RNA by using Agilent RNA 6000 Nano 
RNA quality and quantity was measured by using Agilent RNA 6000 (Agilent Technologies, Inc.) 
following the manufacturer’s protocol. RNA 6000 Nano gel matrix was prepared in new RNA 
6000 Nano chip and 1µl RNA was loaded in the well. After the horizontal vortex, the chip was 
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set up and run in the Agilent 2100 bioanalyzer according to manufacturer's instruction.     
 
2.4. Reverse transcription of RNA 
cDNA was generated from total RNA using Superscript
TM
 III Reverse Transcriptase (Invitrogen). 
In ABgene 0.2ml strip tube (Thermo scientific, UK.) tube, 8µl of DNase treated RNA was 
incubated with 50ng random primers and 1µl 10mM dNTP mix in a total volume of 13µl for 
5min at 65℃. The mixture was immediately chilled on the ice for 2 minutes. 4µl 5x First-strand 
buffer, 1µl 0.1M dithiothreitol (DTT), 1µl (40 U) RNAse OUT and 1µl SuperScript III RT 
(200U) was added to the RNA/Primer/dNTP mixture. When random primers were used for RT, 
the mixture was incubated at the room temperature for 5min. Then, the mixture was incubated at 
50℃ for 1 hour prior to inactivating the reaction at 70℃ for 15 min. Then, 1µl (2U) E. coli 
RNase H was added and the reaction mixture was incubated at 37℃ for 20min to remove RNA 
complementary to the cDNA. For the PCR, 1-2µl cDNA was used.  
 
2.5. Polymerase chain reaction (PCR)  
2.5.1. Standard PCR/primer design 
Standard PCR were performed using GoTaq DNA polymerase (Promega). Reactions were 
performed by using 37.2 μl of water, 10 μl of 10x buffer, 1 μl of 10mM dNTP (Promega), 1 μl of 
10mM forward and reverse primer, and 0.5 μg samples of extracted nucleic acid as template 
under the following conditions: 30 cycles of [18 seconds at 94°C, 30 seconds at 50°C and 90 
seconds at 72°C] and a final extension of 6 minutes at 72°C. Primer sequences are displayed in 
Table 2.5.1. 
 
2.5.1.1. Pan-TTV primers used for the screening 
The sets of degenerate primers (pan-TTV primer) used for screening TTV infection were 
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constructed by using the sequence result from the published data (Thom. et al., 2003) and hemi-
nested primers were designed based on the three parts of highly conserved UTR sequences. In 
addition, we modified the primer design to detect RoTTV for screening the wild rodents. These 
primers are designed to recognise the untranslated region (UTR) which is highly conserved in 
TTV genome structure and this primer set should detect all currently known TTV. PCR was 
performed by hemi-nested pan-TTV primer shown Table 2.5.1. PCR condition was followed by 
standard PCR (section 2.5.1.) 
 
2.5.1.2. Screening PCR using genotype specific primer (ORF1 primer) in wild rodent  
Two sets of primer pairs for each rodent TTV genotype were designed based on the complete 
rodent TTV sequence. These primers should bind sequences in open reading frame 1 (ORF1 
primer). PCR reactions for screening TTV were performed using GoTaq DNA polymerase 
(Promega) (section 2.5.1.) and genotype specific ORF1 screening primer shown Table 2.5.1. PCR 
condition was followed by standard PCR (section 2.5.1.) 
  
2.5.2. Full genome-length PCR 
Amplification of complete genome was carried out using AccuPrime
TM
 Taq High Fidelity 
(Invitrogen). Reactions were performed using 2.5 μl of 10x AccuPrime
TM
 PCR Buffer I, 20.4 μl 
of water, 0.5 μl of  AccuPrime
TM
 Taq High Fidelity, 0.3 μl of 10mM forward and reverse primer 
and 1 μl amplified DNA by rolling circle amplification (RCA, section 2.10.2) as template, and 
the inverted primers shown Table 2.5.1. PCR programme was set up as follows: 30 cycles of 18 
seconds at 94 °C for denaturation, 21 seconds at 50 °C and 3 minutes at 72 °C, and in the end, a 
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Target Orientation Length Sequence 
PAN TTV Screening Primer (used in 3.2) 
TTV UTR CVOS Sense Inner 22 5' VRV RTK MCG AAT GGC WGA GTT T 3' 
TTV UTR CVOA Antisense Outer 20 5'  WGC CCG ADT TGC CCC TTR MC 3' 
TTV UTRCVIA  Antisense Inner 16 5'  CCT YCG RYW CCC GCC C 3' 
TTV Full-length PCR Primer (used in 3.4) 
RoTTV Gt1a Sense  29 5' GGG ACC GGG CGA GTA TCT AGC TGC GAA GC 3' 
RoTTV Gt1a Antisense 30 5' CCG GTC TCG CAS AGW AAA CTC WGC CAT TCG 3' 
RoTTV Gt1b Sense  29 5' GGG ACC GGG CGA GTA TCT AGC TGC GAA GC 3' 
RoTTV Gt1b Antisense 28 5' GCT TCG CAG CAA GTT ACT GCC CGG TCC C 3' 
RoTTV Gt1c Sense outer  25 5' CGC AGC AGC GCG TCT ATA AAC CAT C 3' 
RoTTV Gt1c Antisense outer  26 5' CGC TGA TGT GTT ACT GCC CGG TCC CG 3' 
RoTTV Gt1c Sense inner  25 5' CCG GCG GCC TGG GCG GGA ATC GGA G 3' 
RoTTV Gt1c Antisense inner  26 5' CGC AGC AAA AAC TCA GCC ATT CGT CAT CT3' 
RoTTV Gt2 Sense  24 5' CGA CGA GAC RMA GTC GGR AAG GAG 3' 
RoTTV Gt2 Antisense 31 5' CGT CCT CTG ACA GCA TAA ACT CWG CCA TTC G 3' 
Genotype specific ORF1 TTV Screening Primer (used in 3.7) 
RoTTV Gt1 ORF1  Sense outer  21 5' CGH ACC TAC MGA CGM AGA RCT 3' 
RoTTV Gt1 ORF1  Antisense outer  24 5' CHA CCA TRT CAA ABC CAC ART TRC 3' 
RoTTV Gt1 ORF1  Sense inner 22 5' AST AGR AGA TGT GTK ATC AGA A 3' 
RoTTV Gt1 ORF1  Antisense inner   23 5' CCC ATC CAY ARK TCA CTV CCA TC 3' 
RoTTV Gt2 ORF1 Sense outer  20 5' TTC GTT ACC CTC GCC GGA AC 3' 
RoTTV Gt2 ORF1 Antisense outer  21 5' ACC CTT GGT TGC TTT TGG ACC 3' 
RoTTV Gt2 ORF1 Sense inner  19 5' CCG CCG AAG GGT AAG GAG G 3' 
RoTTV Gt2 ORF1 Antisense inner   21 5' CTC TCC AGA AYC TCT CTT CCC 3' 
Table 2.5.1. Primer pair which were used for TTV screening and amplification of complete genome.  
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2.5.3.Agarose gel electrophoresis 
PCR amplicons were visualised by agarose gel electrophoresis. The agarose gels (2% gel (w/v) 
for less than 1 kbp DNA and 1% gel (w/v) for more than 1kb and less than 3 kbp DNA) were 
made by dissolving LE agarose powder (Promega) into TAE buffer and adding SYBR® Safe to 
stain the DNA (Invitrogen). Then, the product size was determined by visualising and comparing 
bands and ladder under UV light by using UV-transillumination advanced imaging system. 
 
2.6. RFLP (Restriction Fragment Length Polymorphism) for identification of species 
For species identification, degenerate primers were designed based on the rodent mitochondrial 
cytochrome B sequence (Mt Forward: CACTAYACATCAGAYACAWYAACAGC and Mt 
Reverse: TARGGGTGRAAYGGRATTTTRTC). PCR reaction was carried out by using 1 µl 
DNA extraction samples as template. PCR programme was set up under the following condition: 
30 cycles of 18 seconds at 94 ℃ for denaturation, 21 seconds at 50 ℃ and 90 seconds at 72 ℃, 
and a final extension of 5 minutes at 72 ℃ was performed. 
 
To identify the mouse species, suitable restriction enzymes were chosen based on the mouse 
sequences. House/lab mouse (Mus musculus), field vole (Microtus agrestis), wood mouse 
(Apodemus sylvaticus) and bank vole (Myodes glareolus) sequences were submitted in NEB 
cutter web site (http://tools.neb.com/NEBcutter2/) and RsaI and AccI were found to be suitable. 
The restriction enzyme reactions were performed in ABgene 0.2ml strip tube (Thermo scientific, 
UK.) containing 5µl mitochondrial PCR products, 0.5µl restriction enzyme, 3µl NEB buffer 4 
and 21.5µl nuclease-free water, and incubated at 37℃ 30-45 minutes. PCR amplicon was 
digested by RsaI to identify house mouse and field vole, and then AccI was utilized to find wood 
mouse and bank vole.    
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 2.7. PCR product column purification and gel extraction  
2.7.1. MinElute
® 
PCR purification kit 
DNA digested by restriction enzymes, PCR amplified products, and T4 ligated DNA were 
purified by MinElute
® 
PCR purification kit following the manufacturer's protocol. Briefly, 5 
volume of Buffer PB was mixed to 1 volume of PCR product and put into MinElute column and 
centrifuged at 15,000 for 1 minute. After that, MinElute column was washed by Buffer PE and 
DNA was eluted in 15µl Buffer EB.  
 
2.7.2. QIAquick gel extraction kit 
DNA was extracted from agarose gel slices using QIAquick gel extraction kit following the 
manufacturer's protocol. Briefly, 3 volumes of Buffer QG were added to a 1.5ml microcentrifuge 
tube containing 1 volume of gel and the tube was incubated in 56℃ for 10 minutes. Then, 1 
volume of isopropanol was added to gel-resolved Buffer QG and the solution was transferred to a 
QIAquick column and centrifuged at 15,000 for 1 minute. QIAquick column was washed with 
Buffer PE and the DNA was eluted in 50µl Buffer EB.  
 
2.8. Sequence     
2.8.1. Nucleotide sequence 
Sequencing was carried out using BigDye Terminator v3.1 (Applied Biosystems) according to 
the manufacturer’s instructions. BigDye reaction was carried out in ABgene 0.2ml strip tube 
(Thermo scientific, UK.) which contained 7.5µl nuclease-free water, 2.7µl 5x BigDye Buffer, 
0.6µl primer, 0.2µl BigDye Terminator v3.1, and 1µl PCR products. BigDye reaction was 
performed under following conditions: 20 cycles of 30 seconds at 96℃, 20 seconds at 50℃, and 4 
minutes at 60℃. Sequences were read at the University of Edinburgh GenePool Sequencing 
Service. Sequences, with vector nucleotides removed, were submitted for analysis using the 
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NCBI Basic Local Alignment Search Tool for nucleotide or translated sequence homology (blastn 
or blastx). Sequences were considered candidate viruses if the top hits of either BLASTn or 
BLASTx were viral in origin. 
 
2.8.2. Protein coding sequence 
Protein coding sequences in complete genomes were identified using either Simmonic Sequence 
Editor v1.6 software or NCBI ORF Finder. The sequence data from section 2.8.1 were submitted 
to these programmes and the predicted proteins were analysed using NCBI protein BLAST. 
Phylogenetic trees based on the virus complete sequences were constructed using MEGA 
(version 4.1).  
 
Rodent TTV genomic map was constructed by using DNASTAR Lasergene 9 core Suite. Rodent 
TTV complete genomes were submitted and rodent TTV genomic maps were compared to the 
results of ORF finder which was mentioned above.  
 
2.9. Molecular cloning  
2.9.1. Ligation 
For Taq polymerase (Promaga) (section 2.5.1.) or AccuPrime
TM
 Taq High Fidelity PCR 
amplicons (Invitrogen) (section 2.5.2.), the pGEM®-T Easy vector kit (Promega) was used for 
ligation and transformation. For ligation reactions, 2.5μl 2x ligation buffer, 0.5μl pGEM®-T Easy 
vector, 0.5μl T4 DNA Ligase and 1.5μl PCR amplicon were mixed in a PCR tube and incubated 
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2.9.2. Transformation of competent cells with plasmid DNA 
The recombinant DNA was inserted into DH 5α
TM
 competent cells (Invitrogen). The ligation 
mixture was transferred into the tubes containing competent cell (150μl) and incubated on ice for 
30 minutes. After this, the tube was put into the 42℃ water bath for 30 seconds before cooling 
back in ice for 2 minutes. In the tube, 150μl LB broth was added to the competent cells-ligation 
reaction mixture. The cells were incubated at 37℃ for 1 hour with horizontal shaking. The cells 
were spread on LB agar plates containing ampicillin (100μg/ml), IPTG (0.5μM), and X-gal 
(80μg/ml) and incubated at 37℃ overnight. 
 
2.9.3. Colony screening PCR 
For colony screening, primers specific for the M13F (GTA AAA CGA CGG CCA G) and M13R 
(CAG GAA ACA GCT ATG AC) sites located on opposite sides of the multiple cloning site of 
the pCR-Blunt II-TOPO (section 2.10.3.) or pGEM T easy vector were used. Plasmid-containing 
colonies were picked from LB/Agar plates directly into PCR master mix. Reactions were 
performed under the following conditions: Initial bacterial lysis/denaturation 2 minutes at 94°C, 
30 cycles of [18 seconds at 94°C, 30 seconds at 50°C and 90 seconds (3min when PCR products 
is 2-3kb) at 72°C] and a final extension of 6 minutes at 72°C.   
 
2.9.4. Plasmid DNA extraction 
2.9.4.1. Small scale isolation of plasmid DNA using a QIAprep Miniprep kit QIAGEN 
Plasmid DNA was extracted from the competent cells using miniprep kit (QIAGEN, UK) 
according to the manufacturer's protocol. Briefly, a single isolated bacterial colony was incubated 
in 5ml sterile LB broth containing the required antibiotics (100ug/ml ampicilline) for 37℃ 
overnight. The culture was centrifuged at full speed for 5 minutes and the supernatant was 
discarded. The pellet was resuspended in Buffer P1. After that, Buffer P2 was added and mixed 
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by inversion. Buffer N3 was then added to the mixture and mixed by inversion. The tubes were 
centrifuged for 10min and the supernatant was applied in QIAprep spin column. The column was 
centrifuged and washed by Buffer PB and Buffer PE. Finally, plasmid DNA was eluted into 20µl 
of buffer EB.  
 
2.9.4.2. Large scale isolation of plasmid DNA using an Endo free maxiprep 
Plasmid DNA was extracted from the competent cells using Endo free maxiprep (QIAGEN, UK) 
according to the manufacturer's protocol. Briefly, 250ml LB broth which contained a single 
colony was incubated in 37℃ overnight. The culture was centrifuged at 6000 x g for 15 minutes 
at 4℃. The cell pellets were resuspended by Buffer P1 and Buffer P2 was added in the mixture 
and incubated in 5min. Buffer P3 was added and applied in QIAfilter cartridge and incubated in 
10min at room temperature. The mixture was filtered and Buffer ER was added to the filtered 
mixture. Then, the mixture was incubated 30 min on ice. The mixture was applied to a QIAGEN-
tip 500 and was washed with Buffer QC twice. The plasmid DNA was eluted by Buffer QN and 
the eluted DNA was precipitated by the isopropanol. The DNA pellet was washed by 70% 
ethanol and redissolved by 1ml Buffer TE.  
 
2.9.5. T4 ligation by using NEB T4 ligase  
T4 ligation was carried out in ABgene 0.2ml strip tube (Thermo scientific, UK.) which contained 
8µl distilled water, 1µl T4 ligation buffer (NEB), 1µl T4 ligase (NEB) and 100ng DNA. The 
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2.10. Construction of DNA libraries 
2.10.1. Gel extraction  
Before making a library, DNA was purified by agarose gel extraction. First, 5000µg DNA sample 
was run on agarose gel with 1kb ladder (DNA electrophoresis). Then, the area from 500 to 
3000bp in agarose gel which should contain virus DNA was taken. After that, the agarose gel was 
extracted from the gel slice using QIAquick gel extraction kit (section 2.7.2.) and eluted in 30μl. 
 
2.10.2. Rolling Circle Amplification  
Rolling circle amplification (RCA) was performed by using the Repli-G Mini Kit (Qiagen) 
following to manufacturer’s instructions with the exception that Phil-29 polymerase (NEB) was 
utilized as enzyme instead of the supplied enzyme, and the denaturation step before amplification 
was omitted. About 10-100ng DNA from liver or spleen was used as a template for rolling 
cycling amplification. The reaction was performed in 0.6 ml tube containing 1μl NEB phil-29, 
29μl reaction buffer and 10μl H2O and the mixture was incubated at 30℃ overnight.  
 
2.10.3. Digestion by restriction enzyme and cloning and sequence 
RCA amplicons were digested by BstUI restriction enzyme (NEB) at 50℃ for 4 hours and 
terminal phosphates were removed by Antarctic phosphatase (NEB) following to the 
manufacturer’s instructions. Then, DNA fragments were purified with QIAquick gel extraction 
kit (section 2.7.2.) and eluted in 30μl. These DNA fragments were ligated into the pCR-Blunt II-
TOPO vector (Invitrogen) and was transformed into One shot ® Top 10F’ chemically competent 
E. coli. Ligations were performed in ABgene 0.2ml strip tube (Thermo scientific, UK.)  
containing 2μg PCR product, 0.5μg salt solution and 0.5μg PCR® II-Blunt-TOPO®. Reactions 
were incubated at room temperature 5 minutes. The ligation mixture was transferred into tubes 
containing One shot ® Top 10F’ chemically competent E. coli (150μl) (Invitrogen) and it was 
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incubated on ice for 30 minutes. After that, this tube was put into the 42℃ water bath for 30 
seconds before cooling back on ice for 2 minutes. Then, 250μl S.O.C broth (Invitrogen) was 
added into the competent cells-ligation reaction mixture. The cells were incubated 37℃ at 1 hour 
with horizontally shaking. The cells were spread on LB agar plates containing kanamycin 
(50μg/ml).  
 
2.11. Development of assay for gene expression analysis using quantitative real-time 
polymerase chain reaction (real-time-qPCR)  
2.11.1. Generation of standard curve by using TTV complete genome plasmid. 
To set up the standard curve, rodent TTV complete genome containing plasmids were serially 






copies/µl. The number of copies of plasmid in a microliter 
was determined using the following formula: 1µg of 1000bp DNA = 1.52 pmol = 9.1 x10
11
 
molecules. In the RoTTV1 plasmid, 9.1 x 1/ 5,298bp (TTV complete genome 2,283bp and 
pGEM-T easy vector 3,015bp) = 1.72 x 10
11 
TTV copies/µg. DNA concentration (ng/µl) was 
measured by using Nanodrop (section 2.2.2) and 1.72 x 10
11 
TTV copies/ µg x DNA 
concentration (ng/µl) (change to µg/µl) = TTV copies/µl. In the RoTTV2, 9.1 x 1/ 5,564kbp 
(TTV complete genome 2,549bp and pGEM-T easy vector 3,015bp) = 1.64x 10
11 
TTV copies/µg. 
DNA concentration (ng/µl) was measured by using Nanodrop (section 2.2.2) and 1.64 x 10
11 
TTV 
copies/ µg x DNA concentration (ng/µl) (change to µg/µl) = TTV copies/µl.  
 
2.11.2. Components of Real Time PCR reactions 
Real time PCR analysis was performed using a Rotorgene (Corbett Research, Australia) and a 
hydrolysis probe based detection solution (Taqman
®
) for q-PCR and q-RTPCR. Reactions were 
carried out in a 20µl final volume which contained 8µl water, 10µl Brilliant III ultra Fast QPCR 
Master Mix (Agilent Technologies, USA) and 50pmol of each primer and probes shown in Table 
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2.11.2. (Primer design, UK). Each reaction contained 1µl of extracted DNA as a template to 
measure the copy number. Negative control was ready in parallel with dH20
 
used in place of 
template DNA. Standard dilution reactions were performed with plasmid DNA by diluting in 
50ng/µl salmon sperm DNA (Fisher Scientific UK Ltd, UK). Reactions were carried out in 0.1ml 
tubes (Corbett Research, Australia). Following a hot start at 95℃ for 10 minutes to activate the 
hot start Taq polymerase, the samples were amplified for 50 cycles. The PCR programme was a 
two-step qPCR programme and the cycles consisted of 95℃ for 15 seconds (denaturation) and 
60℃ for 60 seconds (Data collection). All samples including the standard dilutions and negative 
controls were run in duplicate to assess accuracy during reaction set-up.  
 
Table 2.11.2. The primer pairs and probes used for the real-time PCR. 
  
2.12. Rapid amplification of 5' and 3' cDNA ends (RLM-RACE) 
RACE was performed using the GeneRacer
TM
 Kit (invitrogen) according to manufacturer’s 
instructions. Briefly, the 5' end of wild mouse RNA or cell culture RNAs was ligated to the 
GeneRacer
TM 
RNA Oligo. The GeneRacer oligo gives a known priming site for the PCR, and 
Target Orientation Length Sequence 
RoTTV1 primer (used in 5.3.) 
RoTTV1 Sense 24 5' CGY ACT AGA AGA ACT AGA AAA TGG 3' 
RoTTV1 Antisense 23 5' CCT CTG ATA ACA CAT CTC CTA GT 3' 
RoTTV2 primer (used in 5.3.) 
RoTTV2 Sense 19 5' ACC AGM AGC TCC AGA CAC A 3' 
RoTTV2 Antisense 20 5' GTA GTC CTC CCC TTG CAG TA 3' 
Probes: target, probe name, length, sequence 
RoTTV1 RoTTV1a 27 5' TCT GAC CTT GAG GTT CCT TCT CCC GCG 3' 
RoTTV2 RoTTV2 32 5' ACA TCA GAG ACC CAA CAS AAA TCA ATC ACG AG 3' 
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this GeneRacer oligo attached mRNA is transcribed into cDNA by using random primers and 
superscript III following the protocol in section 2.4. Finally, the cDNA was amplified by using 
GeneRacer
TM 
5' primer and reverse gene specific primer shown in Table 2.12.1 and Table 
2.12.2. In the 3' Race, mRNA was reverse transcribed using the GeneRacer
TM
 Oligo dT Primer 
to create the 3' priming site for the PCR. Subsquently, PCR was carried out using GeneRacer
TM
 
3' Primer and forward gene specific primer shown in Table 2.12.1 and Table 2.12.2. 
 
PCR was performed by using AccuPrime
TM
 Taq High Fidelity (Invitrogen) (section 2.5.2.). 
Nested     touchdown PCR was chosen to remove the non-specific PCR products. Touchdown 
PCR programme was set up under the following condition: 5 cycles of 5 seconds at 94 °C, 3 
minutes at 72°C, then, 5 cycles of 5 seconds at 94 °C, 3 minutes at 72°C, and finally 25 cycles 
of 5 cycles of 5 seconds at 94 °C for denaturation, 10 seconds at 68 °C and 3 minutes at 72 °C. 
This first round PCR product was diluted 5µl in 245µl with distilled water and 5µl diluted first 
PCR products were used as the template for second round touchdown PCR and the programme 
was changed to 20 cycles in final step of touch-down PCR. The amplified PCR was cloned and 













Target Orientation Length Sequence 
GeneRacer
TM



















3' primer  
Sense Inner 23 5' CGC TAC GTA ACG GCA TGA CAG TG 3' 
3' Race Gene specific primer  
ORF2 Gt1a OS Sense Outer 27 5'CCT GGA CCA CAC ACT TGA AGA CCC TAC 3' 
ORF2 Gt1a IS Sense Inner 30 5' GGC GTG GAG ATT CCC AAG ACA GAG ARC C3' 
O3 Race Out Sense Outer 31 5' GGT ACA CGA CAA GCA AGA ACA CCG ACA CCA G 3' 
O3 Race In Sense Inner 32 5' CAC CGA CAC CAG CTC GAC AGA ATC ATC ATC AG 3' 
Whole transcript primer 
ORF2 OS Sense Outer 30 5' GAT TTT ATC TAC AAG GAG GAT TCA TGG CTG 3' 
ORF2 IS Sense Inner 27 5' GGC TGT GCA TGA TCA GGC AAA CTC ATG 3' 
ORF3 OAS Antisense Outer 30 5' GAT AAC TGA GGA TCC ACA GGC ACA TTG GAG 3' 
ORF3 IAS Antisense Inner 30 5' CAT ATT TTG AGA AGG TGT CAG TGG CGG CCC 3' 
5' Race Gene specific primer  
5 O2 OUT Antisense Outer 29 5' GTT CTT CTA GCA CGC CGA GCA GTT CTT CG 3' 
5 O2 IN Antisense Inner 29 5' GTA GGT GCG CCG TCT GGT TGG TCT CCA GG 3' 
Table 2.12.1. GeneRacer primer and race gene specific primer to detect the transcript of RoTTV1 
 
 





Target Orientation Length Sequence 
3' Race Gene specific primer 
Gt2 3Race O Sense Outer 29 5' CCG ACT CTT CTG TGA CTG CGG GGA CCC TG 3' 
Gt2 3Race I Sense Inner 30 5' GTA CTT CTA CCG GCG GAC CTT TCG TTA CCC 3' 
Whole transcript primer 




27 5' CTC ACC AAC TAA TTT CAA TCC CAC ATC 3' 
Gt2 O4 end IAS 
Antisense 
Inner 
27 5' CAA ACG GGC GGT GGA TGG GTG ACA CGG 3' 
5' Race Gene specific primer 
Gt2 5Race O 
Antisense 
Outer 
29 5' GTT CTT CTA GCA CGC CGA GCA GTT CTT CG 3' 




5' CAG GGT CCC CGC AGT CAC AGA AGA GTC GG 
3' 
Table 2.12.2. Race gene specific primer to detect the transcript of RoTTV2 
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2.13. Protein expression of rodent TTV transcripts 
2.13.1. Primer design of RoTTV transcripts amplification 
For the protein expression, pEGFP-C1 (Clotech) and pcDNA 
TM 
3.1/ myc-His (-) A MCS 
(Invitrogen) were used for the protein expression. To combine the protein predicted coding 
sequence to the plasmids, the coding sequences were amplified by using the primer pairs which 
contained the restriction sites. The primers used for this study were shown in Table 2.13.1. PCR 
programme was same as the standard PCR shown in 2.5.1. Bone marrow cDNA from an infected 
mouse was used as the template for the spliced transcripts and TTV complete genome was used 
as the template for un-spliced transcripts. For the spliced transcripts, nested PCR was carried out 


























 round PCR to amplify the spliced transcripts 
TC-1st PCR; F Sense 34 5' CAG GAT GAA TGT GGA TGT GGA TGA AGA TTT TAT C 3' 
TC-1st PCR; R Antisense 23 5' CAG AAT TCA ATG TTT ATT GGG GG 3' 
†
pEGFP-C1 restriction site containing primer      5' GG(CC)---restriction site--primer 3' 
pEGFP-C1 ORF1:F 
Restriction site; HindIII 
Sense 34 
5' GG---A AGC TT---- 
                   C CAT GGC GTG GAG ATT CCC AAG ACA GAG 3' 
pEGFP-C1 ORF1:R 
Restriction site; Xba I 
Antisense 34 
5' CC---T CTA GA--- 
                                G GTG ACA GGA ACA TCC ATG TCT GG 3' 
pEGFP-C1 ORF1-4:R 
Restriction site; Xba I 
Sense 29 
5' CC---T CTA GA--- 
                                         A ATA CAG ACG ACT CTG TTG AG 3' 
pEGFP-C1 ORF2 :F 
Restriction site; HindIII 
Sense 34 
5' GG---A AGC TT--- 
                           C CAT GAA TGT GGA TGA AGA TTT TAT C 3' 
pEGFP-C1 ORF2:R 
Restriction site; Xba I 
Antisense 29 
5' CC---T CTA GA--- 
                                         T GAG AGG ACA CAT AAT GCC TA 3' 
pEGFP-C1 ORF2-3:R 
Restriction site; Xba I 
Antisense 31 
5' CC---T CTA GA--- 




3.1/ myc-His(-) A MCS restriction site containing primer          5' GGG(CCC)---restriction site--primer 3' 
pcDNA ORF1:F 
Restriction site; Xba I 
Sense 35 
5' GGG ---CT AGA--- 
                         ATG GCG TGG AGA TTC CCA AGA CAG AG 3' 
pEGFP-C1 ORF1:R 
Restriction site; HindIII 
Antisense 32 
5' CC---A AGC TT--- 
                               G GTG ACA GGA ACA TCC ATG TCT GG 3' 
pEGFP-C1 ORF1-4:R 
Restriction site; HindIII 
Antisense 29 
5' CC---A AGC TT--- 
                                         A ATA CAG ACG ACT CTG TTG AG 3' 
pEGFP-C1 ORF2:F 
Restriction site; Xba I 
Sense 33 
5' GGG---TCT AGA--- 
                                   ATG AAT GTG GAT GAA GAT TTT ATC 3' 
pEGFP-C1 ORF2:R 
Restriction site; HindIII 
Antisense 29 
5' CC---A AGC TT--- 
                                         T GAG AGG ACA CAT AAT GCC TC 3' 
pEGFP-C1 ORF2-3:R 
Restriction site; HindIII 
Antisense 31 
5' CC---A AGC TT--- 
                           A TGT TTA TTA TTG GGG GAT AAC TGA G 3' 
Table 2.13.1. The primers which were used to construct the transcripts containing pEGFP-C1 and 
pcDNA 
TM 
3.1/ myc-His(-) A MCS. *For the spliced transcript, 1
st
 PCR primers were used for the 
amplification for the first round PCR. 
†
The primers which have the restriction site to inset to the plasmid. 
†
They also have extra G or C to avoid the mispriming of restriction site.   
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2.13.2. Transfection of pEGFP-C1and pcDNA 
TM 
3.1/ myc-His(-) A MCS constructs  
The plasmids which contain the coding regions identified from the transcripts were transfected by 
using lipofectamine
TM
 2000 reagent (Invitrogen, UK) following the manufacturer's protocol. 
Briefly, 5 x 10
4
 of BHK cells (section 2.15.1.1.) were seeded into 24 well plates and incubated 
one day before the transfection. Two µg of plasmid DNA was diluted in serum/antibiotic free 
growth medium to make the total volume 50µl and the 1µl of lipofectamine 2000 was diluted in 
serum/antibiotics free growth medium to make the total volume 50µl. Diluted lipofectamine was 
incubated in 5 minutes at the room temperature and mixed with the diluted plasmid, and the 
mixtures were incubated 20 minutes at room temperature. The mixture was added to the well in 
24 well plates which contained 150µl growth medium and cells and incubated 5 hours at 37℃ in 
humidified 5% CO2. Because of the toxicity of lipofectamine 2000, if the cells were fragile (such 
as the stem cell culture), the medium had to be replaced with the fresh medium after 5 hours and 
the cells were incubated 24-48 hours.  
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2.13.3. Harvesting for western blot 
Adherent cells were removed from the tissue-culture flask by pipette tip to harvest the cells. 
Firstly, the growth medium was taken from the well and the proteinase inhibitor (cOmplete 
ULTRA Tablet, Roche) dissolved in PBS was put into the well. The bottom of the flask was 
scratched by the pipette tip and the removed cells were kept in 1.5ml microcentrifuge tubes 
(Eppendorf, UK). Samples were centrifuged for 5 minutes for 450 x g. The supernatant was 
discarded and one volume of 2x sample buffer Laemmli (Sigma-Aldrich) was added to the 
sample and boiled for 5 minutes. The samples were used for western blot (section 2.14.).   
    
2.13.4. Staining of Transfected Cells  
For the staining, 2x 10
4 
cell of BHK-21 cells (section 2.15.1.1. ) were seeded into BC Falcon 
Culture slide 8 well (Scientific Laboratory Supplies Ltd., U.K.) and were incubated at 37℃ with 
5% CO2 for 24-48 hours to 70% confluence. 0.8 µg of pEGFP-C1 and pcDNA 
TM 
3.1/ myc-His(-
) A plasmid constructs were transfected into these BHK-21 cells (section 2.13.2.) and incubated 
at 37℃ with 5% CO2 for 24-48 hours until 85-90% confluent.  
 
For the pcDNA 
TM 
3.1/ myc-His(-) A, transfected cells required immunostaining for recombinant 
protein detection. The wells of culture slide were removed following the manufacturer's protocol. 
The cells were fixed for 10 minutes in 4% (w/v) paraformaldehyde and washed twice for 5 
minutes with PBS. The cells were permeabilised by incubation with PBS containing 0.25% (v/v) 
Triton X-100 (t-Octylphenoxypolyethoxyethanol, Sigma) for 20 minutes followed by two 5 
minutes washes in PBS.  
 
Slides were blocked with normal rat serum (Sigma) diluted 1:10 in CAS-Block
TM 
(Invitrogen) for 
30 minutes. Blocking solution was poured off and the cells were stained with Anti-c-myc 
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antibody (9E10 from mouse ascites fluid, Invitrogen) diluted 1 in 300 in CAS-Block
TM 
(Invitrogen) for 1 hour. The primary antibody was detected using FITC polyclonal anti mouse 
IgG (Pharmingen) diluted 1 in 100 for 30 minutes in room temperature in the dark. The 
secondary antibody was poured off and the slides were washed three times in PBS for 5 minutes. 
DAPI (diluted 1:1000 by PBS, invitrogen) or TO-PRO-3 iodide (Molecular Probes, diluted 
1:1000 to 1µM by PBS) were put on the washed slide and incubate 30 minutes for the 
counterstain. Then, the slides were washed three times in PBS for 5 minutes each. Coverslips 
were mounted using MOUNT PERMALUOR (Thermo) and stored, wrapped in foil, at 4℃.  
 
The cells transfected with GFP constructs did not require antibody staining and the slides were 
fixed, permeabilised and counterstained by TO-PRO-3 iodide as described above.  
 
2.13.5. Apoptosis staining by FLICA apoptosis detection kit 
For the understanding of the apoptosis inducing capacity of virus protein, apoptosis staining was 
performed. Apoptosis was detected by FLICA® 660 in vitro Poly Caspase Detection kit 
(Immunochemistry Technology LLC) following the manufacturer's protocol. The GFP transfected 
cells were fixed and washed as described in section 2.13.4. FLICA stock solution was diluted in 
1:50 and put on the slides and incubated for 60 minutes. The stained slides were washed with 
PBS for 5 minutes. Again the slides were washed 1x Apoptosis Wash Buffer. DAPI (1:1000 by 
PBS) was used for the counterstain. Coverslips were mounted using MOUNT PERMALUOR 
(Thermo) and stored, wrapped in foil, at 4℃.   
 
2.13.6. FACS Analysis 
FLICA stained and the fusion protein expressed cells were also analysed by FACS machine. 
Forward scatter (cell size), side scatter (cell granularity), GFP fluorescence (B530/30), and 
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FLICA fluorescence (R670/14) of the cells were measured on a LSR Fortessa Flow cytometer 
(BD Biosciences). Data were analysed using both Cell Quest (BD Biosciences) and WINMDI 
(http://facs.scripps.edu/software.html) software.  
 
2.13.7. Confocal microscopy 
Slides of transfected cells were viewed using a Zeiss LSM710 confocal microscopy (Carl Zeiss, 
UK) at the Roslin institute, University of Edinburgh with the assistance of Mr. Bob Fleming. 
Image analysis was performed using ZEN blue 2011 (Carl Zeiss, UK). 
 
2.14. Western blot 
2.14.1. Protein Electrophoresis 
The cells from the cell cultures were added to the one volume of 2x SDS sample buffer Laemmli 
(Sigma-Aldrich) in 1.5ml microcentrifuge tubes (Eppendorf, UK) (section 2.13.3.) and heated at 
100℃ for 5 minutes. Then, the tubes were centrifuged to precipitate the insoluble pellet. The 
glass gel plates were assembled with spacers using Mini-PROTEAN Tetra cells (Bio-Rad). 
Resolving gels containing 15% acrylamide was poured just after the addition of ammonium 
persulphate (APS) and N, N, N’, N’-Tetrametylethylenediamine (TEMED) (see below). The gel 
was poured to just below the comb inserting area and overlaid with sec-butanol to prevent drying. 
Resolving gel was polymerised for 30 minutes and stacking gel was prepared using this time 
without APS (see below). Then, the sec-butanol was removed and resolving gel was washed 
twice by the distilled water. The APS was added to the stacking gel which was then poured and 
the comb was inserted. The stacking gel was polymerised for 30 minutes. The comb was 
removed and the gels were assembled in the Mini-Protean II gel tank. The SDS running buffer 
(see below) was poured in the assembled gel holder firstly and the remaining buffer was poured 
in the reservoir. The boiled samples and PageRuler Prestained protein Ladder (Thermo) were 
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loaded into each well and run at 30 mA for 1 hours until the samples and ladder had reached the 
bottom of the gel.  
 
SDS recipes     
4%Stacking Gel  
H2O; 2.47ml 
Acrylamide/bis-Acrylamide (37.5:1); 0.53 ml 
Stacking Gel Buffer (0.5M Tris-HCL, 0.4%SDS pH 6.8); 1.00ml   
N, N, N’, N’-Tetrametylethylenediamine (TEMED); 1.4µl 
Ammonium Persulphate (APS); 90µl 
 
Resolving Gel (10%) 
H2O; 2.92ml 
Acrylamide/bis-Acrylamide (37.5:1); 2.33ml 
Resolving Gel Buffer (1.5M Tris-base, 0.4% SDS pH8.9) 
N, N, N’, N’-Tetrametylethylenediamine (TEMED); 2.8µl  
Ammonium Persulphate (APS); 90µl  
 
SDS Running Buffer 
Tris; 5.46g  
Glycine; 25.68g 
Sodium Dodecyl Sulphate; 1.9g  
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2.14.2. Transfer of Protein to Nitrocellulose Membrane  
Transfer membrane, Immobilon ®-P (Millipore) was cut to the same size as the resolving gel 
(approximately 4x8 cm) and 4 pieces of Blotting paper (GE healthcare Life Science) were cut 
slightly larger than the transfer membrane. The membrane was soaked in methanol, and the 
blotting papers and two sponges were soaked in the transfer buffer (10 times diluted x10 
premixed blotting buffers (Bio-rad) containing 20% methanol). For the wet transfer, Bio-rad Mini 
Trans-Blot Cell was assembled. Transfer unit was assembled in the gel holder cassettes following 
order; from cathode (-), one sponge, two blotting paper, resolving gel, membrane, two blotting 
paper and one sponge to anode (+) and the trapped air bobbles were removed by gently rolling 
the side of a pipette over the top sheet in each layer. The transfer unit was put in a modular 
electrode assembly and set on the buffer tank with Bio-ice cooling unit which contained ice to 
make the buffer cold. Finally, the transfer buffer was poured in the tank to cover the transfer unit 
and the lid was put on the tank. A current of 100V was applied for 1 hour. Following the transfer, 
the membrane was carefully taken and marked on the gel attached side. The membrane was 
stained with AMRESCO stain Ponceau S solution (BioExpress) for 1 minute and rinsed with PBS 
until the well-defined bands were appeared on the membrane to show the protein transfer.      
 
2.14. 3. Immunological Detection of Protein Blot 
For GFP and 6x His detection, protein blots were blocked in 5% skim milk in PBSt (0.05% (v/v) 
tween 20) for 1 hour. The primary antibody reaction was carried out by using anti-GFP (sc-8334, 
santa cruz) (1:500) or anti-his (C-term) HRP antibody (3D5, Invitrogen) (1:10000) diluted in 5% 
skim milk PBSt. The reaction was incubated overnight at 4℃. The following day, the membrane 
was washed three times in PBSt for 10 minutes each. Only for anti-GFP antibody, secondary 
antibody was required and Donkey anti-rabbit HRP antibody (AP182P, Chemicon (Millipore)) 
was used at 1:3000 dilution. The reaction was incubated for 30 minutes at 4℃. The membrane 
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was washed three times in PBSt for 15 minutes each. Bound antibody was detected by ECL 
Western Blotting Detection Reagent (GE Healthcare Life Sciences) and the detection reagent 1 
and 2 were mixed and applied on the membrane and the membrane was incubated for 5 minutes. 
The fluorescence was detected by Amersham Hyperfilm ECL in dark room and the film was 
developed by Medical Film Processor (SRX-101 A, Konica Minolta Medical & Graphic INL)  
 
2.15. In vitro experiment 
2.15.1. Maintenance of cell line cell culture 
2.15.1.1. Baby hamster kidney (BHK-21) cell cultures 
Baby hamster kidney (BHK-21) cells are a continuously growing fibroblastoid cell line derived 
from a Syrian golden hamster. BHK-21 cell were cultured in Glasgow modified eagle's medium 
(GMEM, Invitrogen, UK) supplemented with 10% (v/v) tryptose phosphate broth (TPB, 
Invitrogen, UK), 100U/ml penicillin, 100U/ml streptomycin (Merck BDH), 10% NBCS 
(newborn calf serum, Invitrogen) and 2mM L-glutamine (Merck BDH). Cell lines were cultured 
in sterile plastic-ware (Nunc) and incubated at 37℃ in equilibrium with humidified 5% CO2.  
 
2.15.1.2. Mouse embryo fibroblast (MEF) 
Mouse embryo fibroblast (MEF) alpha/betaSV1 line was used in infectious experiment. MEF 
cells were cultured in Dulbecco’s modified Eagles’s medium (DMEM, Invitrogen) supplemented 
with 10% fetal calf serium (FCS, Invitrogen), 1% penicillin and streptomycin (penicillin 10,000U 









For further passaging, adherent cells were removed from the bottom of sterile plastic (Thermo 
Scientific Nunc
TM
) by trypsinisation. Growth medium was removed and the cells were washed by 
using PBS. Incubation with 0.25% trypsin 1x Phenol red (Invitrogen) was used to detach cells 
from the plastic (Thermo Scientific Nunc
TM
). An equal volume of growth medium was added to 
inactivate the trypsin. After that, the cells were centrifuged for 450 x g for 5minutes. The 
supernatant was discarded and cells more resuspended in appropriate volume of fresh medium. In 
the 1.5ml tube, the resuspended cells was diluted 1 to 10 with the 0.1% trypan blue (w/v) and the 
number of unstained viable cells was counted using haemocytometer. Approximately 5 x 10
6
 - 1x 
10
7
 cells were re-seeded into fresh tissue culture flask in about 50 ml of medium.  
 
2.15.2. Primary cell culture 
2.15.2.1. Bone marrow derived macrophage 
The bone derived macrophages were set up by using L929 medium (see below) and  Revolutions-
per-Minute Indicator (RPMI) medium (Invitrogen) containing 10% fetal calf serium (FCS, 
Invitrogen), 1% penicillin and streptomycin (penicillin 10,000U /ml and streptomycin 10,000U/ 
ml) (Gibco, UK). Firstly, femurs were taken from the mouse intactly and placed in cold RPMI 
(Invitrogen). Secondly, all skin and muscles were removed and the femurs were dipped in 70% 
alcohol for 5 minutes to sterilise. The joint ends of femurs were cut with scalpel. Thirdly, a 
hypodermic needle (approx. 26 gauge) (Terumo ® Hypodermic needle) was inserted into femur 
and used to flush the bone marrow cells through femur into Falcon tube (BD Bioscience cell 
culture) by using RPMI in 10 ml syringe (Terumo). The femurs were flushed from both ends to 
harvest maximally. The other leg was also treated using the same way and the cells were 
collected in same Falcon tube. Finally, 20 ml L929 conditioned medium (the source of M-CSF, 
see below) were pooled with the cells in the Falcon tube and the medium containing the cells 
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were mixed gently and seeded into two square culture dishes (Thermo scientific Nunc
TM
) and the 
plates were incubated at 37℃ in equilibrium with humidified 5% CO2.. The cells were split on 
day 4 (50% each RPMI and L929 medium). For the further passage, day 4 growth medium was 
taken to Falcon tube. In the other Falcon tube, 1x DPBS (Invitrogen) was prepared and 10 ml of 
1x DPBS was added to each plate. 10 ml of DPBS were taken in a 10 ml syringe (Thermo) with 
the medium gauge needle (approx.15 gauge) and the cells were washed off on the surface by 
vigorous pressure until washing all over the surface at all orientation of the plates. The collected 
cells in DPBS were put into the conical skirted bottom universal sample tube. The sample 
collection was repeated by using another 5ml 1x DPBS. The collected cells were pelleted by 
centrifugation at 15,000 xg for 5 minutes. The square culture dishes (Thermo scientific Nunc
TM
) 
were reused for the next passage and 5 ml of old medium was added back to the old square 
culture dishes and new square culture dish respecitively. The centrifuged cells were resuspended 
in 20 ml of 50% L929 and 50%RPMI and the cells in divided into the 2 square culture dishes (old 
and new). Macrophages matured and the cells used for the experiment at day 7.     
 
L929 medium      
L929 is a murine aneuploid fibrosarcoma cell line and known to secrete a beta-NGF-like 
molecule to develop the conditioned medium (Pantazis et al., 1983). L929cells were grown up in 
DMEM (Invitrogen) supplemented with 10% fetal calf serum (FCS, Invitrogen), 1% penicillin 
and streptomycin (penicillin 10,000U /ml and streptomycin 10,000U/ ml) (Gibco, UK) for 4-7 
days at 37℃ in equilibrium with humidified 5% CO2.. The growth medium contains factors 
which induce the monocytes to differentiate to macrophages.  
 
2.15.2.2. Bone marrow derived stem cell  
Bone marrow derived stem cells were also set up by using stem cell media (DMEM (section 
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2.15.1.2.) with additional recombinant proteins). Bone marrow cells were collected by using the 
same method as bone marrow derived macrophage (section 2.15.2.1.). For the stem cells, the 
cells were flushed by stem cell media (DMEM, 10% FCS, 5ml of Glutamax, 5ml of Penicillin/ 
streptomycin + (stem cell factor) SCF 100ng/ml, IL-3 10ng/ml, IL-6 50ng/ml). After the 
collection, the other 20 ml of stem cell media were added to the cells and incubated in square 
culture dishes (Thermo scientific Nunc
TM
) at 37℃ in equilibrium with humidified 5% CO2. The 
following day, many dead cells are found, and they were cleaned up by centrifugation and 
resuspension of the cells in fresh stem cell media. The cell density should be 10
6 
cells/ml and the 
cells matured in day 2-3 for use in subsquent experiments.  
 
2.15.3. Transfection  
For the cell lines transfection, Lipofectamine 2000 (Invitrogen) was used and the protocol was 
shown in section 2.13.2. Stem cells were very fragile and lipofectamine 2000 was seen to damage 
the cells. Accordingly, SAFEctin
TM 
-STEM transfection reagent (Deliverics) was used for the 
stem cell transfection following the manufacturer's protocol. Briefly, mouse stem cells were 
seeded into 24 well plate and incubated one day before the transfection to make 60-80% 
confluence. Two 0.6 ml microcentrifuge tubes (Sigma-Aldrich) containing 50µl of serum-free 
medium were prepared, and the appropriate volume of DNA and SAFEctin
TM
-STEM were added 
to each tube respectively and the tubes were vortexed for 5 seconds. These two tubes were mixed 
together and incubated at room temperature for 20 minutes. The incubated mixture was added to 
each well containing the stem cells and 400µl growth media and mixed gently by rocking the 
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2.15.4. Primers for construction of plasmid for the transfection  
2.15.4.1. Single copy of RoTTV complete circular genome. 
Primers were designed based on the RoTTV complete genome. The restriction site was found in 
RoTTV complete genome and the inverted primers were constructed to contain the restriction site 
on RoTTV genomes (Spe I for RoTTV1 and HindIII for RoTTV2) (Table 2.15.4.1.). PCR 
condition was same as described in section 2.5.1. The details of single copy of RoTTV complete 




Target Orientation Length Sequence 
RoTTV1 (Spe I site)  
1012 Gt1a sp SpeI F Sense 23 5'ACT AGT AAC AAT TCT GAT CAG TA 3' 
1012 Gt1a sp SpeI R Antisense 19 5' ACT AGT CTG CAA CAT CTG C 3' 
RoTTV2 (Hind III site)  
Gt2H HindIII F Sense 28 5' AAG CTT ATC AAC AAA AAA ATT ATG GGA T 3' 
Gt2H HindIII R 
Antisense 24 5' AAG CTT TAT TTT TTT TGT TAG GCT 3' 
Table 2.15.4.1. The primers containing the restriction site on RoTTV genome 
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2.15.4.2. Construction of GFP/ RoTTV1 
GFP/RoTTV1 was constructed by the amplification of complete GFP coding sequences and 
RoTTV1 genomes with novel restriction sites added during PCR using the restriction site 
containing GFP and RoTTV1 primers (Table 2.15.4.2.). PCR conditions were the same as 
described section 2.5.1. The detail of GFP/RoTTV-1 construction was shown in section 5.2.5.  
 
Table 2.15.4.2. The primers with the restriction sites for GFP/TTV construction.  
  
Target Orientation Length Sequence 
*
 RoTTV1 with the restriction site   5' GG(CC)---restriction site--primer 3' 
RoTTV F+Hind III 
Restriction site; HindIII 
Sense  22 5' GG---A AGC TT---- ATG GCG TGG AGA TT 3' 
RoTTVR+BamHI 
Restriction site; BamHI 
Antisense 25 5' CC---GGATCC---TCC GGA TGG TTA AAG TC 3' 
*
GFP amplification with the restriction site  5' GG(CC)---restriction site--primer 3' 
GFP F + Bam HI  
Restriction site; BamHI 
Sense 27 5' GG ---GGATCC---ATG GTG AGC AAG GGC GAG G 3' 
GFP R + Hind III 
Restriction site; HindIII 
Antisense 25 5' GG ---A AGC TT---CTT GTA CAG CTC GTC CGT CCA 3' 
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2.15.4.3. Myc tagged concatemerised RoTTV 
Myc tagged RoTTV1 complete genome was constructed by amplification of the complete 
genome by PCR using a primer encoding the c-myc tag (Table 2.15.4.3.). PCR condition was the 
same as described section 2.5.1. The detail of myc tagged concatemerised DNA construction was 
shown in section 5.2.6.  
Table 2.15.4.3. Myc tagged RoTTV1 complete genome primer. Myc tag was attached on the 
reverse primer.  
 
2.15.4.4. RoTTV1 splicing site primer 
To detect the transcripts only, the primers were designed spanning the splicing site of RoTTV1. 
The primers were shown in Table 2.15.4.4. By using the primers, the amplified products of 1080 
bp in size would be amplified from RoTTV1 genomic DNA and 180 bp in size would be shown 
from RoTTV1 spliced cDNA. PCR condition was the same as described in section 2.5.1.  
Table 2.15.4.4.. RoTTV1 splicing site primer.  
Target Orientation Length Sequence 
*
 Myc RoTTV1  F: 5' GGG(CCC)---restriction site--primer 3'  R: 5' GGG(CCC)---restriction site--Myc--primer 3' 
Myc TTV Gt1a F 
Restriction site; Xba I 
Sense  33 
5' GGG---TCTAGA---  
                ATT TTG ACA ATC CAG TGG TGAGGC3' 
Myc TTV Gt1a R  
Restriction site; Xba I 
Antisense 69 
5' CCC---TCTAGA---CAG ATC CTC TTCTGAGAT GAG TTT 
TTG TTC---CTG TTT ATT GGG GGA TAA CTG AGG ATC3' 
Target Orientation Length Sequence 
RoTTV1 splicing site primer (used in 5.7) 
1012 sp OAS Antisense Outer 25 5' GGA CAC ATA ATG CCT CTG ATA ACA C 3' 
1012 sp IAS Antisense Inner 24 5' GTG TAT CTA GGC TGT ATT CCA GTG 3' 
1012 sp OS  Sense Outer 28 5' CAA GAC AGA GAA CCT GGA GAC GGA AAA C3' 
1012 sp IS  Sense Inner 23 5' GGA GAC CAA CCA GAC GGC GCA CC 3' 
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2.16. In vivo transfection  
In the 1.5 ml Eppendolf Tube (Eppendolf), 1µg (in 2µl) of RoTTV DNA and 57.7 µl of 150 mM 
NaCl were mixed for in vivo transfection. 0.3 µl of 0.1 M polycation polyethylenimine (PEI) (see 
below) was added dropwise and vortexed intermittently. The mixture was incubated at room 
temperature for 15-20 minutes before inoculating the mice. The 60 µl of PEI and RoTTV DNA 
complex was inoculated into the mice intranasally.  
 
Stock 0.1 M PEI (4.3 mg/ml in PBS (x1)) 
PEI was measured by using the glass beaker and dissolved in the PBS. The stock PEI was 
adjusted to pH 7.4 with HCL. The reagent was filtered through 0.2µm filter (Millipore).
 






CHAPTER III. CHARACTERISATION OF RODENT TORQUE TENO 
VIRUS IN WILD RODENT POPULATIONS 
 
TTV genetic diversity and high infectious distribution have been reported in animal and 
human populations. RoTTV (RoTTV) infectious prevalence, host species distribution, and 
complete genome sequences were revealed in this study. A phylogenetic tree was constructed 
and RoTTV was compared to human and other animal TTV.       
 
3.1. Background to the study 
3.2. Infectious prevalence of RoTTV in wild rodents using pan-TTV primers 
3.3. Sequence results of screening PCR amplicons     
3.4. Amplification of RoTTV full-length genomes 
3.5. Complete sequence and phylogenetic analysis of RoTTV  
3.6. Genomic structure and coding capacity      
3.7. Design of species specific primer sets for screening RoTTV genomic   
     prevalence in wild rodent 
3.8. Discussion 
 
Appendix 1. Rat TTV infection in lab rats  
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3.1. Background to the study 
Infection with anelloviruses is not restricted to humans. By using highly conserved primers and 
RCA, TTV-related viruses were discovered in farm animals (Leary et al., 1999), pets (Okamoto 
et al.,2002), and wild animals (Okamoto. 2009). These TT viruses were species-specific, and the 
genetic sequence and genome size were quite variable (Hino et al., 2007). TTV was found in 
dogs and cats, and TTV found in feline is the smallest in size (2064nt) (Okamoto et al., 2002).  
 
TTV research has several difficulties (section 1.7.) and a suitable animal model is required. 
Currently, porcine TTV is the first candidate because the epidemiology of porcine TTV and the 
porcine immune system resemble those of humans (Kekarainen and Segalés. 2007). Thus, 
porcine TTV is considered a good animal model for TTV infection. Also, non-human primate 
TTV has also been studied for the pathogenesis research because non-human primate TTV 
resembles human TTV (Tawara et al., 2000).  
 
The studies for animal TTV would be useful because these human and animal TTV have several 
common features. Firstly, animal and human TTV show a high level of genetic heterogeneity. In 
human TTV, at least 39 genotypes with a difference of greater than 30% and five major genetic 
groups with a difference greater than 50% have been found (Hallett et al., 2000). On the other 
hand, chimpanzee has three TTV genotypes including a TTMV-like type (Okamoto et al., 2000; 
Inami et al., 2000) and pig has three TTV genotypes (Okamoto et al., 2002; Niel et al., 2005). 
Smaller TTVs were also observed in the several animals (section 1.1.4.). Secondly, TTV genomic 
structure is relatively conserved among the different TTV genotypes. TTV, TTMDV and TTMV 
in human and animals have a common presumed four open reading frames (ORFs, ORF1-ORF4) 
(Okamoto et al., 2009). Third, co-infection with different genotypes of TTV, TTMDV and/or 
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TTMV in same individual is common in human and animal TTV infection (Maggie and 
Bendinelli., 2010).  
 
The mouse is one of the most useful animal models in all biological research and many papers 
have been published using mouse models (Steven et al., 2012; Liu et al., 2013; Hajj et al., 2012; 
Lemmermann et al., 2012; Niels et al., 2012). Mouse animal models have many advantages. The 
various knockout mice give us the hints to understand the immune response to virus infection. 
Transgenic mice provide the insight into the specific genes and cytokines involved in virus 
infection. Also, mice are small size which reduces the amount of research reagent or drugs and 
only small space is required to keep them. The high reproduction rate of mice provides the 
abundant samples. Inbred strains can remove the difference among the individuals and stabilize 
research results (Webre et al., 2012).    
    
RoTTV was discovered in the wood mouse by using a shotgun cloning technique combined with 
RCA. The UTR of this original clone was found to be compatable with existing pan-TTV primers 
so these could be used for a broader population study. We planned to use RoTTV as an animal 
model because mice are readily available, inexpensive to maintain, and a large number of 
reagents are available to study them. To start the study, we have to understand about the nature of 
RoTTV infection in wild rodent populations.  
 
In this chapter, we will characterise RoTTV in the wild rodent and understand the epidemiology, 
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3.2. Infectious prevalence of RoTTV in wild rodents using pan-TTV primers 
RoTTV was first discovered in the wood mouse (Apodemus sylvaticus). However, there is a 
possibility that RoTTV infects other rodent species in the wild. Therefore, a broader study of 
RoTTV infectious prevalence and genetic diversity was investigated in order to understand 
RoTTV. In the wild rodent population in United Kingdom, four wild rodents species were 
investigated; wood mice (Apodemus sylvaticus), field voles (Microtus agrestis), bank voles 
(Myodes glareolus), and house/lab mice (Mus musculus). These rodent species were classified by 
using RFLP (Restriction Fragment Length Polymorphism) on a PCR for mitochondorial 
cytochrome B and confirmed by sequencing of these amplicons. RFLP is the method to 
characterise the DNA (species in this study) by using a difference in homologous DNA sequence 
that can be shown by the presence of fragments of different lengths after digestion of the DNA 
samples with specific restriction enzyme. In this study, mitochondorial cytochrome B DNA was 
digested by RsaI, and house/lab mice DNA have one restriction site and field voles have several 
restriction site in mitochondorial cytochrome B DNA. Wood mice and bank voles have no 
restriction site on RsaI digestion. A gel image of restriction enzyme digested DNA is shown in 
Fig.3.2.1. House/lab mouse DNA produced two fragments (Lane 8-11) after RsaI digestion and 
field voles DNA were finely digested by RsaI (Lane; 12-13), but wood mice and bank voles DNA 
showed no digestion. Table 3.2.1. shows the rodent species which were used in this project. By 
using RFLP method, the wild samples were confirmed as house/lab mouse (Mus musculus,) 
n=24, field voles (Microtus agrestis) n=80, wood mouse (Apodemus sylvaticus) n=126 and bank 

























number 126 79 39 22 3 25 
1 2 3 4 5 6 7 8 9 10 11 12 13 
Figure 3.2.1. Restricted digestion of mitochondorial DNA PCR amplicons. PCR amplicons 
were digested using RsaI. Digested wood mouse and bank vole DNA showed single uncut 
band (550 bp)(band; 1-7)* but digested house/lab mouse DNA was cut and makes two DNA 
fragments, 200 bp (lower) and 350 bp (upper) (bands; 8-11). Digested field vole DNA was 





Table 3.2.1. Host species which was investigated in this study and number of samples in each species. * 
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Pan-TTV primers applied in this study have been previously used (Thom et al., 2003) and these 
hemi-nested primers were designed based on three highly conserved sequences in the UTR When 
PCR was performed using pan-TTV primers, TTV DNA was detected in liver or spleen from 116 
(92%) of 126 wood mice, 3 (7.6%) of 39 bank voles, 48 (60%) of 80 field voles, and 0 (0%) of 
28 lab/house mice. The amplified products by PCR with pan-TTV primers were sequenced from 
13 animals (7 wood mice, 5 field voles, 1 bank vole) testing positive and measured 77-82 bp 
when primer sequences were removed from both ends. To check RoTTV infection in lab/house 
mouse, 4 lab mice and 25 feeder mice from a pet shop were examined. However, RoTTV 
infection was not observed in lab/house mouse colonies.   
 
  
A B C 
Figure 3.2.2. Screening PCR by using pan-TTV primers. (A) RoTTV positive wood 
mice, (B) RoTTV positive field voles, (C) RoTTV negative house/lab mice. RoTTV 
positive wood mice and field voles PCR results were shown as the positive 
controls. PCR positive bands were detected around 100 bp but house/lab mice 
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3.3. Sequence results of screening PCR amplicons 
Pan-TTV PCR products from section 3.2. were cloned and sequenced and these sequence results 
were analyzed. Sequence results of pan-TTV amplicons are shown in Fig. 3.3.1. Four different 
genogroups were observed and these sequences were tentatively called genogroup 1a, 1b, 1c, and 
2, because genogroup 1a, b, and c showed relatively similar sequences. Genetic distribution in 
each rodent species is shown Table 3.3.1. Genogroup 1a was observed in wood mice, bank voles, 
and field voles. Genogroup 2 was found in wood mice and bank voles. These findings indicated 
that RoTTV has extremely high sequence divergence and several genogroups were observed in 




3.4. Amplification of RoTTV full-length genomes 
Based on common 77-82bp amplicons, distinct RoTTV sequences could be seen. To determine 
the diversity of viruses present in the wild rodent population, inverse primers which partially 
overlapped each other were used for amplification of complete RoTTV genomes in each 
genogroup. Before running full-length PCR, the DNA extracted from the liver, spleen, serum, and 
faecal supernatants of 7 (3 wood mice, 3 field voles and 1 bank vole) viraemic animals were 
amplified by RCA. RCA is sequence independent circular DNA amplification method by using 
phi 29 DNA polymerase (section 2.10.2).  The full-length genomes of RoTTV were amplified by 
PCR with inverted-primers which are shown in Table 2.5.1. RoTTV genogroup 1a genomes were 
Genogroup Rodent species 
1a Wood mice/Bank voles/ Field voles 
1b Field voles 
1c Bank voles 
2 Wood mice/Bank voles 
Table 3.3.1. Genetic distribution in each wild rodent species. One specific RoTTV genogroup 
was distributed in different host species.  
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amplified from 4 wood mice and 1 field vole and were found to be approximately 2.2kb (Lane A 
and B of Fig. 3.4.1). RoTTV genogroup 1b and 1c TTV genomes were amplified from 3 field 
voles and 1 bank vole respectively and were also observed to be approximately 2.2kb (Lane C 
and D of Fig. 3.4.1). RoTTV genogroup 2 genome size was slightly larger than that of RoTTV 
genogroup 1 suggesting these are distinct groups. RoTTV genogroup 2 genomes amplified from 
3 wood mice and 1 field vole and were shown to be approximately 2.5kb (Lane E of Fig. 3.4.1). 
Then, PCR amplicons from each of the wood mouse, field vole and bank vole samples with the 
strongest PCR signal were molecularly cloned. The details of the cloned genomes are shown in 
Table 3.4.1. A total of 31 clones (13 genogroup 1a, 4 genogroup 1b, 1 genogroup 1c, and 13 
genogroup 2) were sequenced over the complete genome.   
 






















Figure 3.4.1. Full-length PCR of RoTTV. (L) DNA Ladder. (A) Genogroup 1a complete 
genome from spleen. (B) Genogroup 1a complete genome from spleen serum. (C) 
Genogroup1b from liver. (D) Genogroup1c from liver. (E) Genogroup 2 from liver. 
Genogroup1a, Genogroup1b, and Genogroup1c genome sizes were approximately 2.2kb. 




















Species Source Primer set** Number 
Wood mice WM1 spleen  1a 1 clones 
 WM1 serum  1a 3 clones 
 WM1 spleen  2 1 clone 
 1012 spleen * 1a 1 clone 
 1014 spleen * 1a 1 clone 
 1012 faeces * 2 2 clones 
 1012 spleen* 2 1 clone 
 1014 faeces * 2 1 clone 
 1014 spleen * 2 1 clone 
Field voles ML89 Liver  1a 2 clones 
 ML89 Liver 2 3 clones 
 ML89 Liver 2b 4 clones 
 ML79 Liver 1b 2 clones 
 ML80 Liver 1b 1 clone 
 ML89 Liver 1b 1 clone 
Bank voles ML211 Liver 1c 1 clone 
Table 3.4.1. Genomes cloned in this study.  
*Complete genome was constructed from faeces and spleen in the same individual.  
** Genogroups which were used for designing the primer. PCR amplicons may not be same 
genogroup with primer genogroups.   
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3.5. Complete sequence and phylogenetic analysis of RoTTV  
Thirty-two complete RoTTV genomic sequences from three rodent species are shown on the CD-
ROM. Each TTV genome size is shown in Table 3.5.1 (RoTTV1) and Table 3.5.2. (RoTTV2). 
The 17 RoTTV1 genomes ranged in size from 2164 to 2318 nt. The 13 RoTTV2 genomes were 
2571 nt in size. Some field vole clones amplified using genogroup 1a primers, showed genogroup 
1b sequence. RoTTV genomic sequences from spleen were identical to those from faecal 
supernatant in the same individual (1012 and 1014) 
 
RoTTV ORF1 sequences were extracted based on ORF finder. The RoTTV ORF1 sequences 
along with 164 available ORF1s of anellovirus were aligned using MUSCLE version 3.8 in 
Simmonic Sequence Editor v1.6 software (section 2.8.2.) and the region of highest homology 
(equivalent to aa 42-241 of AS_WM1_Sp_1 ORF1) was used for the construction of a 
phylogenetic tree and pairwise-comparison analysis. A phylogenetic tree of representatives from 
RoTTVs human TTV genogroups, TTMV, TTMDV and other animal TTV is shown in Fig. 3.5.1. 
RoTTV showed two distinctive groups corresponding to the tentative genogroup 1 (a, b, and c) 
and genogroup 2 classification and will sebsquently be refered to as RoTTV1 (a, b, and c) and 
RoTTV2. RoTTV2 sequences were similar in different species but RoTTV1 sequences differed 
among host species. 
 
Pairwise-distance comparisons of aa sequence across the region described above of all available 
human and chimpanzee anellovirus (TTV; n=129, TTMV; n=14, TTMDV; n=21) and RoTTV 
ORF1s (RoTTV1; n=17, RoTTV2; n=14) are shown in Table 3.5.3. Sequence divergences of 18.7 
% and 2.5 % were observed within genogroup 1 and genogroup 2 sequences respectively. 
However, 74.5% sequence divergence was found between these groups which are comparable the 
difference between these groups and other established anellovirus genera and is greater than the 
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divergence seen between established genera (eg TTV vs TTMV or TTV vs TTMDV). Therefore, 
RoTTV1 and RoTTV2 can be classified as distinct species and the divergence is even enough to 
potentially classify them as distinct genera pending review by the ICTV.      
   
3.6. Genomic structure and coding capacity 
RoTTV genomic maps were constructed by using DNASTAR Lasergene 9 core Suite and NCBI 
ORF Finder. All constructed genomic structures are shown on CD-ROM. Each ORF was 
analysed to find the predicted methionine start codon and a predicted protein size (more than 70 
aa). All RoTTV genomic maps are shown in Fig.3.6.1. In the RoTTV genomic structures, three 
types of RoTTV1 genomic structures and two types of RoTTV2 genomic structure were 
observed. All clones had TTV ORF2 and ORF1 and RoTTV ORF2 was located in the beginning 
of ORF1. Genogroup 1a contained ORF2 (115aa), ORF1 (342aa), ORF3 (145aa), and ORF4 
(83aa) (Fig.3.6.1. RoTTV1 structure 1). The same genomic structure was found in 11 RoTTV1 
clones. Other RoTTV1 group clones also had the same genomic structure but ORF sizes were 
slightly different. Two clones had short ORF2 (94aa), ORF1 (346aa), short ORF3 (123aa) and 
long ORF4 (127aa) compared to the original clone (Fig.3.6.1. RoTTV1 structure 2). Four clones 
had slightly different structures from original clones and they have ORF2 (110aa), ORF1 (344aa), 
ORF3 (137aa), and ORF4 (86aa) (Fig.3.6.1. RoTTV1 structure 3). In contrast, RoTTV2 has 
relatively conserved ORF sizes with only an small difference among RoTTV2 clones. RoTTV2 
consistently had ORF2 (75aa), and ORF1 (576aa). Standard RoTTV2 ORF3 had 128aa, but one 
group which had two clones had shorter ORF3 (83aa) (Fig.3.6.1. RoTTV2 structure 2). In 
addition, 2 ORFs with coding capacities of 156 and 147 aa but no methionine were also found 
and are called ORF4 and ORF5 respecitively. 
 




Clone No. (bp)  ORF2  ORF1 ORF3 ORF4 
WM1_Sp_1 (2236) 125-472 (115) 259-1287 (342) 1271-1708 (145) 1324-1575 (83) 
WM1_Se_1 (2238) 125-472 (115) 259-1287 (342) 1271-1708 (145) 1324-1575 (83) 
WM1_Se_2 (2318) 125-472 (115) 259-1287 (342) 1271-1708 (145) 1324-1575 (83) 
WM1_Se_3 (2318) 125-472 (115) 259-1287 (342) 1271-1708 (145) 1324-1575 (83) 
1012_Fae_1 (2250) 125-472 (115) 259-1287 (342) 1271-1696 (141) 1312-1563 (83) 
1012_Fae_2 (2249) 125-472 (115) 259-1290 (343) 1271-1708 (145) 1324-1575 (83) 
1012_Sp_1 (2248) 125-472 (115) 259-1290 (343) 1271-1708 (145) 1324-1575 (83) 
1014_Fae_1 (2235) 125-472 (115) 259-1287 (342) 1271-1708 (145) 1324-1575 (83) 
1014_Fae_2 (2239) 125-472 (115) 259-1287 (342) 1271-1708 (145) 1324-1575 (83) 
1014_Sp_1 (2238) 125-472 (115) 259-1287 (342) 1271-1708 (145) 1324-1575 (83) 
ML89_Li_1 (2266) 128-412 (94) 262-1302 (346) 1280-1651 (123) 1342-1725 (127) 
ML89_Li_2 (2266) 128-412 (94) 262-1302 (346) 1280-1651 (123) 1342-1725 (127) 
ML79_Li_1 (2182) 80-412 (110) 262-1296 (344) 1280-1693 (137) 1336-1596 (86) 
ML79_Li_2 (2248) 80-412 (110) 262-1296 (344) 1280-1693 (137) 1336-1596 (86) 
ML80_Li_1 (2246) 80-412 (110) 262-1296 (344) 1280-1693 (137) 1336-1596 (86) 
ML89_Li_4 (2164) 80-412 (110) 262-1296 (344) 1280-1693 (137) 1336-1596 (86) 












Table 3.5.1. RoTTV1 genomic sizes and structure. Nucleotide coordinates for each ORF are listed 










Clone No. (bp) ORF2(bp) ORF1(bp) ORF3(bp) ORF4(bp) ORF5(bp) 
WM1_Se_4 (2571) 125-352 (75) 238-1968 (576) 1272-1658 (128) 1460-1930 (156) 1683-2126 (147) 
ML89_Li_4 (2571) 125-352 (75) 238-1968 (576) 1272-1658 (128) 1460-1930 (156) 1683-2126 (147) 
ML89_Li_5 (2571) 125-352 (75) 238-1968 (576) 1272-1658 (128) 1460-1930 (156) 1683-2126 (147) 
ML89_Li_6 (2571) 125-352 (75) 238-1968 (576) 1272-1658 (128) 1460-1930 (156) 1683-2126 (147) 
ML89_Li_7 (2571) 125-352 (75) 238-1968 (576) 1272-1658 (128) 1460-1930 (156) 1683-2126 (147) 
ML89_Li_8 (2571) 125-352 (75) 238-1968 (576) 1272-1658 (128) 1460-1930 (156) 1683-2126 (147) 
ML89_Li_9 (2571) 125-352 (75) 238-1968 (576) 1272-1658 (128) 1460-1930 (156) 1683-2126 (147) 
ML89_Li_10 (2571) 125-352 (75) 238-1968 (576) 1272-1658 (128) 1460-1930 (156) 1683-2126 (147) 
1012_Fae_3 (2571) 125-352 (75) 238-1968 (576) 1272-1658 (128) 1460-1930 (156) 1683-2126 (147) 
1012_Fae_4 (2571) 125-352 (75) 238-1968 (576) 1272-1658 (128) 1460-1930 (156) 1683-2126 (147) 
1012_Sp_2 (2571) 125-352 (75) 238-1968 (576) 1272-1658 (128) 1460-1930 (156) 1683-2126 (147) 
1014_Sp_2 (2571) 124-351 (75) 237-1967 (576) 1406-1657 (83) 1459-1929 (156) 1682-2125 (147) 
1014_Fae_3 (2571) 124-351 (75) 237-1967 (576) 1406-1657 (83) 1459-1929 (156) 1682-2125 (147) 
Table 3.5.2. RoTTV2 genomic sizes and structure. Nucleotide coordinates for each ORF are listed 























 Figure 3.5.1. Representatives of RoTTV and other anellovirus phylogenetic tree based on partial 
ORF1aa sequence. In addition, RoTTV2 sequences in different species are similar. RoTTV1 sequences 
differ between host species. *RoTTV sequences which from faeces and spleen were identical.  
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Table 3.5.3. Group amino acid pairwise-distance comparisons within and among 17 RoTTV1, 13 













RoTTV1(n=17) 18.7% 74.5% 74.1% 77.3% 77.7% 
RoTTV2(n=14)  2.5% 74.3% 75% 74.6% 
TTV(n=129)   49.4% 68.2% 64.6% 
TTMV(n=14)    54.4% 67.5% 
TTMDV(n=21)     50.1% 
 

















Structure1 (n=11)  115 342 145 83 
Structure2 (n=2) 94 346 123 127 











Structure1 (n=11) 75 576 128 156 147 
Structure2 (n=2) 75 576 83 156 147 
*RoTTV1 
**RoTTV2 
Figure 3.6.1 and Table3.6.1. RoTTV genomic maps. *Representative RoTTV1 genomic map of RoTTV. Variation is 
seen in the ORF sizes of different clones. 
†
In the RoTTV1 genomes, three types of genomic structures which had 
different ORF were observed. ** Representative RoTTV2 genomic map of RoTTV. 
‡
 RoTTV2 genomic structures 
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3.7. Design of species specific primer sets for screening RoTTV genomic prevalence in wild 
rodents 
Based on the complete sequence results, two pairs of species specific primer were designed based 
on ORF1 (ORF1 primer). The primers are shown in Table 2.5.1. The wild rodent populations 
were then screened again. The results are shown in Table 3.7.1. RoTTV1 TTV DNA was detected 
in liver or spleen from 101 (80%) of 126 wood mice, 3 (7.6%) of 39 bank voles, 50 (63%) of 79 
field voles, and 0 (0%) of 28 lab/house mice. RoTTV2 TTV DNA was found in liver or spleen 
from 67 (53%) of 126 wood mice, 6 (15%) of 39 bank voles, 6 (7.6%) of 79 field voles, and 0 
(0%) of 28 in lab/house mice. RoTTV2 showed low infectious prevalence compared to that of 
RoTTV1. Moreover, RoTTV1 TTV was widely spread in the different host species. Wood mice 
were frequently infected by TTV RoTTV1 and RoTTV2. In the TTV positive rodents, 37.5% 
(60/160) of wild rodents have RoTTV1 and RoTTV2 DNA.  
 








RoTTV1 positive 101 (80%) 50(63%) 3(7.6%) 0(0%) 
RoTTV2 positive 67(53%) 6(7.6%) 6(15%) 0(0%) 
Coinfection rate 54 (43%) 5(6.3%) 1(2.5%) 0(0%) 
 
 
For further confirmation of the absence of RoTTV in Mus musculus, Mus musculus DNA library 
was constructed following section 2.10.  RCA amplicons from Mus musculus liver DNA were 
digested by restriction enzyme, cloned and sequenced. Originally, RoTTV was discovered in 5 of 
87 colonies from clone libraries from 2 wood mice. However, no RoTTV clones were isolated in 
51 colonies from 2 Mus musculus. As part of the current study, an additional 102 colonies from 5 
Mus musculus clone libraries were isolated and sequenced, but no anellovirus sequences were 
detected in these Mus musculus DNAs.   
Table 3.7.1. Rescreening results of RoTTV using species specific primer.  
 




3.8.1. Distribution of RoTTV in wild rodent population 
RoTTV was discovered by using a shotgun cloning techinique combined with RCA from a wood 
mouse sample. This RoTTV which was firstly discovered was prototype isolate and later it was 
confirmed as a member of RoTTV1a.    
 
In this study, several RoTTV features were revealed and these features were quite similar to those 
of TTV in humans and other animals. Firstly, RoTTV showed high infectious prevalence in the 
wood mouse (92%) and field vole (60%) populations. RoTTV was also observed in bank voles 
but the prevalence was low (7.6%). No infection was seen in house/lab mice (Mus musculus). 
TTV infection has also been observed in human (Hino and Miyama, 2007; Bendinelli, 2001; 
Maggi and Bendinelli, 2010), non-human primates (Thomas, 1999; Thom, 2003; Okamoto, 
2002), pig (Okamoto, 2002), cat (Okamoto, 2002), dog (Okamoto, 2002), tupaia (Okamoto, 
2002), chicken (Thomas, 1999), cow (Thomas, 1999) and sheep (Thomas, 1999). RoTTV would 
be included in this TTV family. High infectious prevalence was also common in the human and 
swine TTV infection, and more than 80% of human and pig populations were found to be 
positive for TTV DNA (Hino and Miyama, 2007). In the wild rodent population, wood mice 
(Apodemus sylvaticus) RoTTV infectious prevalence was extremely high but absent in Mus 
musculus. A similar disparity in infectious status between these species has also been observed in 
parasites such as Toxoplasma gondii (Bordes et al., 2012) and other viruses such as murid 
herpesvirus 4 (Blasdell et al., 2003) Differences berween the species such as immune responses 
and behaviour may influence the different infectious prevalence between wood mouse and other 
rodent species. Furthermore, we believed that every animal might harbour a TTV because TTV 
infection widespread in many animals. However, house/lab mice (Mus musculus) were found to 
be RoTTV negative in wild, lab, and pet shops. Compared to the other rodent species, the 
physiology and immunology of house/lab mice are well studied. Conversely, the physiology, 
especially immunology of wood mice and vole species has not been studied and only a few 
papers have been published. Most of the wood mice immunology papers mention that wood mice 
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have a strong immune system compared to Mus musculus. For example, wood mice showed a 
stronger interferon response and natural killer (NK) cell activity in Central European Encephalitis 
(CEE) virus infection (Kopecky et al., 1991). Furthermore, neutralising antibodies of wood mice 
appear faster and reached higher titer in the early phase of CEE virus and murine gamma herpes 
virus infection (Kopecky et al., 1991; Francois et al., 2010). Also, parasite infection is thought of 
as an important immunomodulatory factor (especially innate immunity) in the wood mice 
(Jackson et al., 2009), and these immunomodulatory systems or strong immune reaction may 
make a difference in their infectious status. However, this information is limited and there may be 
other immune system functions which are present in house/lab mice but not wood mice and vole 
species.  
 
3.8.2. Co-evolution of TTV and host species  
There is another possible reason why TTV infection is not observed in Mus musculus. For TTV 
evolutionary history, it has been hypothesized that co-evolution is the one of the most important 
factors to make the wide genetic diversity (section 1.2.). Although there are contradictory ideas, 
some researchers have suggested that TTV replicates slowly and takes millions of years to mutate 
(Khudyakov et al., 2000). We predicted that RoTTV has not been adapted to Mus musculus and it 
may simply need more time to mutate for the infection. In fact, the Mus musculus species is not 
native mouse in Europe. As early as 12,000 years ago, the Mus musculus was observed in Middle 
East (Auffray et al., 1988). After that, these mice spread to Asia. During the Edo era (100-
400years ago), Japanese hobbyist attracted by the coat colour variants of Mus musculus, bred 
them to produce new colours and sizes of mice and set up a "fancy mouse" trade. From the 
mouse trade, these mice finally spread to Europe and England (Moriwaki, 1994). According to 
this, Mus musculus appeared U.K environment only in the last several hundred. Therefore, TTVs 
may have to adopt in order to infect the house mice because TTV is species specific virus. Thus 
RoTTV must evolve by mutation and it is considered that RoTTV has not mutated enough to 
infect to the lab/house mice. On the other hand, wood mice are sometimes used for 
phylogeographical study because wood mice have relatively a large population in the wild rodent 
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and are present in European region for the past 3 million years (Michaux et al., 1998). This fact 
may also explain why wood mice become the natural host for the many pathogens in U.K.        
 
3.8.3. Genetic diversity of RoTTV 
RoTTV had at least 4 genogroups based on the sequence of screening PCR products and these 
RoTTV types are spread in different host species. Furthermore, screening PCR using species 
specific primers showed 37.5% (60/160) of RoTTV infected wild rodents had both RoTTV1 and 
RoTTV2. Multiple infections of different types of RoTTV in same individual were common. 
Multiple infections of several TTV genotypes have also been observed in human TTV infection 
(Ninomiya, 2008). TTV is thought to be acquired  in humans during infancy and dual and triple 
TTV infection were observed in 86.9% 1 year old children.(Ninomiya et al., 2008) In the swine 
TTV research, vertical transmission of TTV has been indicated (Pozzuto et al., 2009) The early 
acquisition of multiple TTV infections could occur in wild rodents population.  
 
We found that RoTTV has also a circular DNA genome and it was supported by successful 
amplification after RCA and inverted PCR. After sequencing of RoTTV complete genomes, we 
found that RoTTV showed heterogeneity of the entire viral genome sequences and sizes. For the 
phylogenetic tree construction, representatives of TTV, TTMV, TTMDV, animal TTVs, and 
RoTTVs were used and high sequence divergence was shown between RoTTV1 and RoTTV2, 
comparable to the difference between RoTTV and other anellovirus genera in pair-wise 
comparison analysis. Therefore, RoTTV strains could be divided into two species (RoTTV1 and 
RoTTV2), potentially even into different genera and each species had several genotypes. This 
genetic diversity is also common in human and animal TTV infection. Based on the wide range 
of human TTV sequence divergence, human TTV has at least 39 different genotypes, exhibiting 
>30% nucleotide difference from one another, and 5 different groups, showing >50% divergence 
(Okamoto et al., 2004). Therefore, RoTTV genogroups have a similarly high genetic diversity 
among the each genogroup compared to human TTV. In addition, RoTTV1 and RoTTV2 were 
found in the different rodent species; wood mice, field voles and bank voles. Also, RoTTV1 
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genomic sequence differs among the different host species than those of RoTTV2. This is 
unusual because other TTVs are considered to be species specific and would not show cross-
species infection (Isaeva and Viazov, 2002; Brassard et al., 2008; Okamoto et al., 2002; Thom et 
al., 2003). However, the similar infective style which makes a cross-species infection only 
among the rodent species is also observed in muridgammaherpes virus infection (Francois et al., 
2010). Herpesviruses are also known to be highly host restricted but murid gammaherpesvirus 
infection is observed in a wide variety of hosts including mouse, shrew and bank vole (McGeoch 
et al., 2006). According to several studies, it is concluded that this intraspecies transfer could be a 
key factor of gammaherpesvirus evolution (Wibbelt et al., 2007; Prepens et al., 2007; Ehlers et 
al., 2007; Ehlers et al., 2008). It is assumed that the reason why gammaherpesvirus transmits 
among the small rodents rather than large mammals is simply that small rodent species share the 
same habitant. Moreover, because of the horizontal transmission between small rodents, murid 
gammaherpesvirus sequences change rapidly compared to other members of gammaherpesvirnae 
(McGeoch et al., 2001; McGeoch et al., 2005). For intraspecies infection, murid 
gammaherpesvirus could be forced to adjust to new host receptors and immune system and one 
of the essential factors could be fast mutation (see below). This may also explain the finding that 
RoTTV showed cross-species infection in the different small rodent species and extraordinary 
sequence variations.           
 
We have several suggestions about the diversity of RoTTV. Firstly, TTV is a ss DNA virus. 
ssDNA viruses have a higher mutation rate compared to dsDNA viruses, even as high as some 
RNA viruses (Duffy, 2008). It is thought that ssDNA have high substitution rates (Duffy, 2008). 
Secondly, smaller viruses like TTV tend to replicate faster which increases the chance for 
accumulated virus mutations (Duffy, 2008). Thirdly, TTV is thought to use direct infection and 
does not use a vector (Lin et al., 2000). Therefore, TTV has to infect new host by itself and they 
may be required to mutate to apply to a new environment. Fourth, viruses which use the 
horizontal infection have to infect new individuals, thus these viruses may mutate to adjust the 
different individuals and their replication speed is faster than the viruses which infect vertically 
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(Lin et al., 2000). Moreover, TTV high mutation frequency was observed in human TTV 
experiments. In a cell culture experiment, TTV mutation and genetic rearrangement were 
frequently observed in TTV infected cells (Lippik, 2007). The high mutation rate and TTV 
genomic rearrangement may be related to the RoTTV genetic divergence.  
 
RoTTV complete genome sequences from spleen were identical with those from faecal 
supernatant. This indicated that RoTTV was emitted in the faeces and faecal supernatant is a 
good tool for the diagnosis of TTV. Furthermore, faeces would be an important route for TTV 
transmission. TTV was originally called transfusion transmitted virus because TTV was thought 
to be transmitted via blood transfusion (Takahashi et al., 2000). However, transmission via blood 
cannot explain the high infectious prevalence of TTV. As a result, the faecal-oral route was 
believed to be the main route of TTV infection. These results in this study also support this 
hypothesis. Similar results were also observed in swine and cattle TTV research (Brassard, 2008).  
 
3.8.4. Genomic structure of RoTTV 
RoTTV genomic structure was similar to that of TTV in humans and other animals. Genomic 
length of RoTTV was much smaller than those of other human and animal TTV. In human 
infection, 3 sizes of anellovirus were observed; TTV, TTMDV, and TTMV. TTV which was 
originally discovered is 3.8kb (Hino and Miyata 2007). TTMDV and TTMV have a smaller size 
compared to TTV, 3.2kb and 2.8kb respectively (Hino and Miyata 2007). On the other hand, 
RoTTV1 was 2.2kb and this is almost same genome size as tupaia TTV (Okamoto et al., 2002). 
RoTTV2 was 2.5kb. It has been shown that all animal isolates were smaller than human isolates, 
but to compared the previous TTV study, RoTTV genomic size was different from those of 
human and other animal TTV genomes. RoTTV genome sizes were between human TTMV 
(2.8kb) and feline TTV (2.0kb) and these sizes were uncommon except for tupaias (Okamoto 
2002). However, an anellovirus, which has same size as RoTTV, was observed in mosquito. 
These viruses were called as mosquito anellovirus and their genome sizes were 2.3kb and 2.5kb 
which is almost the same size as RoTTV1 and RoTTV2 respectively. We hypothesise that the 
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mosquito is not the true host of mosquito anellovirus and rodents are the source of anellovirus in 
mosquitoes. This idea is also supported by evidence that TTV isolated from rats and rat TTV 
showed to 81% mosquito anellovirus genomes (see Appendix 1.)   
 
The complete preservation of coding capacity for ORF1, ORF2, ORF3 and ORF4 was illustrated 
in Fig.3.6.1. Although RoTTV genome sequence and size were variable, the genomic 
organisation resembles those of TTV, TTMDV, and TTMV which were isolated from humans, 
nonhuman primates and other domestic animals. RoTTV ORF2 was located just before ORF1 
and RoTTV RoTTV1 ORF2 was 50% identical to swine TTV ORF2. RoTTV2 ORF2 was 84% 
identical with mosquito anellovirus ORF2. Interestingly, mosquito anellovirus was 80% identical 
to RoTTV1 ORF1 and 89% identical to RoTTV2 ORF1. These analogies of sequences between 
mosquito anellovirus and RoTTV indicate that RoTTV is closely related to mosquito anellovirus. 
Mosquito anellovirus was discovered in mosquitos in San Diego County (Nq et al., 2011). 
Mosquitos are an important vector and reservoir of various virus populations. In the present 
study, it is indicated that wild rodent species share similar TTV with mosquito. After ORF1, there 
were one or two ORFs in RoTTV1 and RoTTV2. According to the predicted genomic 
organization of other TTV genome, ORF3 and ORF4 should be located after ORF1 (Okamoto, 
2002). Thus, we believed these two ORFs would be ORF3 and ORF4 respectively. In the 
RoTTV2 genome structure, structure 1 had an antisense ORF (the data was not shown). TTV is 
described as single stranded negative sense DNA virus (Okamoto et al., 2009). Therefore, this 
antisense ORF which was often observed in RoTTV2 should not exist. This antisense ORF has 
no TATA box and poly A tail. This fact also supports that RoTTV2 TTV has antisense ORF but 
likely is not translated or transcribed. Finally, this antisense has to be checked by using northern 
blot. Thus, this antisense ORF has to be analyzed carefully.  
 
3.8.5. Classification of RoTTV 
In this study, 31 RoTTV1 and RoTTV2 isolates were totally separated from CAV which is most 
closely related to TTVs among known human and animal viruses. Basic Local Alignment Search 
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Tool (BLAST) analysis revealed that RoTTV1 and RoTTV2 isolates were closer to mosquito 
anellovirus (Nq et al., 2011). The genomic length of TTV tends to be smaller in the lower order 
animals. In this study, we can support this idea because RoTTV was much smaller than any other 
human and animal TTV except for feline TTV (Okamoto et al., 2002). At present, there are no 
precise criteria to distinguish between TTV and TTMV. Therefore, RoTTV might be called as 
rodent TTMV based on the genome size, but in the interim, we would propose these viruses as 
RoTTV. This is consistent with other anelloviruses being called TTV in other animal species.   
 
TTV has many unknown chraracteristics such as pathogenesis, virus localization, and host 
immune response. Current TTV research has been limited by the lack of good animal model and 
cell culture system. RoTTV has the potential to be an ideal animal model for TTV research. 
 
In conclusion, RoTTV was discovered in wild rodent population and, in spite of sequence 
divergence, the genomic organization was similar to TTV in human and other animals. Further 
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Appendix 1. Rat TTV infection in lab rat 
A.1. Background to this study 
To look for other potential animal models of TTV infection, RoTTV distribution in lab rats was 
studied. By finding RoTTV in the lab rats, we could also identify the virus contamination in the 
lab animal. If TTV is widespreaded in the lab rat colonies, this virus may disturb the rat immune 
system and affect the outcome of other experiments involving these animals.  
 
A.2. Samples 
Colony 1: two rats (Rattus norvegicus) were euthanized by cervical dislocation and sera were 
taken. Colony 2: ten rats were euthanized by CO2. Livers and spleens from these rats were taken.  
 
A.3. Screening PCR by using pan-TTV primer 
Screening PCR was carried out using the pan-TTV primer set which was used for screening wild 
RoTTV. When PCR was performed using the pan-TTV primers, TTV DNA was detected in 
serum from 2 rats (100%) and liver or spleen from 10 rats (100%). The amplified products by 
PCR with pan-TTV primers, which measured 54bp (primer sequence at both ends removed) were 
sequenced for the 12 rats which tested positive and analysed. According to the sequence results, 
12 rats TTVs showed 96-98% sequence identified to each other.   
 
A.4. Full-length PCR to amplify rat TTV 
Based on common 54bp sequences, inverse primers Ratinv1 (sense 5' CGG STA TGC CTG GTC 
CTC C 3') and Rat inv2 (antisense5' CGG GAA GCG AAG CGC CGA C 3') for amplification of 
rat TTV in each were constructed to amplify the full-length genomes. Before running full-length 
PCR, DNA extracted from the liver of 4 viraemic rats was amplified by the RCA method. Rat 
TTV genomes were found to be approximately 2.5kb in size in 4 rats Fig. A4.1. These amplified 
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A.5. Genomic structure and coding capacity 
RoTTV genomic maps were constructed by using DNASTAR Lasergene 9 core Suite and NCBI 
ORF Finder. All RoTTV genomic maps are shown in Fig.A5.1. Rat TTV genomic structure was 
similar among the each rat TTV clones and it was also similar to those of RoTTV from the wood 
mice and voles. All clones had TTV ORF2 and ORF1 and rat TTV ORF2 was located upstream 
of ORF1 with a partial overlap. Rat TTV contained ORF1 (79aa), ORF2 (396aa), ORF3 (218aa), 
and ORF4 (132aa).  
 
A.6. Discussion 
TTV has been discovered in almost every animal population. However, TTV in rodents had not 
been described until the discovery of RoTTV in from wood mice. This suggested that rat TTV 
might exist in wild or lab rats. Interestingly, all 12 rats were positive using the screening PCR. In 
this study, there were 2 groups and they come from two different labs. Although some rats were 
separated in different cages, the 10 rat group all came from the same animal house. The high 
infectious prevalence might be caused by virus propagation in the colony. However, the other two 
rats came from a totally different colony but they shared a quite similar virus. This indicates that 
rat TTV is widely distributed in lab rat population. Rat TTV genomic structure was similar to 
TTV from the other animals including RoTTV from wood mice and voles. Surprisingly, the rat 
virus complete genome sequence was 81% identical to mosquito anellovirus complete genomes. 
This sequence result also supports the hypothesis that rodent species provides TTV to mosquito 
and the mosquitoes are not natural host of TTV (section 3.8.4.).   
 
The rat is also an important lab animal and many research reagents are available for rat 
experiments. Rat TTV is relatively easy to be detected in the rat. However, this means control 
rats may be difficult to find in the rats colonies. Epidemiological study would be required to 

























Figure A4.1.1. Full-length PCR of rat TTV. (M) DNA ladder. Rat 
TTV complete genome was observed to be approximately 2.5kb in 
size.   
Figure A.5.1. Rat TTV genomic structure. Rat TTV genomic 
structure was similar to RoTTV1. All rat TTV genome structure 













CHAPTER IV. TRANSCRIPTS IDENTIFICATION AND PROTEIN 
EXPRESSION OF RODENT TORQUE TENO VIRUS   
 
The cell types supporting TTV replication are still unknown. This information is important 
not only for understanding of TTV pathogenesis but also for establishing a successful TTV 
cell culture system. TTV infected wood mice were examined to study virus RNA distribution 
and transcript profile which was them applied to the protein expression in BHK-21 cells. 
      
4.1. Background to the study 
4.2. TTV RNA detection in systemic organ of RoTTV infected wild rodents 
4.3. RACE (Rapid amplification of cDNA ends) and transcripts of RoTTV 
4.4. Characterisation of the spliced TTV mRNAs and genomic organization    
4.5. Predicted proteins and subcellular localisation of RoTTV fusion proteins  
4.6. Apoptosis inducing capacity of RoTTV proteins 















4.1. Background to the study 
TTV DNA is present in almost every organ and tissue and it may indicate TTV has a wide cell 
tropism (Reviewed by Hino and Miyata. 2007). There are many candidates for the replication site 
of TTV because double stranded circular DNA, which is potentially replicating virus, has been 
observed in human lung (Bando et al., 2001), liver (Okamoto et al., 2000a), bone marrow 
(Okamoto et al., 2000b), stimulated peripheral blood mononuclear cells (PBMC) (Mariscal et al., 
2002), spleen, lymph node, thyroid gland, pancreas and kidney (Okamoto et al., 2001).  
However, a TTV experiment using Rhesus monkeys showed different results. Although TTV 
DNA was found in various organs (Luo et al., 2000) TTV replicative form was detected only in 
liver, bone marrow and small intestine (Xiao et al., 2002).  This may indicate that genetically 
different virus types show different tissue tropism in different host species.  Alternatively, TTV 
could replicate in cells of the immune system and is detected throughout the tissues because of 
the wide distribution of these cells. Therefore, we have to carefully evaluate whether TTV really 
replicates in each of the tissues (Takahashi et al., 2002).    
 
As there is no efficient cell culture system to support TTV replication, the TTV transcriptional 
profile has been studied by using the cells transfected with genotype 1 or genotype 6 containing 
plasmids. Experiments have been carried out using cloned human TTV genotype 1 isolate and the 
monkey kidney cell line Cos-1. Three clone derived transcripts; 2.9-3.0kb, 1.2kb and 1.0kb were 
observed from transfected Cos-1 cells (Kamahara et al., 2000; Okamoto et al., 2000), and a more 
recent study showed one more transcript (0.6 kb) in genotype 1 transfected Huh 7 cells (Mueller 
et al., 2008). A similar result was also observed in bone marrow cells from TTV infected patients. 
These mRNAs were generated as the result of splicing and in the shorter mRNA of 1.2kb, 1.0kb, 
and 0.6kb (Muller et al., 2008) the 5' ends of ORF1 and ORF2 connect to distant ORFs to make 
five new ORFs (section  1.4.2.). The splice site was conserved among the different TTV 
genotypes (Kamahara et al., 2000; Okamoto et al., 2000). This indicated that TTV has several 
splicing sites to create the various mRNAs for various putative proteins.     
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Based on TTV transcripts profile, protein expression has been performed in a few studies. TTV 
genotype 6 showed three mRNAs and at least six predicted proteins (Qiu et al., 2005). The 
transcriptional profile of P/1C1 (genogroup 1) was studied and four transcripts and seven 
predicted proteins were found (Mueller et al., 2008). The proteins from these transcripts were 
expressed in human 293 cells and HEL32 cells and the predicted proteins were all observed (Qiu 
et al., 2005; Mueller et al., 2008) (section  1.4.3.).  
 
In chapter III, the RoTTVs found were classified as RoTTV1 and RoTTV2, and RoTTV1 had 
four predicted ORFs and RoTTV2 had five predicted ORFs. However, it was not known whether 
the ORFs were actually transcribed. In this chapter, for understanding of the RoTTV transcripts 
and protein, infected wild mice were examined to study RoTTV RNA expression pattern and 
RoTTV transcripts. In addition the proteins were expressed based on the transcripts profiles.  
 
4.2. TTV RNA detection in systemic organs of RoTTV infected wild rodents 
There are two aims to examine RoTTV RNA from the systemic organ. One aim is finding TTV 
replication site could assist in setting up a cell culture system (chapter V). The other is 
establishing the transcriptional profile based on the extracted RNA. The wild rodent samples 
described in chapter III were relatively old and had been stored at -20℃. It was highly unlikely 
that intact RNA could be recovered from these samples. Therefore, fresh rodent tissues were 
required for the RNA study. Four RoTTV1 positive wood mice were caught in United Kingdom 
and their bone marrow, lung, liver, spleen, and kidney were taken. Total RNA was extracted from 
these tissues and RT-PCR was performed by using RoTTV1 specific primers (Table 2.5.1.). The 
PCR results are shown in Table 4.2.1.  RoTTV1 RNA was not observed in every tissue, but RNA 
was consistently detected in bone marrow and lung tissue. Interestingly, liver was not a common 
site for RoTTV1 RNA in the infected wild wood mice. The RT-PCR result of mouse C is shown 
in Fig. 4.2.1. Mouse C showed RoTTV1 only in bone marrow and lung RNA. Bone marrow 
cDNA showed a stronger RoTTV1 amplicon signal than that of lung cDNA. This result was also 
supported by real-time RT-PCR, and RoTTV1 cDNA from bone marrow showed 1200 copies/ µl, 
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but cDNA from lung was 1-4 copies/ µl. This suggested that rodent RoTTV1 was actively 
replicated in the bone marrow. β-actin detection in these cDNAs confirmed the RNA integrity 











Case No. Bone marrow Lung Liver Spleen kidney 
Mouse A NS
‡
 + － － － 
Mouse B NS           + + + + 
Mouse C ++ + － － － 
Mouse D ++ + － + + 
Table 4.2.1. RNA distribution of RoTTV1 
Results of RT-PCR for RoTTV1 ; ++ strong positive, + positive, - negative.  NS=no sample 
 
 






















Figure 4.2.1. RT-PCR of mouse C by using RoTTV1 specific primer. 
 (L) DNA Ladder. (A) Bone marrow  (B) spleen (C) liver (D) lung (E) kidney.  RoTTV1 
transcript was observed in bone marrow and lung cDNA. Bone marrow showed stronger 
TTV transcript expression than that of lung, and lung also showed the positive band. 
Spleen had positive band but it was also observed in RT (-) RT-PCR. It was later confirmed 
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Figure. 4.2.2. RT-PCR by using β-actin primer. 
 (L) DNA Ladder. (A) Bone marrow  (B) spleen (C) liver (D) lung (E) kidney.  β-actin was 
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4.3. RACE (Rapid amplification of cDNA ends) and transcripts of RoTTV 
Full length nucleotide sequence of RoTTV1 and RoTTV2 
Using DNA extracted from the RoTTV1 infected wood mouse from which the transcriptional 
profile was to be mapped, a complete genome was amplified and cloned for sequencing. The 
RoTTV1 clone was named AS_HL1_Li_1 and this clone had the same four ORFs as other 
RoTTV1 clones (chapter III) and a genome length of 2201 nt. The RoTTV2 complete genome, 
AS_WM1_Se_4 clone was obtained from the screening study from chapter III and the genomic 
structure was a typical RoTTV2 structure with five ORFs. The genomic maps from RoTTV1 and 
RoTTV2 clones are shown in Fig. 4.3.1.  
        
 
 
RACE (Rapid amplification of cDNA ends)  
The amount of lung RNA was sufficient for RACE analysis of RoTTV1 (Rapid amplification of 
cDNA ends). RoTTV2 RNA was extracted from AS_WM1_Se_4 clone transfected BHK-21 cells 
(chapter V) for RACE analysis. By using RNA from these samples, RoTTV transcripts were 
identified (section 2.12.). RoTTV transcripts were amplified by using the gene specific primers 
(TTV primers) and GeneRACER primers (adaptor primer) shown in Table 2.12.1. Single 
products were amplified from 3’RACE and 5’ RACE PCR respectively.  For 3’ RACE, the gene 
specific primer was located at nt 261 (see RACE primer shown in Fig. 4.3.2.A.) and the amplicon 
was approximately 320 bp in size. For 5’ RACE, genespecific primer was located in nt 240 (see 
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RACE primer shown in Fig. 4.3.2.A.)  and the amplicon was approximately 330 bp in size. The 
PCR amplicons from the RACE cDNA were cloned using the pGEM®-T Easy vector kit and 
sequenced. RoTTV1 3' end and 5' end sequences are shown in Fig. 4.3.2.B. The 5' terminus of 
RoTTV1 is predicted to start at nt 2174 with the sequence 5' AGTTTACT- downstream of TATA 
box (ATATAA). Also, the extreme 3'-end containing the poly A sequence -AATAAA 3' starting at 
nt 1699 was detected. Also, a single splicing event was observed between nt 398 and 1289. Based 
on RACE PCR results, two sets of primers were designed including first methionine of ORF2 
and stop codon of ORF2-3 (Table 2.12.2) to confirm the transcript (see confirm primer shown in 
Fig.4.3.2.A). Amplicons of cDNA approximately 580 bp and approximately 1450 bp Fig. 4.3.3.A 
were amplified by PCR from lung cDNA representative of spliced (0.8kb) and unspliced (1.7kb) 
transcripts. However, only the 0.8 kb transcripts could be amplified from bone marrow cDNA 
(data not shown).  Finally, the RoTTV1 transcript map is shown in Fig. 4.3.2.A. and shows the  
two distinct species of TTV mRNA, one unspliced and one spliced mRNA.  
 
RoTTV2 transcript was also amplified by RACE PCR. Single products were amplified from 
3’RACE and 5’ RACE PCR respectively.  For 3’ RACE, the gene specific primer was located in 
nt 243 (see RACE primer shown in Fig. 4.3.4.A.) and the amplicon was approximately 650 bp in 
size. For 5’ RACE, genespecific primer was located in nt 221 (see RACE primer shown in Fig. 
4.3.4.A.) and the amplicon was approximately 300 bp in size. The PCR amplicons from the 
RACE cDNA were cloned using the pGEM®-T Easy vector kit and sequenced. RoTTV2 3' end 
and 5' end sequences are shown in Fig. 4.3.4.B. The 5' terminus of RoTTV2 mRNAs starts at nt 
2534 with the sequence 5' CATGGACT- downstream of TATA box (TATATAA). Also, the 
extreme 3'-end containing the poly A sequence -AATAAAAA 3' starting at nt 2127 was detected. 
Also, single splicing was observed between nt 348 and1703. To confirm the results, the PCR was 
performed by using 3' gene specific primer and the primers designed based immediately 
downstream of poly A tail (Table 2.12.2) (see confirm primer show in Fig.4.3.4.A); the amplified 
products of cDNA c (100-200 bp) (Fig. 4.3.3.B, product-c) and cDNA d (700-900 bp) (Fig. 4.3.3. 
B, product-d) were observed on 1.5% agarose gel. The sequences from PCR products were 
 
Chapter IV                                                                                          Results 
124 
 
identical to those of cDNA sequences from RACE and furthermore, several other spliced 
transcripts were found from the PCR. The RoTTV2 transcripts map is shown in Fig. 4.3.4.A. and 
shows the five distinct species of TTV mRNA with one unspliced mRNA and four different 
spliced transcripts. In the four spliced mRNAs, the splicing events were found to occur between 
nt 348 and nt 1703 (0.77 kb), nt 348 and nt 2049 (0.4 kb), nt 336 and nt 1984 (0.47kb), nt 356 
and nt 2008 (0.47kb). The length of these five mRNAs was deduced to be approximately 2.1 kb, 
0.77 kb, 0.4 kb, 0.47 kb, and 0.47 kb respectively by sequence analysis of the corresponding 
cDNA from RACE. 
 
Without prior reverse transcription, no PCR reaction was observed using any of the primers 
shown in Table 2.12.2. This indicated that the above-mentioned PCR products truly come from 
the RNA molecules suggesting that, as predicted in chapter III, the ORFs in 3’-5’ genomic 
orientation are not transcribed. TTV genome has been demonstrated as negative sense single 




























cDNA                                                              
                                                                              AGTTTACTCTGCGAGACCGGGGGACCGGGCGAGTAACT 
 
Genome              
                          AATGTGCCTGTGGATCCTCAGTTATCCCCCAATAAACATTGAATTCTGACAATCCAGTGGTGA 
cDNA 








Donor site                                Acceptor site 
















Figure 4.3.2. cDNA analysis of RoTTV1 (clone; AS_HL1_Li_1). (A) Summary of the RoTTV1 transcriptional map. 
The genetic map of RoTTV1 is shown on the top. The nucleotide numbers initiation site and polyadenylation 
cleavage site are indicated. In addition, the primer sites of Race and conformation PCR were indicated as orange 
arrow.  Four of the predicted ORFs are diagrammed below. The ORF1 and ORF2 proteinsare encoded from the 
unspliced 1.7 kb mRNA by using AUG (nt 259) and AUG (nt 125), respectively. ORF1-4 which is initiated at AUG 
(nt 259) and ORF2-3 which is initiated at AUG (nt 125) are encoded from the single spliced 0.8 kb mRNA. (B) 
Mapping of 5’ and 3’ end of RoTTV1 (clone AS_HL1_Li_1) transcripts. Mapping of 5' end of the RoTTV1 (clone 
AS_HL1_Li_1) transcripts and the genomic sequence with TATA box are given above. Mapping at the 3' end of the 
RoTTV1 (clone AS_HL1_Li_1) transcripts with poly A (nt 1718) is shown. (C) Sequence of the donor and acceptor 
site in RoTTV1 (clone AS_HL1_Li_1). The consensus sequence of splice donor (SD) and splice acceptor (SA) sites 
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Figure 4.3.3. The PCR amplified products of RoTTV mRNA in various lengths. RT-PCR of RoTTV1 
mRNA by using ORF2 and ORF3 primers (Table 2.12.1) was performed; (A) the band;a (580 bp) 
showed the shorter mRNA 0.8 kb and the band; b (1450 bp) showed the unspliced mRNA 1.7 kb. RT- 
PCR of RoTTV2 mRNA by using 3' RACE gene specific primers and  the primers designed based on 
the upstream of poly A tail was performed; (B) the band; c (100-200 bp) showed the shorter mRNA 
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GTTCTATATAAGTACAGGCACTGACGAATGGCAGAGTTCATGGACTGAAGGAGTAGAAAATGCTGTCAGAG 
cDNA                                                                      




                       TTAGTTGGTGAGTGTGCTTAATAAAAACCTTTAAACCATAAAAAATGTGTGATTAATATAAG 
cDNA 























2500 2506 2534 
2127 2151 
Donor site                                   Acceptor site 
Transcript2 
AAGG GTAAGG***********CACAG ACGA 
 
Transcript3 
AAGG GTAAGG***********CGGAG TCCA 
 
Transcript4 




GAAC ATACCG************GTTCT GATG 
Figure 4.3.4. cDNA analysis of RoTTV2 (clone AS_WM1_Se_4). (A) Summary of the RoTTV2 
transcriptional map. The genetic map of RoTTV2 is shown on the top. The initiation site and 
polyadenylation cleavage site are indicated with nucleotide numbers. . In addition, the primer sites of 
Race and conformation PCR were indicated as orange arrow.  Nine predicted ORFs are shown below. 
The ORF1 and ORF2 proteins are encoded from the unspliced  2.1 kb mRNA by using  O1 AUG (nt 
238) and O2 AUG (nt 125), respectively. Other 0.77 kb, 0.4 kb, 0.47 kb , and 0.47 kb mRNAs are also 
predicted to initiate translation from O1 AUG (nt 238) and O2 AUG (nt 125).  (B) Mapping of 5’ and 3’ 
end of RoTTV2 (clone AS_WM1_Se_4) transcripts. Mapping of 5' end of the RoTTV2 (clone 
AS_WM1_Se_4) transcripts and the genomic sequence with TATA box are given above. Also mapping 
of the 3' end of the RoTTV2 (AS_WM1_Se_4) transcripts with poly A (nt 2151) is shown. (C) Sequence 
of the donor and acceptor site in RoTTV2 (clone AS_WM1_Se_4). The consensus sequence of splice 
donor (SD) and splice acceptor (SA) sites in splicing site is shown. Transcript 3 and Transcript 4 do not 
followed the GT-AG splicing rule. Transcript3 shows GG-GA splicing and Transcript 4 shows the AT-
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4.4. Characterisation of the spliced TTV mRNAs and Genomic Organization.  
In the RoTTV1 clone AS_HL1_Li_1, the 1.7 kb mRNA (Transcript 1) is not spliced, and ORF2 
was predicted to start at the first ATG codon (nt 125) in frame 3 and ORF1 was predicted to start 
at the second ATG codon (nt 259) in frame 2. Consequently, ORF2 would encode 116 aa in frame 
3 and ORF1 would encode 342 aa in frame 2. The 0.8 kb mRNA (Transcript 2) had a single 
splicing event that bound nt 398 to nt 1289. The donor site at nt 398 was located 74 nt upstream 
of the stop codon of ORF2, creating the new ORFs: ORF2-3 (nt 125-398 and nt 1289-1575 in 
frame3) and ORF1-4 (nt 259-398 and 1289-1575 in frame2).   
 
The donor and acceptor sites of the splicing event in RoTTV1 mRNA are shown in Fig. 4.3.2.C 
and follow the GT-AG splicing rule (Mount. 1982) and the intron consensus rule (Breathnach et 
al., 1978). Finally, it was concluded that the coding region including the four ORFs is deduced to 
be nt 125-1708 and the noncoding region is located at nt 1708-2244 and nt 1-124 accounting for 
approximately 30% of RoTTV1 genome.  
 
In the RoTTV2 clone, AS_WM1_Se_4, the 2.1 kb mRNA (Transcript 1) had no splicing, and 
ORF2 was predicted to start at the first ATG codon (nt 125) in frame 1 and ORF1 was predicted 
to start at the second ATG codon (nt 238) in frame 3. Therefore, ORF2 would encode 75 aa in 
frame 1 and ORF1 would to encode 576 aa in frame 3. The 0.77 kb mRNA (Transcript 2) had a 
single splicing event that bound nt 348 to nt 1703. The donor site of the splice at 348 was located 
at 4 nt upstream of the stop codon ORF2 creating other new ORFs: ORF 1-4 (nt 238-348 in 
frame 3 and nt 1703-1930 frame 1) and ORF2-5 (nt 125-348 in flame 1 and nt 1703-2127 in 
frame 2) encoding 112 aa and 215 aa respectively. The 0.4 kb mRNA (Transcript 3) had a single 
splicing event. Although the donor site of the splice was present at same position as that in the 
0.77 kb mRNA, its acceptor site was located at nt 2049 suggesting the formation of other new 
ORFs: ORF1-5 (nt 238-348 in frame 3 and 2049-2127 in the frame 2) and ORF2-7 (nt 125-348 in 
flame 1 and 2049-2092 in frame 3) encoding 62 aa and 88 aa respectively. The 0.47 kb mRNA 
(Transcript 4) had a single splicing event that bound nt 336 to nt 1984. The donor site of the 
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splice at 336 was located at 16 nt upstream of the stop codon of ORF2 creating other new ORFs: 
ORF1-6 (nt 238-336 in frame 3 and 1984-2127 in frame 2), and ORF2-6 (nt 125-336 in frame 1 
and nt 1984-2058 in frame 3) encoding 80 aa and 94 aa respectively. Another 0.47 kb mRNA 
(Transcript 5) had a single splicing event that bound nt 356 to nt 2008. The donor site of the 
splice at 356 was located 4 nt downstream of the stop codon of ORF2 and this mRNA encoded 
the complete ORF2 in frame 1 identical to 2.1 kb mRNA (data was not shown in Fig. 4.3.4.). The 
splicing event created a new ORF: ORF1-6: nt 238-356 and 2008-2058 in frame 3 encoding 55 
aa. 
 
The splice donor and acceptor sites in two RoTTV2 mRNAs followed the GT-AG splicing rule 
(Mount. 1982) (Fig. 4.3.2.C) but those of the two 0.47 kb mRNAs did not (Fig. 4.3.2.C). Two 
0.47 kb cDNA clones and four 0.47 kb clones were isolated from PCR amplified products and 
these multiple clones support the presence of these new non-GT-AG splicing transcripts. It is 
known that the human erythrovirus B19 has a CT-AG splice (Brunstein et al., 2000; Vashisht et 
al., 2004; Kamada et al., 2006) and RoTTV2 could also have these transcripts. Finally, it was 
concluded that the coding region including the four ORFs (ORF1-4) is deduced to be nt 125-2127 
and the noncoding region was located at nt 2128-2571 and nt 1-124.  
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4.5. Predicted protein and localisation of RoTTV Fusion Protein  
4.5.1. Prediction of RoTTV1 and RoTTV2 viral proteins 
A high level of variability in ORF1 amino acid sequence, especially in RoTTV1 was observed in 
the RoTTV clones (as described in section 3.5). The ORF1 proteins of RoTTV1 and RoTTV2 
have a conserved arginine-rich N-terminal region (Fig. 4.5.1.1.). In RoTTV2, the ORF1 protein 
has some rolling circle replication (RCR)-associated motifs identical to those found in an other 
anelloviruses, CAV, and PCV capsid proteins (section 1.4.). In RoTTV2 ORF1, motif II (HXH) 
was located at aa 336-338 as HRH and motif III (YXXK) was located at aa 47-50 as YYRK. 
Motif I (FTL or FXTL) described in human TTV studies was not detected in RoTTV2. 
Accordingly, RoTTV1 and RoTTV2 showed a conserved arginine-rich N-terminal region but the 
RCR associated motifs were only observed in RoTTV2 and those of RoTTV1 might be less 
conserved or completely lost.   
 
As described in other anelloviruses and CAV (Peng et al., 2002; Peter et al., 2002), RoTTV 
ORF2 contained a protein-tyrosine phosphate (PTP) motif (WX7HX3CXCX5H) at aa 14-34 for 
RoTTV1 and a protein-tyrosine phosphate (PTP) like motif was also observed at aa 15-35 for 
RoTTV2 but the amino acid sequence was FX7HX3CXCX5H. These motifs were preserved in 
the ORFs created by the spliced transcripts of RoTTV1 and RoTTV2. 
 
In addition, RoTTV1 ORF2-3 showed a serine and lysine rich area at the C-terminus (Fig. 
4.5.1.2.). TTV, TTMV, and CAV are known to have a similar motif in their ORF2-3 and this 
motif is similar to the phosphorylation site of the nonstructural protein hepatitis virus C (NS5A) 


































Figure 4.5.1.2. The entire amino acid sequence of RoTTV1 ORF2-3 (Clone HLWM). Serine residues are 
shown in red and basic amino acid, arginine and lysine, are underlined. Serine rich area with lysine and 
arginine residues was located in C-terminus of ORF2-3. WX7HX3CXCX5H motif was located in N-







Figure 4.5.1.1. Arginine-rich N-terminus in ORF1 of RoTTV1 (AS_HL1_Li_1) and RoTTV2 (clone 
AS_WM1_Se_4).  Arginine residues are shown in red. 
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4.5.2. Subcellular localisation of RoTTV1 fusion protein 
The identified transcripts of RoTTV1 were used as the basis for the fusion protein expression 
study. The coding sequences of RoTTV1 were amplified by PCR using restriction site containing 
primers (Table 2.13.1.). RoTTV1 complete plasmid (clone AS_HL1_Li_1) was used for 
amplifying ORF1 and ORF2 coding sequence and cDNA from RoTTV1 infected bone marrow 
(section  4.2. AS_HL1_Li_1) was used for amplifying the spliced coding sequence, ORF1-4 and 
ORF2-3. The amplified products by PCR were cloned to pGEM®-T easy then, subcloned in 
pEGFP-C1 (Clotech) and pcDNA
TM 
3.1/ myc-His(-) A MCS (Invitrogen) plasmids using 
appropriate restriction  enzymes. The recombinant plasmids were transfected into BHK-21 cells. 
RoTTV1 ORF fusion proteins were expressed and detected by fluorescence. For the pcDNA 
TM 
3.1/ myc-His (-) fusion transfected cells (section  2.13.4.), an anti-myc immune stain was 
required. The nuclei were counterstained by TO-PRO-3 iodide.   
 
As shown in Fig. 4.5.2.1. (A, B) and Fig. 4.5.2.2. (A, B), the fusion proteins were expressed 24 h 
post-transfection, and two detection strategies (GFP or c-myc) showed similar results. The ORF1 
protein localised the nucleus, especially to nucleolus-like structures (arrow heads) and the ORF2 
protein predominantly localised to the cytoplasm with punctate granules around the nucleus 
(arrow). ORF1-4 was located in the cytoplasm and nucleus, especially in nucleolus like structures 
(arrow head). ORF2-3 was located in the cytoplasm with punctate granules (arrow) around the 
nucleus and also within the nucleus. RoTTV1 ORF 1, ORF2, ORF1-4 and ORF 2-3 correspond 
to human TTV genotype 1 ORF1, ORF2, ORF1-1, ORF2-2 and RoTTV protein expression 
patterns were similar to those of  human TTV genotype 1 (Muller et al., 2008).  
 
At 48h post transfection, ORF1-4 transfected BHK-21 cells showed morphological changes such 
as fused cells Fig. 4.5.2.3.A or nuclear fragmentation like change Fig. 4.5.2.3.B. In apoptotic 
cells, nuclear fragmentation, formation of chromatin spheres with in the cytoplasm, and 
chromatin condensation are typically observed. Also, cellular swelling in apoptotic cells is found 
as secondary necrosis (Bishop et al., 1993). It was predicted that ORF1-4 might have an 
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apoptosis inducing function similar to TAIP of human TTV or Apoptin of CAV (section  1.4.3.).    
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4.6. Apoptosis inducing capacity of RoTTV protein  
4.6.1. Confocal microscopy of apoptosis stained cells    
As shown in Fig. 4.5.2.3., the morphological changes in ORF1-4 transfected cells were similar to 
those of apoptotic cells. For studying the apoptosis inducing properties of ORF1-4, FLICA
® 
660 
in vitro poly caspase detection (ImmunoChemistry Technology) was used to stain the apoptotic 
cells in ORF1-4 GFP fusion protein expressing BHK-21 cells. FLICA 660 poly caspase inhibitor 
probe contained the preferred binding sequence to bind all caspases (Val-Ala-Asp) and shows 
strong red fluorescence in apoptotic cells. The transfected cells were stained by FLICA and DAPI 
for the counter stain and the cells were analyzed by a Zeiss LSM710 confocal microscopy (Carl 
Zeiss, UK). The results are shown in Fig. 4.6.1.B. Following transfection of ORF1-4 GFP 
constructs, BHK-21 cells had many apoptotic cells but the fragmented cells which had a strong 
GFP expression were not stained by FLICA (Fig. 4.6.1.B (arrow)). This result was also observed 
for other RoTTV1 proteins (Fig.4.6.1. A, C). ORF1 was not studied as its presence could not be 
confirmed by western blot analysis (Data shown in section  4.7.) 
 
4.6.2. FACS analysis of apoptosis stained cells/ confocal microscopy and cell counting 
For counting the GFP expressed and FLICA stained cells, GFP fusion protein expressed BHK-21 
cells were trypsinised and stained by FLICA, and these cells were analyzed by BD LSR Fortessa 
cell analyzer (BD Biosciences, USA). However, the staining conditions needed to be optimized 
for the FACS analysis and almost all cells were stained by FLICA (The data was not shown). 
Therefore, the stained and protein expressed cells were counted on the several images from 
section 4.6.1. The FLICA stained and GFP positive cells were manually counted by an 
experimenter in a blinded fashion. ORF1 was removed from this study because full length ORF 1 
was found not to be expressed in BHK-21 cells (section  4.7.) The number of cells, natural 
apoptotic rate and fusion protein effects are shown in Table 4.6.2. The rate of virus fusion protein 
effects (FLICA and GFP double positive cells/total cell number) was not higher than naturally 
apoptotic rate (FLICA only positive cells/total cell number) of BHK-21 cells (Fig. 4.6.2.).  
  
 































Figure. 4.6.1. FLICA staining in GFP and RoTTV1 ORF fusion protein. FLICA stained cells (apoptotic 
cells); red. GFP fusion protein; Green, DAPI (nucleus); Blue. (A) ORF2 GFP fusion protein, (B) ORF1-4 
GFP fusion protein, (C) ORF2-3 GFP fusion protein.  ORF1-4 expressing cells showed fragmentation 
(arrow) but FLICA staining was negative. Also, normal ORF1-4 expressing cells were FLICA negative 
(arrow head). This result was same as other ORFs; (A) ORF2 (C) ORF2-3.   
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ORF2 66 8 42 4 120 
ORF1-4 65 63 24 15 167 
ORF2-3 95 22 18 8 143 
GFP 29 9 62 10 110 




ORF2 GFP fusion protein  
Naturally apoptotic rate; 8/74=11% 
Fusion protein effects; 4/46=8.6% 
 
ORF1-4 GFP fusion protein  
Naturally apoptotic rate; 63/128=49% 
Fusion protein effects; 15/39=38.5% 
 
ORF2-3 GFP fusion protein  
Naturally apoptotic rate; 22/117=19% 
Fusion protein effects; 8/26=30% 
 
GFP fusion protein 
Naturally apoptotic rate; 9/38=24% 
Fusion protein effects; 10/72=14% 
 
 
Table 4.6.2. The number of FLICA positive and GFP expressing BHK-21 cells counted to identify RoTTV1 
protein apoptosis inducing capacity. 
*
Total number of cells. 
†
The number of FLICA positive cells (apoptotic 
cells) but not to express GFP or fusion protein. 
‡





number of GFP or GFP fusion protein and FLICA double positive cells.   
Figure. 4.6.2. Natural apoptotic rate and fusion protein effects. Naturally apoptotic rate was calculated 
following the formula; FLICA positive cells/total untransfected cell number (Blue+Blue/Red), and 
fusion protein effects was calculated following the formula; FLICA and GFP double positive cells/total 
GFP expressed cell number (Blue/Green+Blue/Red/Green). Fusion protein effects were smaller than 
naturally apoptotic rate in all RoTTV1 ORF fusion protein.  
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4.7. Confirmation of viral protein expression 
To confirm the synthesis of the four RoTTV1 proteins and determine the molecular weight, 
RoTTV ORFs the N-termined were eGFP tag expressed in BHK-21 cells and protein expression 
at 24 h post transfection was verified by western blot analysis. Anti-GFP antibody (sc-8334, 
Santa Cruz) was used for the blotting and the result is shown in Fig. 4.7.1.1. GFP was detected in 
a band at approximately 26.9 kDa and fusion proteins were detected in a band size at 
approximately 50 kDa and 38 kDa  (predicted size 40 kDa) for ORF2, approximately 50 kDa 
(predicted size 42.6 kDa) for ORF1-4 and approximately 65 kDa and 38 kDa (predicted size 52.5 
kDa) for ORF2-3. ORF2 and ORF2-3 showed two bands and the lower bands were similar in size 
to each other. However, by analysing Splicing Site Prediction 
(www.fruitfly.org/seq_tools/splice.html) and PeptideCutter (web.expasy.org/peptide_cutter/), it 
was not clear how the lower bands of ORF2 and ORF2-3 were generated. The actual sizes of the 
proteins were slightly higher than predicted and this may indicate that protein modifications such 
as glycosylation, phosphorylation, and acetylation have occured. Although, the ORF1 protein was 
detectable by both anti c-myc immune stain and GFP detection in fixed cells, ORF1 protein was 
not detectable by Western blot analysis.  












Figure 4.7.1.1. Detection of recombinant RoTTV1 proteins by western blot analysis with anti GFP 
antibody. (M) PageRuler (Thermo scientific). (1 and 6) positive control (pGFP C-terminus), (2) 
pGFP ORF1 fusion protein, (3) pGFP ORF2 fusion protein, (4) pGFP ORF1-3 fusion protein, (5) 
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4.8.1. RoTTV1 RNA distribution 
The present study showed that RoTTV1 RNA was predominantly distributed in the bone marrow 
and lung tissue and indicated that these two tissues are the replication sites of RoTTV1. Human 
TTV replication site has been studied in TTV infected patients (Okamoto et al., 2001; Kikuchi et 
al., 2000; Lopez-Alcorocho et al., 2000) and TTV DNA and RNA have been found in various 
tissues including liver, bone marrow, lung, spleen, pancreas, kidney, lymph node, skeletal muscle, 
and thyroid gland although the TTV viral load was different among the individuals and higher in 
bone marrow, lung, spleen, and liver (Okamoto et al, 2001). However, it has also been suggested 
that TTV replicates in cells of the immune system and the immune cells may be the carrier of 
replicating virus. Detection of viral RNA or double-stranded intermediate of TTV throughout 
tissues may be due to the presence of immune cells (Takahashi et al., 2002). When TTV was 
discovered it was thought to be a hepatitis virus (section 1.5.2.1.) but other reports have disputed 
this hypothesis (Hijikata et al., 1999; Hsieh et al., 1999; Nakano et al., 1999; Naoumov et al., 
1998; Niel et al., 1999; Prati et al., 1999; Viazov et al., 1998; Yamamoto et al., 1998; Nobili et 
al., 2005). In the present study, the liver was not the main replication site compared to the other 
organs and this finding is supported by recent human TTV studies. Also, bone marrow cells 
including haematopoietic cells (Okamoto et al., 2000; Takahashi et al. 2002; Mariscal et al. 2002; 
Maggi et al. 2001; Lopez-Alcorocho et al., 2000; Mariscal et al., 2002; Zhong et al., 2002) and 
cells in respiratory tract (Bando et al. 2001; Maggi et al. 2003a; Okamoto et al., 2001) have been 
better studied in recent years (Aramouni et al., 2003) and human TTV RNA levels were highest 
in these tissues. Also, in the present study, RoTTV1 RNA titre of bone marrow was 1000 fold 
higher than that of lung, and human TTV was suggested to infect by using faecal-oral route 
(section 1.3.2.2.). Therefore, we conclude that RoTTV1could replicate in lung but continuous 
replication may occur in the bone marrow cells.   
 
The replication site may be related to the TTV associated disease. In respiratory disease, it has 
been shown that TTV replication and high viral titer were observed in the pulmonary epithelium 
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of 1-24-month-old children with acute respiratory disease, and group 4 TTV was frequently 
observed in bronchopneumonia patients (Bando et al. 2001; Maggi et al. 2003a; Okamoto et al., 
2001; Chung et al., 2007). Also, in haematologic disease, aplastic anemic and thrombocytopenia 
were also suggested as human TTV related disease (Kikuchi et al., 2001; Tokita et al., 2001).  
Therefore, RoTTV1 infected rodents may show respiratory disease or haematologic disease in 
associated with TTV infection.  
  
The RoTTV RNA expression pattern may depend on the virus genotype. It was found that human 
TTV from PBMC and plasma showed different genotypes in the same individual (Okamoto et al., 
1999; Okamoto et al., 2000). Thus, it was concluded that RoTTV1 would replicate in lung and 
bone marrow cells but it may not be same as RoTTV2 or other human and animal TTVs.  
 
Bone marrow is also a predicted replication site of human and animal TTVs. TTV is small single-
stranded DNA virus and small DNA viruses tend to have the highest dependence on the host cell 
replication system for virus replication. TTV is also predicted not to encode a DNA polymerase 
based on the genomic analysis (Kakkola et al., 2007). Therefore, TTVs have to infect highly 
replicating cells which are in S-phase and the bone marrow may be the main replication site of 
RoTTV1 for this reason. 
 
4.8.2. Transcriptional profile and species specific structure of RoTTV transcript 
The results gained in the present study indicated that at least two RoTTV1 mRNAs of 1.7 kb and 
0.8 kb in size are transcribed in lung and bone marrow of a RoTTV1 infected wild mice, and at 
least five RoTTV2 mRNA of 2.1 kb, 0.77 kb, 0.4 kb, 0.47 kb and 0.47 kb are transcribed in 
RoTTV2 complete genome transfected BHK-21 cells. Their transcriptional profile was similar to 
those of human and porcine TTVs. Both mRNAs from RoTTV1 and all five mRNAs from 
RoTTV2 are transcribed from a common internal promoter in their genomes such as TATA-box 
(ATATAA in RoTTV1 and TATATAA in RoTTV2) at nt 2146-2150 and nt 2500-2506 
respectively. The extreme 5' end of RoTTV1 mRNA was located at the position nt 2174 which is 
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24 nt downstream of the putative promoter (Fig. 4.3.2.B).  Also, the extreme 5' end of RoTTV2 
mRNA was located at the position nt 2534 which is 28 nt downstream of putative promoter (Fig. 
4.3.4.B). These AT-rich promoter regions are located about 25 nt upstream of the mRNA start 
points in cellular and viral promoter and they are considered to bind with RNA polymerase for 
the initiation of transcripts (Corden et al., 1980). Furthermore, all sequences from 3' RACE 
contained poly A starting immediately downstream of the polyadenylation signal (AATAAA) 
located at nt 1697-1702 in RoTTV1 and nt 2125-2130 in RoTTV2. Therefore, RoTTV1 and 
RoTTV2 would use the common internal promoter and poly A signal and shared common 5' and 
3' ends. This is in agreement with human and porcine TTVs studies (Okamoto et al., 2000).  
 
 In RoTTV1, the unspliced transcript was 1.7 kb in size and encodes ORF1 (nt 259-1286) and 
ORF2 (nt 125-472). The shorter transcript which had a splicing event at nt 398-1289 creates the 
new ORFs ORF1-4 and ORF2-3. These ORFs used the same ATG codons at 259 and 125 as 
ORF1 and ORF2 respectively. Also, the splicing event follows the GT-AG rule do as other TTVs 
and CAV (Mount 1982; Kamada et al., 2006; Mueller et al., 2008. Fig. 4.3.2.C). On the other 
hand, RoTTV2 showed five transcripts, 2.1 kb, 0.77 kb, 0.4 kb, 0.47 kb and 0.47 kb. It was also 
speculated that the unspliced 2.1 kb transcript encoded ORF1 (nt 238-1986) and ORF2 (nt 125-
352) and other spliced transcripts would use the first methionine (ATG) of ORF1 and ORF2. 
Four splicing events were found in RoTTV2 and two of them were in accordance with GT-AG 
splicing pattern (Okamoto et al., 2000) but other two showed GG-GA and AT-CT splicing 
patterns. Human TTV, parvovirus, CAV and other small DNA viruses all show the common GT-
AG splicing pattern  (Okamoto et al., 2000; Vashisht et al., 2004; Kamada et al., 2006; Muller et 
al., 2008) but erythrovirus B19 has been reported to have a CT-AG splice (Brunstein et al., 2000) 
and was predicted to use a novel splicing pattern or pathway. Several GG-GA and GT-AG spliced 
transcripts were isolated from RoTTV2 RNA and they would utilise an uncharacterised splicing 
mechanism.  
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4.8.3. Common splicing site of RoTTV1 and RoTTV2 
A common splicing site between RoTTV1 and RoTTV2 was found. For human TTV transcripts, 
all identified human TTVs transcripts have a splicing event (nt 182-284 in genotype 6 (Qiu et al., 
2005) and nt 185-277 in genotype1a (Kamahora et al., 2000) which does not affect ORFs 
(Okamoto et al., 2000; Qiu et al., 2005; Muller et al., 2008). However, RoTTV1 and RoTTV2 do 
not have this first splicing event in this study and this first splicing event also has not been 
observed in porcine TTV and CAV transcriptional studies (Kamada et al., 2006; Martinez-Guino 
et al., 2011). Animal TTV transcriptional profile has not been well-studied but it is possible that 
animal TTVs do not have first splice. The other common splicing event is found in the middle of 
ORF2 with overlapping part of ORF1 in human and porcine TTVs creating new ORFs (Okamoto 
et al., 2000; Martinez-Guino et al., 2011).  This is also observed in RoTTV1 and RoTTV2 
creating two new ORFs in RoTTV1 (ORF1-4 and ORF2-3) and seven new ORFs (ORF1-4, 
ORF2-5, ORF1-5a, ORF2-7, ORF1-5b, ORF2-6, ORF1-6) in RoTTV2.  
  
4.8.4. ORF proteins of RoTTV1, predicted function, and protein localisation  
ORF1; ORF1 is predicted to encode the capsid protein and Rep protein of TTV (Takahashi et al., 
1998; Bendinelli et al. 2001; Takahashi et al. 1998). However, no rolling-circle replication (RCR) 
motifs (motif 1; FTL, motif 2; HXH or HXQ, and motif 3; YXXK) were observed in RoTTV1. 
These motifs were observed in human and animal TTVs but the appearance patterns are variable 
in different species and clones of TTV and some motifs were lost or less conserved (Muller et al., 
2008; Martinez-Guino et al., 2011). RCR motiefs were not observed in RoTTV1 but motif II and 
motif III were found in RoTTV2 ORF1. By using these motifs, it has been deduced that ORF1 
works as a replicase (Muller et al., 2008). 
 
In this study, the ORF1 fusion protein localised to the nucleus, especially in nucleolus like 
structures. This is in agreement with the recent human and porcine TTV reports (Muller et al., 
2008; Martinez-Guino et al., 2011). There are two reports describing human TTV ORF1 
expression in cell culture (Qiu et al., 2005; Muller et al., 2008), and one report indicated ORF1 
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was expressed in cytoplasm (Qiu et al., 2005) and the other report showed ORF1 in nucleus 
(Muller et al., 2008). ORF1 is suspected to be the capsid protein and also related to replication by 
using a rep-motif. Also, human TTVs and RoTTV have an Arg-rich region in the N-terminus of 
ORF1 and it is known to be most conserved region in ORF1 (Fig. 4.5.1.1.) (Bendinelli et al., 
2001; Takahashi et al., 1998). This region showed homology to the nucleolar localisation signals 
(NuLS) of oncogene MEQ of a herpesvirus (Marek's disease virus; MDV) (Liu et al., 1997) and 
adenovirus protein V (Matthews et al., 2001) to induce the nucleolar transport (reviewed by 
Hiscox 2002). Furthermore, in human TTV a similar localisation pattern of ORF1 was confirmed 
as nucleolar (Muller et al., 2008). Accordingly, RoTTV1 ORF1 expression in the nucleus may 
indicate it plays an important role in synthesising DNA. However, the full length ORF1 coding 
sequence was difficult to amplify by PCR (required 35 cycles in both rounds of nested PCR) and 
ORF1 GFP fusion proteins were not detected by western blot (Fig. 4.7.1.). This result is 
unexpected for a predicted capsid protein, but the same result was also reported in human and 
porcine TTV studies (Qiu et al., 2005; Martinez-Guino et al., 2011). One suggestion is the ORF1 
coding sequence is unstable or low copy number. In this study, the unspliced RoTTV1 ORF1 
mRNA was not amplified from bone marrow cDNA but could be found in the lung. However, 
bone marrow showed higher cDNA copy number and it is believed to be main replication site. 
Thus, TTV copy number in bone marrow should be high enough to detect virus ORF1 mRNA. In 
human TTV studies, premature stop codons in the middle of TTV ORF1 were observed 
suggesting the production of defective TTV genomes which also could indicate that ORF1 is 
unnecessary (Erker et al., 1999; Luo et al., 2000; Khudyakov et al., 2000; Pollicino et al., 2003; 
Jelcic et al., 2004). RoTTV1 is likely to replicate in bone marrow but may not produce unspliced 
RNA transcripts. This also suggested that the full length ORF1 might not be necessary for TTV 
replication.  In the porcine TTV study, the unspliced transcript has not been found yet and it is 
indicted that some animal TTV might not to have ORF1 (Martinez-Guino et al., 2011).  
 
Even when ORF1 coding sequence is predicted, it has also been difficult to detect the ORF1 
protein (Qiu et al., 2005; Martinez-Guino et al., 2011). ORF1 was not detected in the first human 
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TTV protein studies (Qiu et al., 2005) and porcine TTV studies (Martinez-Guino et al., 2011). In 
the human study, it was concluded that ORF1 expression level was too low to detect it by using 
Western blot regardless of being a predicted structural protein (Qiu et al., 2005). In a porcine 
TTV study, it was concluded that ORF1 protein might be expressed in the cell culture but the 
protein was unstable and degraded rapidly (Martinez-Guino et al., 2011). In the present study, the 
samples for western blot were collected by using PBS containing proteinase inhibitor. However, 
ORF1 protein was not detected by western blot (Fig. 4.7.1.). One human TTV report succeeded 
in detection of ORF1 protein by using pCMV-HA plasmid and it was concluded that genogroup 1 
(clone P/1C1) promoter may be more tightly regulated than the heterologous CMV promoter and 
therefore the use of different plasmids may allow the detection of ORF1 by Western blot (Muller 
et al., 2008). Accordingly, the result might change, when other plasmids which have other 
promoter system are used in the study. The alternative may be that fill-length ORF1 is never 
expressed.  
 
ORF1-4; In this study, ORF1-4 fusion protein was also expressed in nucleus especially in 
nucleoli like structures and in the cytoplasm. Expression in the nucleoli like structures was more 
frequently observed than for ORF1. Also, Arg-rich region which has NuLS like sequence in N-
terminus of ORF1 was conserved in ORF1-4 (see ORF1 above) and these nucleoli-like structures 
in the nucleus were confirmed as the nucleoli in human TTV study (Muller et al., 2008). Some 
DNA and RNA virus proteins tend to be observed in nucleoli; for example, the replication 
complex of Borna virus for the replication and transcription (Pyper et al., 1993), Rev and Tat 
protein of HIV-1 for RNA processing (Michienzi et al., 2000), IVa2 and V of adenovirus for the 
delivery of viral DNA to the host cell during the infection (Matthew et al., 1998). These viral 
proteins  are considered to be related to cellular transcription (Liu et al., 1997), virus 
transcription (Matthews et al., 1998), virus translation (Hiscox et al., 2001) or cell division 
(Wurm et al., 2001). Therefore, ORF1-4 would be predicted to have an important role of virus 
infectious cycle similar to other viruses.  
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ORF1-4 transfected cells showed the morphological changes such as nuclear fragmentation and 
formation of the chromatin sphere 48 hours post infection and the intensity of GFP expression 
was decreased compared to 24 hours post infection. These morphological changes are typical of 
apoptosis (Bishop et al., 1993) and human TTV protein is known to have a protein associated 
with the induction of apoptosis, TTV apoptosis inducing protein (TAIP) (Kooistra et al., 2004).  
CAV unspliced mRNA encodes VP2 and VP3 proteins and they have an apoptosis inducing 
activity (Zhuang et al., 1995; Noteborn and van der Eb. 1999; Noteborn et al., 2005) and human 
TTV ORF3 showed the homology to CAV VP3 (Kooistra et al., 2004). CAV VP3 showed a high 
level of apoptosis inducing capacity in tumours regardless of the tumour origin, but TTV TAIP 
induced apoptosis to hepatocellular carcinoma (HCC) preferentially and the apoptosis inducing 
capacity was weak in non-HCC cell lines (Kooistra et al., 2004). Accordingly, human TTV would 
use a different apoptosis inducing mechanism from that of CAV. In this study, the conserved 
hydrophobic region (L or (I), S or (A), XIXIXLXL) of apoptin and TAIP was not observed in the 
RoTTV1 amino acid sequence.  
 
To confirm the apoptosis inducing capacity, FLICA apoptosis detection kit was used for apoptosis 
staining. However, the cells which showed the morphological changes, were negative for FLICA 
and the apoptotic rate of GFP fusion protein expressed cells was lower than the natural apoptotic 
rate (section  4.6.2.). FLICA detects activated caspases apoptotic cells by using the probe and all 
apoptotic cells should activate at least one caspase (Liang et al., 2001). Thus, we concluded that 
RoTTV1 protein does not have apoptosis inducing capacity and the morphologic changes in 
ORF1-4 transfected BHK-21 cells were thought to be caused by necrosis or other viral protein 
effects.   
 
ORF2; ORF2 is assumed to code for a nonstructural protein involved in viral replication 
(Okamoto et al., 1998. Reviewed in Bendinelli et al., 2001), and the ORF2 protein expression 
pattern supported this hypothesis. ORF2 was predominantly expressed in the cytoplasm, and this 
is in agreement with previous human TTV studies. Also, in the present study, punctate granules 
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were observed around the nucleus (Fig. 4.5.2.1.A.). Some virus proteins localised to the 
cytoplasm which produce punctate granules and two types of granules have been reported; Golgi 
apparatus shown in herpes simplex virus (Nozawa et al., 2003) or endoplasmic reticulum (ER) 
shown in Dengue virus (Miller et al., 2006). The granules distributed in Golgi apparatus were 
shown around nucleus (Nozawa et al., 2003) and the granules distributed in ER were found in 
almost entirely in the cytoplasm (Miller et al., 2006). ORF2 granules were similar to those of 
Golgi apparatus and should be confirmed by Golgi-58K staining. If TTV ORF2 protein was 
located in Golgi apparatus the protein may be targeting the Golgi membrane or intracellular 
trafficking pathway of progeny capsids.                
 
ORF2 also showed the common WX7HX3CXCX5H motif in RoTTV1 (Fig. 4.5.1.2.), and CAV 
VP2 is known to have same motif and it has protein-tyrosine phosphatase (PTPase) activity 
which regulates the cellular and/or viral protein during infection (Peter et al., 2002). Therefore, 
RoTTV ORF2 could have a similar function to that of CAV.  This motif was also conserved in 
ORF2-3 and is presumed to have a similar function (Fig. 4.5.1.2.).  
 
In the western blotting analysis, ORF2 showed two bands of 50 kDa and 38 kDa in size 
(predicted size 40 kDa) and the lower band size of ORF2 was similar to the lower band of ORF2-
3. In the human study, a stop codon followed by an ATG were located in the middle of ORF2 and 
it was divided into two smaller protein coding areas, ORF2a and ORF2b in some clones (Tanaka 
et al., 2000). However, RoTTV has no stop codon in ORF2 and it is considered that the smaller 
bands were result of the post-translation cleavage or splice variants of mRNA (Reviewed in 
Stryer, 2001).  
   
ORF2-3; Compared to ORF2, ORF2-3 localised to the nucleus and cytoplasm and it indicated 
that the structure or amino acid sequence encoded by the ORF3 region would contain the nuclear 
localisation signals. The N-terminus region of the ORF2-3 amino acid sequence was identical to 
that of ORF2 and it contained the WX7HX3CXCX5H motif and is predicted to have a protein -
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tyrosine phosphatase (PTPase) activity that regulates the cellular and/or viral proteins during 
infection (Peter et al., 2002) (see ORF2 mentioned above). 
 
ORF2-3 showed a serine-, arginine-, and lysine- rich region in the 100 aa at the C-terminus (Fig. 
4.5.1.).  This region is similar to human TTV, TTMV and CAV (Asabe et al., 2001) and the 
predicted protein could be phosphorylated similar to hepatitis C virus (HCV) nonstructural 
protein 5A (NS5A) (Asabe et al., 2001). This phosphorylated human TTV ORF3 is predicted to 
be involved in the virus replication cycle and this is also observed in other virus infections such 
as vesicular stomatitis virus (Barick et al., 1992; Spadafora et al., 1996; Hwang et al., 1999), the 
origin binding protein of the herpes simplex virus (Isler et al., 2001), the NS1 protein of the 
minute virus of mice (Nuesch et al., 1998), and the capsid protein of hepadnaviruses (Yu et al., 
1994). Therefore, RoTTV1 ORF2-3 could be phosphorylated in the same way as other viruses 
and work in the virus replication phase.  
 
ORF2-3 was also expressed not only in cytoplasm but also in the nucleus indicating that the 
region encoded by ORF3 contained the nuclear localisation signal (NLSs) like "pat4" which 
consists of a continuous stretch of four basic amino acid (arginine and lysine) (Robbins et al., 
1991; Hiscox et al., 2002). This supports ORF2-3 localisation in nucleus.   
 
Western blot analysis showed two bands of ORF2-3 proteins and the lower band was a similar 
size to ORF2 lower band (see ORF2) suggesting that ORF2-3 may also be spliced or cleaved in a 
similar manner to ORF2 (see above). In this study, almost all proteins detected by western blot 
showed larger products compared to the predicted protein sizes and this was also shown in a 
human TTV study (Muller et al., 2008). There are several factors that may influence the product 
size. The expressed fusion proteins may be targeted for protein modification such as 
glycosylation, phosphorylation, and acetylation, and it would give products of a higher molecular 
weight than the predicted bands (reviewed in Stryer, 2001). Furthermore, the proteins may be 
aggregated by using the disulfide bonds, and the complex structure could affect the denaturation 
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and gel running (Reviewed in Stryer, 2001). The fusion proteins of human TTV and RoTTV 
showed slightly bigger in size than those of the predicted, and they could be affected by these 
factors.   
    
In conclusion, we have described RoTTV1 RNA localisation in virus infected wood mice and 
predicted the virus replication site. This information is important for setting up the cell culture 
system and studying pathogenesis of RoTTV. Furthermore, we have identified the transcriptional 
profile and some RoTTV1 proteins were expressed in BHK-21 cells. These results can be applied 










CHAPTER V. TTV REPLICATION IN VITRO 
    
As RoTTV1 RNA was located in bone marrow, we concluded that this is a site of active viral 
replication. Wood mouse bone marrow derived macrophage and bone marrow stem cell 
cultures were grown for rodent TTV infection and transfection. Furthermore, concatemerised 
RoTTV complete genomes were used for transfection based on the reported porcine TTV 
infection study. The genomes were also transfected into BHK-21 cells.  
 
5.1. Background to the study 
5.2. Reagents for in vitro infection/transfection 
5.3. Bone marrow derived macrophage/Wood mouse bone marrow derived stem cell 
5.4. Type I IFN KO mouse embryo fibroblast (MEF) 
5.5. Baby Hamster Kidney cell (BHK-21) 
5.6. Comparative study of old and young passage of BHK-21 cells 
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5.1. Background to the study 
One of the difficulties in carrying out research on TTV is the lack of a suitable cell culture 
system. Various types of the primary cells and cell lines have been used for human and porcine 
TTV studies and in vitro transcription has been shown in a variety of cell lines (Okamoto et al., 
2000; Kamahora et al., 2000; Kamada et al., 2004; Qiu et al., 2005; Kakkola et al., 2007; Muller 
et al., 2008; Kakkola et al., 2009; Huang et al., 2012). However, virus production was not 
observed for porcine TTVs (Huang et al., 2012).  
 
In the human TTVs study, there have been the multiple attempts to propagate TTV in cell culture. 
TTV genome transfected cell cultures did not produce virus genomes into the culture supernatant 
(Kakkola et al., 2007; Kakkola et al., 2009). TTV genotype 1 DNA positive serum was added to 
Raji cell line and phytohemagglutinin (PHA) stimulated PBMC cell cultures and the copy 
number of TTV genomes in the culture supernatant was increased (Desai et al., 2005; Mariscal et 
al., 2002, Maggi et al., 2001). However, the TTV infection in these cells was not sufficient to 
fully isolate virus. Firstly, in the cell culture system, the level of TTV replication was very low 
and the copy number of TTV DNA produced decreased over the studied time period. Secondly, 
the produced virus did not propagate to the intact cells efficiently.  
 
Recently, human TTV replication was observed in 293TT cells, however these replicated viruses 
were smaller than original virus (de Villiers et al., 2011). The smaller virus DNA was transfected 
into 293TT cells and DNA was detected in the cells and medium. However, the problem with this 
cell culture is that the copy number of TTV in the medium was low and by 10 days was 
decreasing. In addition, the transfected 293TT cells stopped DNA production of TTV when the 
cells were passaged (de Villiers et al., 2011). Furthermore, infectious material was not observed 
in the culture supernatants and actual propagation has not been shown (de Villiers et al., 2011). 
 
Concatemerised TTSuV DNA failed to infect 12 different cell lines including porcine cell lines. 
However, concatemerised TTSuV DNA was directly inoculated to the piglet and the virus was 
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replicated (Huang et al., 2012) indicating that concatemerised TTV can replicate in the cells.   
 
In this chapter, we demonstrate the continuous in vitro replication of RoTTV and virus 
propagation. Based on the result of chapter IV, bone marrow derived cells were studied firstly 
and the other cell lines and the various infectious agents including concatemerised DNA were 
used to study RoTTV replication.  
 
5.2. Reagents for in vitro infection/transfection 
Several infectious reagents were prepared and constructed for the infection and transfection. 
5.2.1. Liver homogenate 
RoTTV infected liver was disrupted in PBS using a microtube pestle (Sigma-Aldrich). These 
samples were then homogenised using a fine Hypodermic needle (Approx. 15 gauge first and 23 
gauge later to make fine homogenate) (Terumo) and hypodermic syringe (Terumo) and then 
centrifuged at room temperature for 1 minute for 5000 x g. Supernatant of liver samples was 
taken and filtered by sterilised 0.2μm filter Cartridge (Sartorius).  
 
5.2.2. Faecal supernatant 
Infectious reagent from faecal supernatant was prepared using the same method for DNA 
extraction from faecal supernatant (section 2.2.1.). This time, the centrifuged faecal supernatant 
was filtered by sterilised 0.2μm filter Cartridge (Sartorius).  
 
5.2.3. Single copy of RoTTV complete circular genome. 
Unique restriction sites were found in the RoTTV1 and RoTTV2 complete genome sequences 
(Spe I for RoTTV1 and HindIII for RoTTV2) and the inverted primers were constructed to 
contain these restriction sites (Table 2.15.4.1.). The amplicons were cloned (section 2.9.), plasmid 
preparations were performed and the plasmids were digested using the appropriate restriction 
enzyme (SpeI for RoTTV1 and HindIII for RoTTV2), and RoTTV complete genomes were 
purified by size fractionation on agarose gel (section 2.7.2.). Finally TTV complete genomes 
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were self-ligated by NEB T4 ligase (section 2.9.5.). The plasmids were transfected into the cells. 
A schematic representation of the construction of single copy of RoTTV complete circular 











Figure 5.2.3.1. Construction of single copy of RoTTV genome 
Inverted PCR was performed to amplify 
RoTTV complete genome by using the 
restriction site containing primers.  
The amplicons were cloned and amplified in E. 
coli. RoTTV complete genomes were 
separated from pGEM vector by using the 
appropriate restriction enzyme digestion and 
size fractionation. 
RoTTV complete genome fragment was 
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5.2.4. Construction of GFP/ RoTTV1 
GFP/RoTTV1 was used for the confirmation of virus promoter function. GFP/RoTTV1 were 
constructed by the restriction site containing GFP and RoTTV1 primers (Table 2.15.4.2.). 
RoTTV1 primers were designed at the 5’ end of ORF2 and such GFP should not disrupt any 
coding sequences shown in chapter IV. GFP genome sequence was amplified with the restriction 
sites by PCR from pGFP plasmid and the PCR fragment was cloned (section 2.9.). The RoTTV1 
genome was amplified with the restriction sites by PCR and the PCR fragment was cloned 
(section 2.9.). GFP clones were digested by the appropriate restriction enzyme (Sph I for pGEM 
T easy vector and HindIII (Promega)) and run on agarose gels to purify the GFP fragments 
(section 2.7.2.). RoTTV1 clones were digested to linearise the plasmid by using the restriction 
enzyme (Sph I from pGEM T easy vector and HindIII (Promega) with Alkaline Phosphatase for 
removing phosphate groups and the products were purified by MinElute
® 
PCR purification kit 
(section 2.7.1.). The GFP fragments and the linearised RoTTV1 clones were ligated to each other 
on the Sph I and HindIII sites by using NEB ligase (section 2.9.5.) and the ratio of RoTTV1 
genome and GFP volume was 1:5. The ligated plasmids were cloned (section 2.9) and plasmid 
preparations were digested by Bam HI (Promega) and the digested products were self-ligated by 
NEB T4 ligase (section 2.9.5.). A schematic representation of GFP/RoTTV1 construction is 
shown in Fig. 5.2.4.1. 
  
 


























TTV complete genome with restriction 






The amplicons from 1) were cloned and 
HindIII and SphI (from pPGM) sites 
were digested and linearised.  
BamHI HindIII 
GFP 
GFP coding sequence with restriction 
sites was amplified by PCR and cloned. 
The clons were then digested by HindIII 
and SphI from pGEM T easy vector and 









2) and 3) were ligated to each other and 
and removed from vector by BamHI 
digestion and TTV/GFP fragments were 




TTV/GFP fragments were self-ligated 
and used for the transfection. 
Figure 5.2.4.1. GFP/TTV construction.  
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5.2.5. Tandem-dimerised RoTTV complete genomes 
By using concatemerised RoTTV complete genomes, the continuous complete RoTTV genomes 
were transfected into the cells and they were constructed by RCA (section 2.10.2.), restriction 
enzyme digestion (section 2.10.3.), and cloning (section 2.9.1.). The single copy of TTV 
complete genomes described in section 5.2.3. were used as the template of RCA. The amplified 
long TTV multiple copies of genome were digested by incomplete restriction enzyme digestion. 
Partially digested reactions were separated by agarose gel electrophoresis and gel slices 
containing more than two copies of complete genome were cut to extract concatemerised 
genomes (section 2.7.2.). The genomes were cloned into pGEM T easy vector (section 2.9.) (Fig. 




































Figure 5.2.5.1. Concatemerised RoTTV genome clone construction. Circular RoTTV genomes 
were amplified by RCA. The amplions were digested by incomplete restriction enzyme digestion. 
Two copies of complete genome were cut to extract concatemerised genomes and cloned. 
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5.2.6. Myc tagged concatemerised RoTTV 
To reproduce myc tagged virus, myc tagged RoTTV1 complete genome was constructed by myc 
tagged primer (Table 2.15.4.3.) and RCA. The concatemerised genome was made by a similar 
method to 5.2.5. Single copy of myc RoTTV1 was prepared by the method discussed in section 
2.15.5. and RCA (section 2.10.2.). The amplicons were incompletely digested, and the double 
size of RoTTV DNA was cloned (section 2.9.). 
 
5.3. Bone marrow derived macrophage/bone marrow derived stem cell 
Bone marrow derived macrophage 
As shown by the results in chapter IV, RoTTV is predicted to replicate in the bone marrow and 
bone marrow derived macrophages were set up following the protocol described in section 
2.15.2.1. Two types of bone marrow derived cell cultures were prepared; Type I interferon 
receptor KO mice and RoTTV negative wood mice. Bone marrow derived macrophages from 
both mouse species stimulated with LPS (E.coli Φ55 B5) were also used for the infectious 
experiment. In addition, two infectious agents were used for TTV infection; faecal supernatant 
and single copy RoTTV complete genomes.  
 
Faecal supernatant was prepared from RoTTV infected wild (section 5.2.2.) mice. Serial dilutions 
of the samples were made and virus was detectable down to the 100 times
 
dilution by PCR. Two, 
five, ten, and fifty times diluted faecal supernatants were added to the wells which contain the 
bone marrow derived macrophages (wood and type I IFN KO mice) and incubated 4 days. Total 
DNA was extracted from the entire cultures (both cells and supernatant). The virus copy number 
was compared to those of input faecal supernatant. Serial dilution was performed on DNA from 
input faecal supernatant and cell culture (medium and cells), and PCR was carried out on two 
replicate samples from each dilution. After compensation for different input volumes, RoTTV 
genome was observed until the same dilution (100 times) in both original samples and cell 
culture samples. Accordingly, there was no difference between the virus titer in input faecal 
supernatant and the virus titer in total DNA in cell culture, and hence no evidence that RoTTV 
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replicated in bone marrow derived macrophages.   
 
Single copies of RoTTV1 and RoTTV2 genomes were constructed as described in section 5.2.3. 
and transfected into the bone marrow derived macrophages by using lipofectamine 2000 
(Invitrogen) following the protocol shown in section 2.13.2. The pEGFP-N1 plasmid was used to 
monitor the transfection efficiency, but the transfection efficiency was low (<10%) and TTV 
RNA was not observed by RT-PCR.  
 
Bone marrow derived stem cells 
Bone marrow derived macrophages are the differentiated cells from the stem cells in bone 
marrow and RoTTV may require differentiated cells. Accordingly, the bone marrow stem cell 
cultures from the wood mice were prepared for RoTTV replication. Similar results to the bone 
marrow derived macrophages were also observed in bone marrow derived stem cells. Bone 
marrow derived stem cell cultures were set up following the protocol described in section 
2.15.2.2. and bone marrow derived stem cells are shown in Fig. 5.3.1. Stem cells are fragile and 
the cells would be damaged by lipofectamine 2000 transfection. Therefore, SAFEctin
TM 
-STEM 
transfection reagent (Deliverics) was used for the stem cell transfection (section 2.15.3.).   
Figure 5.3.1. Bone marrow derived stem cell culture (Day 3). 
Stem cells were swelling at this time and used for the infection. 
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The single copy clone preparations of RoTTV were constructed as described in section 5.2.3. and 
transfected into the stem cells. Also, GFP/TTV plasmid was constructed as described in section 
5.2.4. to confirm the virus promoter function and the transfection of plasmid into the stem cells. 
At the same time, pEGFP-N1 plasmid was used to monitor the transfection efficiency, but the 
transfection efficiency was low (<10%) and the promoter of GFP/TTV was not observed to 
function by fluorescence microscopy. RoTTV RNA was not observed in RT-PCR.  
 
5.4. Type I IFN KO mouse embryo fibroblast (MEF) 
Primary cells such as bone marrow derived macrophages and stem cells are very fragile and the 
transfection efficiency is low. A rodent cell which is less easily killed and shows good 
transfection efficiency was required to deliver the plasmid into cells and Type I IFN receptor KO 
MEF cells were therefore used for the infection and transfection studies. MEF cells were first 
confirmed as RoTTV negative by PCR (data not shown). Two infectious reagents were used for 
Type I KO MEF; the liver homogenate of RoTTV1 infected mice (section 5.2.1.) and the 
concatemerised RoTTV1 and RoTTV2 complete genome (section 5.2.5.).  
 
Liver homogenate 
In 6 well plate, 1.2 x 10
6
 cells were infected with 0, 20 and 200μl of liver homogenate, MEF cells 
showed morphological change over a period of 2-3 days. These cells detached from the bottom of 
the tissue culture flask and culture medium colour changed from pink to red.  
 
Serial dilution was performed on DNA from original homogenate and cell culture (medium and 
cells), and PCR was carried out on two replicate samples from each dilution. After compensation 
for different input volumes TTV genome was observed until the same dilution (100 times) in both 
original samples and cell culture samples. As virus was detected at the same dilution between 
original samples and cell culture samples, we believe that rodent TTV did not replicate in the 
cellular fraction of the culture. In a separate experiment, DNA was extracted from MEF cells 
only. No virus was observed in these cells indicating that TTV was not able to enter on attach to 
 





The concatamerased RoTTV genome  
The concatemerised DNA was constructed are described in section 5.2.5. The concatemerised 
RoTTV1 and RoTTV2 DNA plasmids were transfected into Type I IFN KO MEF in 24 well 
plates and the cells were incubated for 48 hours. Transfection efficiency was approximately 50-
60% in pEGFP-N1 plasmid transfected MEF cells. Total RNA was extracted from MEF cells and 
mRNAs of RoTTV -1 and RoTTV2 were detected by RT-PCR by using RoTTV1 and RoTTV2 
species specific primers (Fig. 5.4.1.). CPE was not observed in MEF cells.  
 
In the previous study, the transcripts were detected in human and porcine cell lines (Okamoto et 
al., 2000; Kamahora et al., 2000; Kamada et al., 2004; Qiu et al., 2005; Kakkola et al., 2007; 
Muller et al., 2008; Kakkola et al., 2009; Huang et al., 2012) but evidence of productive TTV 
infection was not observed in these reports. To confirm virus replication, the medium of RoTTV 
transfected cells was taken for measurement of the virus genome copy number. Before measuring 
virus DNA, the transfected cells were passaged 5 times in 75 cm flask (BD Bioscience, UK) to 
remove as much as possible, the plasmids used for transfection (Fig. 5.4.2.). From the passage 6, 
400µl of media was taken in day 0, day5 and day10 and the DNA was extracted. The virus 
replication was monitored by qPCR and results are shown in Fig. 5.4.3.     
  
 


























Figure 5.4.1. RoTTV1 and RoTTV2 transcripts were observed at 48 hours post-transfection by 
RT-PCR using RoTTV1 and RoTTV2 species specific primer. RT-PCR was performed in 
quadruplicates using same template  cDNA. RoTTV1 PCR products; 180bp and RoTTV2 
PCR products; 250bp. RT+; Reverse transcriptase including RT-PCR. RT-; Reverse 
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Figure 5.4.2. Experimental protocol of RoTTV1 virus replication study.   
The transfected cells were passaged 5 times and 400µl of culture supernatant was taken in 
day 0, day 5, and day 10.  
 





     
 
The RoTTV1 viral load was high at day 5 post transfection, peaking at 1 x 10
5
 genomes 
equivalents/ml and it then decreased to 1 x 10
4 
genomes equivalents/ml. This indicated that while 
Type I IFN KO MEF do produce virus, they are not suitable for the constant virus replication.  
 
5.5. Baby Hamster Kidney cell (BHK-21)  
Type I IFN KO MEF did not show constant virus replication. MEF are a Mus musculus cell line, 
and it was concluded that Mus musculus is not a natural host of RoTTV based on the screening 
study of wild rodent species. However, it was also found that RoTTV was present in a number of 
rodent species other than Mus musculus (chapter III). Accordingly, another rodent cell line, Baby 
Hamster Kidney cells (BHK-21) was used for RoTTV infection. BHK-21 cells were first 
confirmed as RoTTV negative by PCR (data not shown).  
 
RoTTV1 and RoTTV2 concatemerised genome plasmids were transfected into BHK-21 cells and 
the transcripts of RoTTV1 and RoTTV2 were also detected by RT-PCR (Fig. 5.5.1.). Transfection 
efficiency was approximately 80-90% in pEGFP-N1 transfected BHK-21 cells. The transcripts of 
Figure 5.4.3. RoTTV1 viral DNA copy number in the supernatant culture fluid of the P5 
transfected Type I IFN KO MEF. The virus titer was increased at day 5 and decreased by day 10.  
Days post-passaged 
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RoTTV2 were used as templates for RACE (section 4.3). Also, the transfected cells were 
passaged 5 times to remove the input plasmid and from passage 6, 400µl of the supernatant was 
taken on day 0, day 5, day 7, and day 13. Total DNA in 400µl was extracted from the supernatant 
and qPCR was used to monitor RoTTV replication. The result is shown in Fig. 5.5.2. RoTTV1 
viral titer increased constantly up to 2.5 x 10
6
 genome equivalents/ml by Day 13. BHK-21 cells 
were becoming over confluent on day 13. The media was used for the virus propagation 
experiment (section 5.7). No CPE was observed in RoTTV1 infected BHK-21 cells. These results 
indicate that BHK-21 showed the constant and high copy number of RoTTV1 replication. In cells 
transfected with concatemerised RoTTV2, viral DNA was not found to increase in the 
supernatant.  
 
A c-myc tag was added to the end of ORF2-3 of RoTTV1 and myc RoTTV1 concatemerised 
DNA was constructed as described in section 5.2.6. The concatemerised DNA was transfected in 
BHK-21 cells and the cells incubated and the transcripts were observed in samples collected 2 
days post-transfection. In addition, the cells were fixed and stained by anti-myc antibody based 




















Figure 5.5.1. RoTTV1 and RoTTV2 transcripts were observed at 48 hours post-transfection 
by RT-PCR in the concatemerised DNA transfected BHK-21 cells. RT-PCR results using 
RoTTV1 and RoTTV2 species specific primers are shown and RT-PCR was performed in 
triplicate using the same cDNA. RoTTV1 PCR products; 180bp and RoTTV2 PCR products; 
250bp. RT+; Reverse transcriptase including RT-PCR. RT-; Reverse transcriptase excluding 
RT-PCR. N; negative control. L; DNA ladder.  
 
Figure 5.5.2. RoTTV1 viral DNA titer in the supernatant culture fluid of Passage 6 BHK-
21 cells. The viral titer increased up to 2.5 x 10
6
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5.6. Comparative study of old and young passage of BHK-21 cells 
Virus replication was confirmed by using the same BHK-21 cells used in section 5.5 (passage 30) 
(Old BHK21) and a lower passage batch of BHK-21 cells (Passage 10) (Young BHK). RoTTV1 
concatemerised DNA was transfected into the two BHK-21 cell lines and the cells were passages 
5 times with washing in PBS twice each passage to remove the input plasmids. The 400 µl of 
supernatant was taken in day 0, day 1, day 3, day 4, day 5, and day 6, and virus replication was 
monitored by qPCR. The copy number of RoTTV1 in the medium of old and young BHK-21 
cells is shown in Fig. 5.6.1.  
 





A huge difference of viral replication was shown between old BHK-21 cells and young BHK-21 
cells. The RoTTV1 viral load of the supernatant culture fluid in old BHK-21 cells increased up to 
1.5 x 10
5 
genome equivalents/ml in Day6 and it was extremely slow compared to that of young 
BHK-21 cells. Young BHK-21 cells increased rapidly up to 1.6 x 10
6
 genome equivalents/ml at 
Day 6. The cell appearance showed no difference and the growing speed of cells appeared similar 
between old BHK-21 cells and young BHK-21 cells.          
  
Figure 5.6.1. RoTTV1 viral DNA copy number in the culture supernatant of RoTTV1 transfected 
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5.7. Virus propagation 
The supernatants of RoTTV1 transfected BHK-21 cells in section 5.5. was used to study the 
ability of presumed virus present in these supernatants to infect fresh BHK-21 cells. The 
supernatant containing (2.5 x 10
6
 genome equivalents/ml) was put onto the fresh BHK-21 cells in 
a 24 well plates and the cells were incubated and sampled were taken at 5 days and 11days post-
infection. The medium was old and nutritionally-poor media after the experiment described in 
section 5.5, but still supported growth of the BHK-21 cells. The cells started to show sign of 
damage and clumped but became confluent and were collected from the bottom of 2 wells of a 24 















Total RNA was extracted from BHK-21 cells at day 5 and day 11 post-infection and RT-PCR was 
performed in triplicate using RoTTV1 spliced area primer (Fig. 2.15.4.4.). These primers only 
detect the spliced transcripts and they can distinguish between the transcripts and virus DNA. 
RoTTV1 transcripts were not detected in day 5 BHK-21 cells and three non-specific bands were 
observed. However, strong RoTTV1 transcripts were detected in 2 of 3 replicates at day 11 (Fig. 




 copies/µl Untransfected fresh cells 
Figure 5.7.1. Experimental design of RoTTV1 propagation.  
Supernatants positive for viral DNA were put onto the fresh BHK-21 cells and the cells 
were incubated for 5 days or 11 days.  
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Figure 5.7.2. RT-PCR of RoTTV1 transcripts detecting the viral propagation. A; BHK-21 cell 
incubated for 5 days. B; BHK-21 incubated with viral DNA containing supernatants for 11 
days. RT-PCR was performed in triplicate from a single RT reaction. RoTTV1 PCR products; 
180bp. RT+; Reverse transcriptase including RT-PCR. RT-; Reverse transcriptase excluding 
RT-PCR. L; DNA ladder. 
 
RoTTV1 transcript was not observed at day 5 (A) but it was observed in 2 of the 3 replicates 






















In most areas of viral research, a cell culture system is highly beneficial for understanding the 
molecular biology of virus and establishing the model system to examine the functions of viral 
proteins and their interactions with the host cells. For human TTV cell culture, various cells were 
used for virus replication such as human peripheral blood mononuclear cells (PBMCs) (Maggi et 
al., 2001; Mariscal et al., 2002; Desai et al., 2005), human hepatocyte cell lines (Desai et al., 
2005), leucocyte cell line (Desai et al., 2005), and 293 TT cells (de Villiers et al., 2011). 
However, the level of virus replication was very low and continuous propagation was not shown 
in these cells. Similar studies were also performed for porcine TTV and 12 cell lines including 
BHK-21 and porcine cell lines were used for attempts to replicate TTSuV2 infection (Huang et 
al., 2012) but virus was not detected in the supernatant of culture fluid of TTSuV2 transfected 
cells. Therefore, cells which produce virus constantly are required for TTV research. For the 
study of virus, various rodent cell lines are available and this is one of the reasons why RoTTV 
represents an attractive model system.  
 
Before the study, all primary cells and cell lines were screened by species specific RoTTV primer 
or pan-TTV primer. TTV is widely distributed in human and animal population, and the reagents 
for the cell culture and porcine cell line have shown contamination with TTV (Kekarainen et al., 
2009; Teixeira et al., 2011), although some porcine cell lines have been confirmed as TTV free 
(Huang et al., 2012). Therefore, wood mice used for the primary cell line, Type I IFN receptor 
KO MEF, and BHK-21 cells were screened before the experiment and we found they were free of 
RoTTV.  
 
In this study, three cell types were used for RoTTV infection and these cells have some potential 
advantages and disadvantage for RoTTV replication. The primary cells such as bone marrow 
derived macrophage or stem cell were used for cell culture. In chapter III, we found that more 
than 90% of wood mice had RoTTV1 or RoTTV2 and wood mice were indicated as a natural 
host of RoTTV. Furthermore, in chapter IV, RoTTV RNA was detected in bone marrow and it 
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was concluded that bone marrow was main replication site of RoTTV. Based on these results, 
bone marrow derived macrophage and stem cell cultures were prepared for the RoTTV1 
infection. RoTTV replication was not observed in these primary cell lines but it could be related 
to the agents used for RoTTV infection. Faecal supernatant was used for the infection but the 
viral copy number of faecal supernatant was low (virus was only detectable until 10
2
 dilution by 
PCR) and also a longer incubation period might be required for RoTTV infection. In addition, 
wood mice stem cell culture had almost all factors for RoTTV infection such as natural host 
derived cell culture and target cells for infection, but the primary cells showed low transfection 
efficiency and the viral replication was not observed. However, it is possible that if the 
supernatant of culture fluid of RoTTV1 infected BHK-21 (section 5.7) was used for infection of 
these primary cells, and the virus might replicate in these cells.   
 
The next candidate was Type I IFN receptor KO MEF cells. After primary cell culture 
experiment, the cell lines which have shown good transfection efficiency were chosen for 
RoTTV replication. Furthermore, this cell line lacks the Type I IFN receptor and is more likely to 
support virus replication. Before the transfection experiments, the liver homogenate of RoTTV 
infected wild wood mouse was used for RoTTV infection. MEF cells incubated with the liver 
homogenate were damaged and detached from the bottom of the tissue culture flask. However, 
RoTTV virus replication was not observed in the cell culture and it was hypothesised that the 
liver homogenate contains strong liver enzymes which damaged the MEF cells.   
 
For the transfection of Type I IFN receptor KO MEF cells, the concatemerised RoTTV genome 
was constructed for the infection. The advantage of the concatemerisation is the vector does not 
disturb RoTTV genome and the continuous complete genome sequence was transfected into the 
cells (Fig. 2.15.7.1.). The concatemerised RoTTV1 and RoTTV2 produced viral transcripts in 
transfected MEF cells. Similarly, transcripts were detected in the various cell lines used in human 
and porcine TTV studies (Okamoto et al., 2000; Kamahora et al., 2000; Kamada et al., 2004; Qiu 
et al., 2005; Kakkola et al., 2007; Muller et al., 2008; Kakkola et al., 2009; Huang et al., 2012). 
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This indicated that the promoter of RoTTV worked correctly and was making the transcripts for 
protein synthesis. However, the secreted RoTTV1 in the supernatant of culture fluid of RoTTV1 
MEF cell decreased by day 10 and RoTTV2 did not show any replication of virus in supernatant. 
In chapter III, RoTTV infection was not observed in Mus musculus in wild rodents which may 
indicte that the cells of Mus musculus may lack the function to reproduce RoTTV continuously.  
 
BHK-21 cells were the most successful cell line for RoTTV replication in this study and have 
several advantages. Firstly the transfection efficiency of BHK-21 cell was high (more than 80-
90%) and almost all cells gained the concatemerised RoTTV1 genomes. Secondly, BHK-21 cell 
are not Mus musculus cell lines. Thirdly, BHK-21 cells are known to be widely permissive to the 
replication of several viral species (Martin et al., 2010; Huang et al., 2011; Park et al., 2013). 
RoTTV1 concatermerised DNA transfected BHK-21 cells still reproduced the high copy number 
of RoTTV1 even after 5 passages and the replication was continued at the end of the experiment. 
Human TTV replication by using human cell line was observed but the copy number was low 
(Chang liver cell; 2.2 x 10
2
 genome equivalents/ml) (Desai et al., 2005). Furthermore, another 
problem of TTV cell culture study is the difficulty in achieving continuous replication. It was 
reported that PHA stimulated PBMCs showed 3.6 x10
4
 genome equivalents/ml once but the virus 
titer dropped down immediately (Desai et al., 2005). In this study, RoTTV1 replicated 
continuously and it is indicated that BHK-21 cells is the best cell line to support RoTTV1 
replication.  
 
RoTTV1 replicated in Type I IFN receptor KO MEF and BHK-21 cell but RoTTV2 replication 
was not observed. This species difference was also observed in human and porcine TTV 
infection. The various genotypes of human TTV were transfected into Hodgkin's lymphoma and 
virus replication was found only in TTV-HD types (de Villiers et al., 2011). Also, the 
concatemerised TTSuV1 and TTSuV2 genomes were inoculated to into piglets and only TTSuV2 
showed replication. It is suggested that the promoter/enhance activity of the different TTV 
genotypes was variable depending on the types of cells and the different genotypes may have 
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different transcriptional regulation activity in TTVs (Kamada et al., 2004). Therefore, the 
different species of RoTTV may show different host cell tropism.  
 
Also, RoTTV1 may infect the new host more easily than RoTTV2. In chapter III, RoTTV1 
showed higher genetic diversity than RoTTV2 and RoTTV1 complete genomes were isolated 
from wood mice, field voles and bank voles.  
 
RoTTV1 replicating BHK-21 cells did not show CPE. CPE related to TTV infection was reported 
in Chang liver cells and the focal accumulations of dense and rounded cells were observed (Desai 
et al., 2005). TTV is widely distributed in human and animal population and it is believed that 
TTV does not have any strong pathogenicity. Also, to establish persistent infection, RoTTV 
cannot destroy every host cell. It is known that viruses apply two common mechanisms to 
achieve and maintain a persistent infection; (1) evasion of host immune response (Mathur et al., 
1986) and (2) change of virus replication and transcription style which reproduces incompetent or 
defective virus unable to lyse the host cells (Huang and Baltimore, 1970; Brinton et al., 1982; 
Poidinger et al., 1991; Meyer and Southern,1997). The later mechanism was observed in the 
various viruses such as Sendai virus (Chandrika et al., 1995), Sindbis virus (Weiss et al., 1983), 
Semliki Forest virus (Atkinson et al., 1986; Barrett & Dimmock, 1984), and vesicular stomatitis 
virus (VSV) and rabies virus (Cave et al., 1985; Holland et al., 1976) and a recent TTV study 
also suggested that TTV may use the similar mechanism. TTVs transfected 293TT cells 
reproduced the subviral molecule of TTV (µTTV) (de Villiers et al., 2011). Also, TTVs 
intragenomic rearrangement was suggested by the same group and plant viruses of the 
Geminiviridae showed the similar subviral genomes (Leppik et al., 2007). TTV may establish the 
persistent infection by using these subviral molecules. TTVs are thought to infect 90% of healthy 
individuals and established the persistent infection in the hosts. TTVs may use the non-
pathogenic method for the replication.  
 
BHK-21 cells showed a huge difference of virus replication between young and old passaged 
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cells. TTV replicated rapidly in young passage and the copy number was higher than that of old 
passage of BHK-21 cells. Old passage cells are believed to divide slowly and eventually arrest 
cell division (Campisi and d'Adda di Fagagna, 2007). It is predicted that TTVs use the host cell 
replication mechanism and TTV would infect the highly replicating cells. Accordingly, when the 
host cells stop cell division, TTVs would also stop replication. It was confirmed that TTV 
replication was completely blocked by aphidicolin (an inhibitor of eukaryotic nuclear replication) 
treatment of 293 T cells. There are two hypotheses for the end of cell line division; anti-tumour 
and anti-cancer suppressive mechanisms function or loss of regenerative capacity (Campisi and 
d'Adda di Fagagna, 2007). These cellular changes such as the aging or alternation of gene 
expression would hamper the virus replication and young BHK-21 cell actively replicated and 
supported the virus replication. However, the replication speed of old and young BHK21 cells 
looked to be similar in this study. BHK-21 was originally developed from polyoma virus 
transformed hamster kidney cells in 1962 (Macpherson and Stoker. 1962) and is highly 
susceptible for the various virus species (Stoker and Macpherson. 1964). Furthermore, BHK-21 
cells showed the high growth rate and are used in various studies including herpesvirus study in 
our lab (Geere et al., 2006) indicating that the stocks available are likely to be highly passaged 
cells. Accordingly, it is difficult to identify BHK-21 cells quality in this study. Old BHK-21 cells 
would be exposed to trypsin and other environmental factors more often than young BHK-21 
cells, but it was considered that these stimulations and agings in tens of passages would not show 
a huge difference of virus replication. Further study is required to understand RoTTV-1 
replication in vitro.         
 
Some viruses such as Simian Human Immuno Deficiency virus (SHIV) and West Nile Virus 
(WNV) increased the virus replication after about 20 passages and it was indicated that these 
viruses took time to adapt the cell culture (Ciota et al., 2012; Kwofie and Miura. 2013). On the 
contrary, RoTTV1 increased constantly and it was indicated that RoTTV1 does not need further 
adaptation for replication in BHK-21 cells.  
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In this study, the supernatants of RoTTV1 transfected BHK-21 cells were infectious and 
RoTTV1 in the supernatant propagated infection to the fresh BHK-21 cells resulting in detectable 
loads of viral RNA being produced. The primers for the RT-PCR were designed to cover the 
splicing site of RoTTV1 and only amplified RoTTV1 cDNA would create the correct size of 
band (Fig.5.7.2.). For TTV study, TTVs propagation is a major difficulty and human TTVs and 
porcine TTVs have not been propagated into intact cells. Accordingly, it was first success to 
demonstrate TTV propagation in vitro study.  
 
Recently, a study investigating TTV replication and propagation was published and the paper 
showed the subviral molecules in TTV genome transfected 293TT cells (de Villiers et al., 2011). 
However, we question two claims of this study; the constant viral replication and viral 
propagation. In the study, the cells transfected with TTV genomes reproduced subviral molecules 
of TTV (µTTV) but the number produced decreased soon after the transfection. This indicated 
that 293TT cells temporarily reproduced the virus but could not sustain continuous replication. 
Also, the subviral molecules were transfected into 293TT cells to produce other subviral 
molecules, and this was defined as viral propagation in the paper. However, if it is propagation, 
the viruses in the supernatant or frozen transfected cells would have to infect fresh cells as we 
have. We believed that in the present study, we have shown that RoTTV1 actually replicated in 
BHK-21 cells and have shown true virus propagation by using the virus containing supernatant of 
culture fluid to infect fresh cells. For the future study, RoTTV should be analysed by using 
electron microscopy (EM) to confirm the virus replication.  
 
In conclusion, RoTTV1 replicated in BHK-21 cells and the replicated virus can be propagated 
into fresh uninfected cells. This culture supernatant will be used in in vivo studies (chapter VI). 
Also, these experiments demonstrate a suitable cell culture system providing tools for exploring 
the virus-cell interaction and molecular and biochemical mechanism of TTV infection. 
 






CHAPTER VI. IN VIVO EXPERIMENTS OF TTV INFECTION IN WOOD 
MICE AND TYPE I IFN RECEPTOR KO MICE 
 
Only a few papers have reported in vivo infection studies. One such study reported that 
concatemerised TTV complete genomes replicated in one month old piglets. The rodent TTV 
infectious experiment was planned based on the protocol of this paper. Following our 
demonstration that RoTTV1 can be isolated from BHK-21 cells, this virus was inoculated 
into wood mice. 
 
  
     6.1. Background to the study 
     6.2. TTV infection using concatemerised genome in wood mice/Type I IFN KO mice 
     6.3. TTV infection using cell culture supernatant in wood mouse 
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6.1. Background to the study 
As there is no established TTV cell culture system, very few studies on TTV infection in vivo 
have been reported. The majority of published studies used TTV infected samples such as the 
serum of human TTV1a infected patient (Tawara et al. 2000), TTSuV1 containing porcine serum 
(Krakowka and Ellis. 2008), and TTSuV2 containing liver homogenate (Mei et al., 2011) as the 
infectious agent and the pathological findings from these studies may show the pathological 
character of other pathogens present in the inoculum. Therefore, the virus isolation in a cell 
culture system or by other methods is needed in order to study TTV infection in vivo.  
 
Recently, an in vivo porcine TTV study was performed by using the concatemerised TTSuV2 
complete genome (Huang et al., 2012). In these experiments, the concatemerised TTSuV2 DNA 
was directly inoculated into the lymph node or muscle of 40 days old piglets and virus replication 
was observed and viral copy number is increased continuously (Huang et al., 2012).     
 
In this chapter, in vivo RoTTV1 infection experiments were performed by two methods; in vivo 
transfection of RoTTV1 concatemerised DNA and infection with cultured RoTTV1 virus in 
BHK-21 cell culture supernatant. As shown by the results in chapter IV, the lung was concluded 
as a site of RoTTV1 replication and these infectious reagents were inoculated intranasally.  
 
 6.2. TTV infection using concatemerised genome in wood mice/Type I IFN receptor KO 
mice 
Based on the previous TTSuV2 study (Huang et al., 2012), an infectious experiment was 
performed and we applied two points from this paper; 1) young animals were used for the 
infection, and 2) concatemerised DNA was inoculated. In addition, two points were added to this 
study; 3) as we have confirmed that the lung is a replication site of RoTTV1, the infectious agent 
was inoculated intranasally, and 4) to facilitate the in vivo transfection, the transfection agent, 
polyethylenimine (PEI) was used.  
 




Initial results/In vivo transfection of wood mice colony 
The wood mice were confirmed as RoTTV negative by using PCR before the study. 
Concatemerised RoTTV1 genome was constructed as described in section 5.2.5. and 1 µg of 
RoTTV1 concatemerised DNA and 0.1M PEI reagent were mixed in a 1.5 ml microcentrifuge 
tube (microtube) as described in section 2.16. The mixture was incubated for 15-20 minutes at 
room temperature and then inoculated intranasally into 4 female wood mice aged 23-70 days 
(Table 6.2.1.). One month post-infection, lung, liver, spleen, kidney, intestine, and bone marrow 
were removed and PCR was performed using DNA from lung, liver and spleen, and RoTTV1 















Figure 6.2.1. Screening of in vivo transfected wood mice by PCR using RoTTV1 species specific 
primer.  
 
P: positive control, N: negative control, M: wood mouse 
Lane1: lung, Lane2: liver, Lane3: spleen.  
 
All transfected mice showed RoTTV1 DNA remaining in the lung and RoTTV1 DNA was also 






Mo1.1    N Mo1.2 N Mo1.3 Mo1.4 P 
1       2      3 1      2      3 1      2      3 1      2      3 
N 
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RoTTV1 DNA was detectable in all 4 mice and TTV DNA was present in spleen or/and liver in 3 
mice. DNA inoculated intraperitoneally was usually cleared from the mice within one month 
(data not shown) the result suggested that PEI functioned for in vivo transfection and RoTTV1 
concatemerised DNA spread to the various tissues. However, RNA was not detectable in these 
tissues.  
 
The virus copy number in the various tissues was measured by using qPCR and the results are 
shown in Fig. 6.2.2. In all animals, the lung showed the highest DNA copy number of RoTTV1, 
Mouse 1.4 had 1.74 x 10
6
 copies/µg in the lung and a high copy number was also observed 4 x 
10
3
 copies/µg in liver DNA. However, this mouse showed a high virus copy number only in the 
lung and liver and the viral copy number was low in other tissues. Conversely, mouse 1.2 showed 
a relatively low copy number in lung compared to that of mouse 1.4, but viral DNA level was 
high in spleen, kidney, and intestine indicating that even in the same species and age, wood mice 
showed different viral DNA distribution in each tissue.  
 
Due to the limitation of the mice, there were no mice used for the negative control and this was 
the pilot study.   
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Second experiments/in vivo transfection of wood mice colony 
A second experiment was also performed by using two groups with longer infection periods. Four 
females and four males aged 45-49 days (Table 6.2.2) were infected intranasally with 1µg of 
RoTTV1 concatemerised DNA. For each of the 2 time points (1 and 2 months post-infection), 
four mice were infected. The results of the second experiment are shown in Table 6.2.2. The lung, 
liver, spleen, kidney, intestine, and bone marrow were removed from four mice (Mo1.7-Mo1.10) 
and PCR was performed using DNA extracted from lung, liver, and spleen, and RoTTV1 species 
specific primers. One month post-infection, lungs (except for Mo 1.9) were negative for RoTTV 
DNA suggesting that the input concatermerised DNA was cleared. At two month post-infection, 
the lung from all four mice (Mo1.11-Mo1.14) showed RoTTV1 DNA. Although TTV DNA was 
detectable in lung of these mice, systemic viral DNA distribution and RoTTV1 RNA was not 






   
  
Table 6.2.2. Second experiment of RoTTV1 in vivo transfection. * Mice identification number 
and there were two groups used for the infection; Mo1.7-1.10 for one month post-infection and 
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In vivo transfection of Type I IFN KO mice 
An in vivo experiment was also performed using Type I IFN receptor KO mice. Although lab 
mice were Mus musculus (which is not natural host of RoTTV), these mice are Type I IFN 
receptor deficient and RoTTV1 may be more likely to infect them. The experimental protocol 
was the same as that used for wood mouse infection and 1µg of concatemerised RoTTV1 DNA 
and PEI complex was intranasally inoculated into 3 male Type I receptor KO mice aged 30 days. 
At one month post-infection, the lung, liver, spleen, kidney, intestine and bone marrow were 
removed from these lab mice and PCR was carried out using DNA extracted from lung, liver, and 
spleen, and RoTTV1 species specific primers. The PCR result is shown in Fig. 6.2.3. RoTTV1 
DNA was detected in the lungs of all mice and in the spleen of mouse 1. However, RoTTV1 




Figure 6.2.3. Screening PCR of Type I IFN receptor KO mice inoculated RoTTV1 concatemerised 
DNA.  
N: negative control, IFN-KO: Type I IFN receptor KO mouse 
Lane1: lung, Lane2: liver, Lane3: spleen 
 




1    2    3 1    2    3 1    2    3 
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6.3. TTV infection using cell culture supernatant in wood mouse 
Experimental protocol 
Section 6.2 showed RoTTV1 DNA was detectable at two month post-infection but RoTTV1 
RNA and robust RoTTV1 infection was not observed using in vivo transfection of the 
concatemerised DNA. In chapter V, RoTTV1 was propagated in BHK-21 cells, therefore this 
virus was used to infect mice. Female wood mice aged 80-90 days were infected intranasally 
with 10
5 
copies of generated virus. For each of 3 time points (2 weeks, 4 weeks and more) four 
mice were infected. As the negative control, fresh Glasgow Minimum Essential Medium 
(Invitrogen) was also inoculated intranasally into two female mice aged 80-90 days old per time 
point.  
 
DNA was extracted from the lung and spleen from 4 infected and 2 negative control wood mice 
two weeks post-infection and PCR was performed by using RoTTV1 species specific primers. 
RoTTV1 was not observed in lung and spleen from four infected mice and RNA was also 
negative by RT-PCR. The same result was also observed in the wood mice 4 weeks post-













Experimental design based primarily on TTSuV paper  
The in vivo experiment was designed based on a published study of TTSuV2 infection (Huang et 
al., 2012). Concatemerised and single copies of TTSuV2 DNA were directly injected into lymph 
node and muscle of 40 days old piglets and TTSuV2 replication was observed.  
 
Age 
As the previous study used young piglets (Huang et al., 2012), young wood mice were used for 
RoTTV1 infection in this study. Young individuals have relatively less developed immunity and 
are growing rapidly and therefore likely to have more actively replicating cells. TTV is predicted 
to use the host cellular replication machinery and infect the highly replicating cells (Kakkola et 
al., 2007). RoTTV1 is more likely to infect these young and actively replicating cells. One year 
old mice were used for in vivo infection in a pilot study but no virus DNA was detectable in the 
study (Data not shown). Therefore, the young mice used in present study were hoped to be 
suitable for experimental RoTTV1 infections.  However, it is possible that infection of even 
younger mice may be neccessory for the robust virus replication.  
 
Concatemerised DNA/cultured virus  
Contatemerised DNA was also used in chapter V for in vitro study. The advantage of the 
dimerised genomes is that a continuous complete genome sequence from any given point is 
present and uninterrupted by vector sequence (Fig. 2.15.7.1.). In the previous study of TTSuV2 
(Huang et al., 2012), cocatermerised TTSuV2 DNA and single copies of TTSuV2 DNA were 
injected into the piglets. Accordingly, concatemreised RoTTV1 DNA was also used for in vivo 
transfection.  
 
In chapter V, cultured viruses were generated from BHK-21 cells and the viruses containing 
culture supernatant use to infect fresh BHK-21 in vitro. Therefore, culture supernatant was also 
used for the inoculation to more accurately mimic natural infection.  
 




Due to the small size of Apodemus sylvaticus, the infectious agent cannot be easily injected 
directly into the lymph nodes. Also, we have seen RNA in lung tissues frequently (section 4.2) 
and it was predicted that lung tissue is one of the important replication sites for RoTTV1. Thus, 
infectious agents were inoculated into wood mice and IFN receptor KO mice intranasally.   
 
Naked DNA injection has sometimes been used for virus infection such as murine hepatitis B 
virus and hepatitis delta virus (Chang et al., 2001; Chang et al., 2003). In addition to that, in the 
present study, PEI transfection reagent was used for in vivo transfection. PEI is used frequently 
for in vivo and in vitro transfection and it has been used to successfully deliver DNA efficiently in 
a number of systems (Behnam et al., 2013; Huang et al., 2013). PEI would support penetration of 
the cell membrane by viral DNA and increase the chance for the successful transfection.  
 
Initial experiment result 
In this study, RoTTV-1 DNA was detectable even one month post-infection and it is indicated 
that PEI successfully functioned as an in vivo transfection reagent in present study. However, no 
RNA was observed in these tissues.  
 
RoTTV1 distributions were different among the individuals, and mouse 4 showed high viral copy 
number in the lung and liver only, but RoTTV1 DNA was detectable in various tissues in mouse 
1.2. Human TTV DNA has been detected in all tissues and serum (Reviewed by Hino and 
Miyata., 2007) and it is predicted that, if replicating, RoTTV1 DNA would also be observed in 
the various tissues.  
 
There are several interpretations of this experiment, especially because of the lack of RNA 
detection in virus DNA positive tissues. RoTTV1 replication might be low level and not to 
sufficient detect RNA. Therefore, a longer experimental time may be required to produce the 
detectable RNA. This is also discussed in the second experiment. Also, the main replication site 
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may be in tissues and other than those that we screened for RNA detection.  
 
Based on a previous study of plasmid persistence following in vivo transfection, the level of DNA 
shown in this initial experiment was high and these DNA were unlikely to be due to the 
remaining redistributed input DNA (Dr. Gerry McLachlan, personal communication). Therefore, 
we need to confirm the viral replication by using 2 methods, DNase I treatment and vector 
specific qPCR. DNase I digests only the double-stranded DNA, and input plasmid DNA and 
replicated TTV would be distinguishable by using this enzyme. Furthermore, qPCR could be use 
to compare total TTV DNA copy number and input plasmid copy number by using TTV and 
vector sequence primers and probes. In future work, this will have to be investigated to confirm 
the virus replication. 
  
Second experiment      
In the second study, it was expected that the first experiment would be confirmed but the in vivo 
transfection did not appear to be as efficient compared to initial experiment. The transfection 
reagent and concatemerised DNA were older and may be less efficient, but these reagents are 
known to be stable materials. Another possible reason is that the wood mice (Apodemus 
sylvaticus) are sensitive to anesthesia and there were problems with anesthesia in the second 
experiment. Wood mice are not widely used as experimental animals and more work may be 
required to optimize anaesthesia conditions. Because of these problems, it is possible that the 
amount of DNA delivered into the animals in the second experiment was too low. This low 
amount of RoTTV1 DNA load would hamper establishment of the virus infection and it may take 
a much longer to establish the detectable infection or host immune system could eradicate the 
virus. It is not clear why the efficiency of PEI transfection decreased in second infection and 
further study is needed to establish a robust procedure for transfection of TTV DNA into wood 
mice. 
 
RoTTV1 concatemerised DNA was cleared from 3 mice one month post-transfection but 
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RoTTV1 DNA was detected from all 4 mice two months post-transfection. We hypothesise that 
RoTTV1 replicates slowly and therefore it is difficult to detect RoTTV RNA in early phase of 
infection. It has also been suggested that human TTV replicates slowly (Okamoto et al., 1999; 
Biagini et al., 1999; Khudyakov et al., 2000). Active mutation occurs in fast replicating viruses 
and highly replicating viruses tend to show the high genetic diversity (section 1.2.), but TTV 
might take long time to achieve their high genetic diversity (Biagini et al., 1999; Khudyakov et 
al., 2000).  
 
A second hypothesis is that RoTTV-1 primary infection may occur preferentially in females. In 
this study, all RoTTV1 DNA positive mice from the 2 in vivo transfection experiments were 
female except 1male wood mouse and 3 male Type I IFN receptor KO mice. It may indicate that 
female individuals are more susceptible to TTV than males. However, there is no report that TTV 
prevalence or susceptibility of female individuals is higher than those of males and further 
experiments in the current system would be required to demonstrate a correlation.    
 
We also hypothesized that TTV would infect Type I IFN receptor KO mice and RoTTV1 DNA 
was detectable in lung and spleen one month post infection. However, further studies are required 
to determine if RoTTV1 infection can be established in Type I IFN receptor KO mice. Type I IFN 
receptor KO mice are Mus musculus and in chapter III, RoTTV infection was not observed only 
in Mus musculus. In chapter V, Type I IFN receptor KO MEF cells did not support the continuous 
replication of RoTTV1 and it may indicate that the cells of Mus musculus may lack the function 
to reproduce RoTTV.  
  
In addition to the other possibilities, the wood/lab mice used in this study might not be young 
enough for RoTTV infection. Young animals show the high replication (discussed above) and 
have not developed their robust immune system. Also, human TTV is also predicted to infect the 
hosts in early stage of life (Ninomiya et al., 2008). Accordingly, it is predicted that younger 
individuals are more likely to become infected with RoTTV. In this study, 30 days-old wood/lab 
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mice were used for the infection. In the lab, mice were weaned at 30 days of age and 30 days 
piglets were used for the previous pig in vivo experiment (Huang et al., 2012). However, to 
compare the life span of pigs and mice, 30 days old mice are relatively much older than those of 
pigs. Therefore, younger mice might be required for RoTTV1 infection. 
 
In chapter V, RoTTV1 replication was observed in BHK-21 cells and RoTTV1 in culture 
supernatant was inoculated into the wood mice. However, virus replication was not found in 
these wood mice. Wood mice have been found to have stronger immune responses including a 
stronger interferon response and natural killer (NK) cell activity than lab mice in Central 
European encephalitis(CEE) virus and parasite infection models (Kopecky et al., 1991; Francois 
et al., 2010; Jackson et al., 2009) (section 3.8.1.). Despite these robust immune responses, a high 
infectious prevalence of RoTTV in wood mice is seen. This may indicate that intranasal infection 
might not be a suitable infectious route for RoTTV1. Similar difficulty of virus infection was also 
observed in murine gammaherpesvirus-68 (MHV-68). For human gamma herpes virus such as 
EBV and KSHV, virus transmission routes have been suggested including horizontal transmission 
by saliva (Niederman et al., 1976; Hadinoto et al., 2009), vertical transmission by uterine cervix 
(Sixbey et al., 1986; Silver et al., 2011), and sexual transmission by male genital tract (Israele et 
al., 1991; Naher et al., 1992). However, for MHV-68 infection, the main infectious route is still 
not known (Francois et al., 2013). Horizontal transmission of MHV-68 has been studied for 30 
years but transmission under laboratory conditions has not been observed (Barton et al., 2011). 
However, recently, one paper showed the sexual transmission in lab mice (Francois et al., 2013). 
Two hypotheses have been suggested to explain the results. Firstly, mice cannot perform the 
physiological behaviors such as scent-marking and male fighting in conventional animal caging. 
Secondly, MHV-68 life cycle has been well-studied but unexplored infectious routes such as the 
sexual transmission could influence of the results (Francois et al., 2013). Therefore, future and 
ongoing studies may have to consider the other infectious routes, virus copy number, and 
physiology of wood mice for RoTTV1 infection. 
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In conclusion, RoTTV1 was inoculated intranasally by using two agents, in vivo transfection and 
isolated RoTTV1 infection. In in vivo transfection, potential production of RoTTV1 DNA was 
observed in wood mice but more work is required to establish a robust infection protocol for 
RoTTV1. Also, new experimental design including physiological knowledge of wood mice and 
new infectious routes may be needed for the inoculation of isolated viruses. Further study has to 
beperformed.   
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The objective of the current study was to investigate the possibility of rodent TTV as a human 
TTV animal model. Rodent TTV (RoTTV) was found in wild wood mice by using RCA in our 
laboratory and RoTTV represents a powerful tool for the study of characterisation of virus nature, 
transcripts profile identification, protein identification, cell culture system and pathogenesis in 
vivo.  
 
Characterisation of rodent torque teno virus in wild rodent population 
At the start of study, RoTTV was characterised by using the wild rodent samples. It was revealed 
that RoTTV genomic structure was similar to that of human and other animal anelloviruses. TTV 
is a small single-stranded DNA virus and the genome size is 2.2kb in RoTTV-1 and 2.5kb in 
RoTTV-2. RoTTV is smaller than human TTMV which is the smallest size of human anellovirus, 
but the genomic structures are similar to those of human and other animal anellovirses. The UTR 
which is  relatively conserved in all anellovirus genomes was also observed in RoTTV-1 and 
RoTTV-2 and RoTTV ORF2 was located upstream of ORF1 as in other anelloviruses.        
 
RoTTV showed a high infectious prevalence in the wild rodent population, especially in wood 
mice (Apodemus sylvaticus) but was absent from Mus musculus. Furthermore, 2 virus species 
containing multiple genotypes were found in RoTTV and the different genotypes of viruses were 
often present in a single individual. This high infectious prevalence and the multiple infection in 
single individuals are both characteristic of human TTV infection (Bendinelli et al.,2001; Moen 
et al.,2002; Maggi et al.,2005; Biagini et al.,2006a; Biagini et al.,2006b; Ninomiya et al.,2008, 
Maggie and Bendinelli. 2010).  
 
The genomic structure, genomic diversity and high infectious prevalence of RoTTV are similar to 
human and other animal anelloviruses and this suggests that RoTTV could be an ideal animal 
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Transcript identification and protein expression of rodent torque teno virus  
The transcriptional profile of anelloviruses has only been studied for human and porcine TTVs 
(TTSuV) (Martinez-Guino et al., 2011). It is important to understand the transcriptional profile 
and protein function for the study of pathogenesis of TTVs and other anellovirus. In this study, 2 
transcripts coding 4 predicted proteins and 5 transcripts coding 9 predicted proteins were 
observed from RoTTV-1 and RoTTV-2, respectively. Based on the transcriptional profile of 
RoTTV-1, protein expression was performed in BHK-21 cells and ORF2, ORF2-3, ORF1-4 
showed the different expression pattern in BHK-21 cells and these proteins were detected by 
western blot. However, full length ORF1 was not detected by western blot although ORF1 
showed the distinctive pattern of protein expression in BHK-21 cells. Similar difficulties in 
detection of human and porcine TTV ORF1 proteins were reported (Qiu et al., 2005; Martinez-
Guino et al., 2011). However, one human TTV report succeeded in detection of full length ORF1 
protein and it was concluded that the use of different plasmids and/or protein tags may allow the 
detection of ORF1 by western blot (Muller et al., 2008). Therefore, RoTTV-1 ORF1 protein 
expressed by different plasmids might be detected by western blot.  
 
RoTTV-1 ORF2 and ORF2-3 showed similar lower bands and these smaller bands were 
predicted to be the result of RNA splicing or cleavage after translation. Accordingly, RT-PCR 
should be carried out by using RNA extracted from ORF2 and ORF2-3 transfected BHK-21 cells 
to confirm RNA splicing. No predicted cleavage/splicing could not been found in these proteins. 
The products that were seen in the present study would have to be protein-sequenced to identify 
the protein and confirm whether the lower bands from ORF2 and ORF2-3 are identical or not. 
Further study is required to understand the function of these proteins to study their role in the 
pathogenesis of RoTTV.  
 
Torque teno virus replication in vitro 
The lack of a good system for in vitro TTV replication has been a major problem for research in 
the field. In the wild, RoTTV is presented in a relatively wide variety of rodent species and the 
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several cell cultures were prepared for RoTTV replication. In this study, RoTTV-1 showed 
continuous and stable replication in BHK-21 cells and it is the first time a robust anellovirus cell 
culture system has been described. For future studies, characterising the replicated virus may be 
required. In a recent study, TTV transfected 293TT cells reproduced subviral molecules of TTV 
(µTTV) and their genome sizes were smaller than the original genome of human TTV (de Villiers 
et al., 2011). In human studies, intragenomic rearrangements of TTV have also been reported 
(Leppik et al., 2007) and RoTTV also can be sequenced in each time point to compare the 
mutation rate and genomic structure. This result would be the starting point to understand of the 
virus-cell interaction and molecular and biochemical mechanism of TTV infection.  
 
Furthermore, RoTTV-1 replicated efficiently in young passage BHK-21 cells compared to old 
BHK-21 cells. Future studies will require strict conditions to study the virus replication including 
the same batch of cells and long term experiments to show the clear difference between old and 
young BHK-21 cells.  
 
TTV virus propagation was observed in BHK-21 cell culture. RoTTV-1 RNA was detected in the 
fresh BHK-21 cells cultured by using RoTTV-1 containing culture supernatant. This is also the 
first time anellovirus propagation in vitro has been clearly demonstrated. For firther confirmation 
of virus replication, electron microscopy would be used for finding RoTTV.   
 
In vivo experiment of Torque teno virus infection in wood mice and type I IFN KO mice 
In the present study, in vivo transfection of concatemerised DNA was used as a potential 
infectious method. Although RoTTV-1 DNA was cleared one month post-transfection in some 
cases, detectable RoTTV-1 was observed at two months post-infection. In a previous study 
TTSuV2 concatemerised DNA was directly injected into the lymph node and muscle and the 
virus replication was observed. In the present study, we can suggest a new approach which is 
more likely to deliver TTV genomic material into the host cells by using PEI transfection reagent.   
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For the future study, RoTTV-1 RNA and systemic infection are needed to show the robust 
infection. For the in vivo transfection, we believe that further experiments with longer infection 
period may be needed to detect robust virus replication.  
 
An infection experiment was also performed by using the supernatant of culture fluid. The 
culture fluid was inoculated intranasally but no replication was observed. TTVs are predicted to 
use the faecal-oral route for the transmission and RoTTV-1 RNA was detected in the lung and 
bone marrow. Accordingly, it was presumed that the intranasal infection would be the best way to 
apply the virus to the lung and gastrointestinal tract. However, sometimes, the virus infection 
requires the complex mechanism like murine gamma herpes virus (Barton et al., 2011) and 
RoTTV-1 infection may be achieved depending on the behavior of rodents such as scant-marking 
and male fighting. This can also explain why wood mice showed the high infectious prevalence 
compared to the other rodent species such as field voles and bank voles. Further study is required 
to understand the natural infection of RoTTV in wild rodents.  
 
In conclusion, we characterised RoTTV; virus epidemiology in wild rodent species, genetic 
diversity, RNA localisation, transcriptional profile, protein expression in vitro, and protein 
localisation in the cultured cells in this study. Also, a robust cell culture system was established 
for the continuous replication of RoTTV-1. Finally, as a new approach of TTV infectious 
experiment, PEI in vivo transfection could be suggested for in vivo study of RoTTV. This basic 
knowledge of RoTTV would provide a starting point for future experiments and it is predicted 
that TTV pathogenesis, host-virus interaction, and immunology can be studied by using the 
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